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Formålet	  med	  dette	  ph.d.-­‐projekt	  var	  at	  konstruere,	  afprøve	  og	  anvende	  en	  intracellulært,	  
vækst-­‐uafhængig	  og	  direkte	  kvantificerbar	  glykolytisk	  flux	  biosensor	  i	  E.	  coli.	  
Kendskab	   til	   det	   metabolske	   flux	   i	   bakterieceller	   er	   af	   stigende	   betydning,	   da	   det	   er	  
afgørende	   for	   den	   bakterielle	   fysiologi.	   Endvidere,	   vil	   viden	   om	   det	   glykolytiske	   flux	   kunne	  
forbedre	  in	  silico	  modellering	  og	  metabolic	  engineering.	  
Den	   udviklede	   biosensor	   er	   baseret	   på	   transkriptionsfaktoren	   Cra	   og	   forbinder	   det	  
metaboliske	   flux	   til	   ekspressionen	   af	   grønt	   fluorescerende	   protein	   (GFP).	   Det	   dynamiske	  
område	   af	   den	   konstrueret	   biosensor	   dækker	   alle	   de	   glycolytiske	   flux	   der	   kan	   fremkaldes	   af	  
forskellige	   kulstofkilder.	   Derudover	   er	   det	   også	   vist,	   at	   den	   er	   i	   stand	   til	   at	   monitorere	   en	  
yderligere	  flux	  stigning.	  
Sensoren	  blev	  anvendt	  til	  at	  studere	  flux-­‐ændring	  som	  følge	  af	  gen-­‐knockouts	   i	  E.	  coli	  på	  
enkelt-­‐celle	  niveau.	  Dette	  var	  muligt	  ved	  hjælp	  af	  et	  paralleliseret	  high-­‐throughput	  assay.	  Efter	  
vækst	   i	   flere	   generationer	   i	   næringsrige-­‐	   og	   minimale	   medier,	   kunne	   2126	   gen-­‐knockouts,	  
primært	  uden	  for	  kernen	  stofskifte	  processer,	  screenes.	   	  3	  gen-­‐knockouts	  med	  en	  høj	   flux	  og	  
158	  med	  en	   lav	  flux	  fænotype	  blev	  fundet,	  disse	  omfatter	  mange	  flageller	  og	  fag-­‐gener	  samt	  
mange	  hidtil	  ukarakteriserede	  proteiner.	  
Den	  udviklede	  glycolytiske	  flux	  biosensor	  tilbyder	  et	  værktøj	  til	  at	  screene	  for	  metaboliske	  
flux	   ændringer	   på	   en	   effektiv,	   hurtig	   og	   parallelisebar	   måde.	   Anvendelsen	   af	   nye	  
screeningstilgange	   kan	   forbedre	   vores	   forståelse	   af	  mikrobiel	   fysiologi	   og	   kan	   benyttes	   til	   at	  
forbedre	  mikrobielle	  cellefabrikker.	  
	   	  
	  V	  
	  





The	   aim	   of	   this	   PhD	   project	   was	   to	   construct,	   test	   and	   apply	   an	   intracellular,	   growth-­‐
independent	  and	  direct	  measureable	  glycolytic	  flux	  biosensor	  in	  E.	  coli.	  	  
Studying	  the	  metabolic	  flux	  of	  bacterial	  cells	  is	  of	  growing	  interest	  as	  it	   is	  of	  fundamental	  
importance	  to	  bacterial	  physiology	  as	  well	  as	  for	  in	  silico	  modeling	  and	  metabolic	  engineering.	  
The	  metabolic	  flux	  contains	   information	  about	  how	  efficiently	  a	  bacterium	  can	  utilize	  a	  given	  
carbon	   source	   and	   in	   which	   extend	   it	   is	   directed	   towards	   the	   different	   central	   metabolic	  
pathways.	   The	   knowledge	   of	   these	   fluxes	   can	   contribute	   to	   the	   development	   of	   efficient	  
production	  pathways	  and	  the	  identification	  of	  possible	  accumulation	  points	  in	  the	  engineered	  
pathway.	  Furthermore	  it	  can	  give	  information	  about	  regulatory	  networks	  within	  the	  cell.	  	  
The	  developed	  biosensor	   is	  based	  on	  the	  transcription	  factor	  Cra	  and	   links	  the	  metabolic	  
flux	   to	   the	   expression	   of	   green	   fluorescent	   protein	   (GFP).	   The	   dynamic	   range	   of	   the	   final	  
biosensor	  construct	  covers	  the	  whole	  range	  of	  natural,	   intracellular	  glycolytic	   fluxes,	   induced	  
by	  different	  carbon	  sources	  and	  it	  could	  also	  be	  shown	  that	  it	  is	  even	  capable	  of	  monitoring	  a	  
further	  flux	  increase.	  
The	  sensor	  was	  applied	  to	  study	  the	  flux-­‐altering	  effects	  of	  gene	  knockouts	  in	  E.	  coli	  at	  the	  
single	  cell	   level	   in	  a	  vastly	  parallelized	  and	  high-­‐throughput	  manner.	  After	  growth	  for	  several	  
generations	   in	   rich	   and	   minimal	   media,	   2126	   gene	   knockouts,	   mainly	   outside	   of	   the	   core	  
metabolism,	   could	   be	   screened.	   3	   gene	   knockouts	  with	   a	   high	   flux	   and	   158	  with	   a	   low	   flux	  
phenotype	  were	  found,	  comprising	  many	  flagella	  and	  phage	  related	  genes	  as	  well	  as	  many	  so	  
far	  uncharacterized	  proteins.	  
Taken	   together,	   the	   glycolytic	   flux	   biosensor	   offers	   a	   tool	   to	   screen	   for	   metabolic	   flux	  
changes	  in	  an	  efficient,	  fast	  and	  parallelizable	  way,	  opening	  up	  for	  novel	  screening	  approaches	  
that	   enhance	   our	   understanding	   of	   microbial	   physiology	   and	   can	   be	   applied	   to	   improve	  
microbial	  cell	  factories.	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Outline	  of	  the	  thesis	  
Chapter	  1	  –	  Introduction	  
The	  introduction	  focuses	  on	  the	  development	  and	  application	  of	  different	  kinds	  of	  biosensors.	  
In	  regards	  of	  the	  subject	  of	  the	  PhD	  thesis,	  there	  is	  an	  emphasis	  on	  transcription	  factor	  based	  
biosensors,	   in	   particular	   the	   catabolite	   activator/repressor	   (Cra),	   and	   their	   application	   in	  
metabolic	  engineering.	  
	  
Chapter	  2	  –	  Biosensor	  development	  
This	   chapter	   presents	   the	   development	   of	   the	   Cra	   based	   glycolytic	   flux	   biosensor,	   which	  
enables	  the	  measurement	  of	  the	  glycolytic	  flux	  in	  single	  cells	  during	  growth.	  
	  
Chapter	  3	  –	  Biosensor	  application	  
This	  chapter	  presents	  the	  application	  study	  of	  the	  Cra	  biosensor.	  It	  is	  showing	  the	  example	  of	  a	  
highly	   parallelized	   screen	   for	   the	   physiological	   effects	   on	   the	   glycolytic	   flux	   for	   all	   possible	  
knockout	  mutants	  in	  the	  E.	  coli	  genome.	  
	  
Chapter	  4	  –	  Conclusion	  and	  future	  perspectives	  
The	  last	  section	  of	  this	  PhD	  thesis	  is	  dedicated	  to	  discuss	  the	  placement	  of	  the	  findings	  of	  this	  
study	  in	  the	  current	  scientific	  field	  and	  a	  further	  outlook.	  
	  
	  






































The	   use	   of	   biological	   systems	   to	   sense	   for	   environmental	   changes,	   desired	   products	   or	  
dangers	   has	   a	   long	   tradition	   in	   human	  history.	  An	  early	   example	   are	   canary	  birds	   that	  were	  
used	  to	  sense	  for	  toxic	  gases	   in	  mines,	  but	  still	   today	  pigs	  are	  used	  to	  search	  for	  truffles	  and	  
snoop	  or	  rescue	  dogs	  to	  find	  landmines,	  drugs	  or	  buried	  humans	  (Slomovic	  et	  al,	  2015).	  In	  all	  
these	  cases,	  humans	  took	  and	  take	  advantage	  of	  traits	  of	  different	  organism,	  to	  detect	  signals	  
they	  cannot	  detect	  with	  their	  own	  senses.	  
	  
Modern	  research	  on	  biosensors	  follows	  a	  similar	  approach	  in	  order	  to	  find	  new	  solutions	  
for	   medical	   and	   environmental	   diagnostics	   (Slomovic	   et	   al,	   2015),	   biotechnological	  
developments	  or	  the	  in	  vivo	  study	  of	  biological	  processes	  that	  were	  not	  measurable	  until	  now.	  
Many	   biosensors	   are	   taking	   advantage	   of	   sensors	   or	   sensing	   principles	   that	   already	   exist	   in	  
nature.	  The	  term	  biosensor	  is	  used	  for	  a	  range	  of	  different	  biological	  sensors,	  including	  whole-­‐
cells,	  proteins	  and	  RNA	  molecules.	  The	  sensors	  are	  then	  further	  adjusted	  to	  fit	  the	  purpose	  and	  
coupled	   to	  a	  detectable	   readout.	   The	   term	  biosensor	   is	   generally	  not	   reserved	   for	   a	   specific	  
tool	  or	   application	  but	   is	   applied	   for	   a	  wide	  and	  diverse	   range	  of	  possible	   sensors,	   readouts	  
and	  applications.	  	  
	  
Even	   though	   this	   study	   will	   focus	   on	   genetically	   encoded	   biosensors,	   especially	   those	  
based	  on	  transcription	   factors	   (TF),	  a	  view	  highlight	  of	  non-­‐genetically	  encoded	  biosensors	   is	  
presented	   here	   in	   order	   to	   give	   an	   idea	   of	   the	   variety	   of	   different	   biosensors	   and	   their	  
applications	  that	  were	  developed	  in	  the	  recent	  years.	  
Biosensors	   range	   from	   nano-­‐bodies	   that	   can	   enable	   time-­‐resolved	   studies	   of	   cellular	  
responses	  in	  vivo	  on	  a	  molecular	  scale	  (Irannejad	  et	  al,	  2013)	  to	  whole	  organism	  that	  promise	  
to	  be	  used	  as	  living	  diagnostics	  within	  a	  patient	  (Kotula	  et	  al,	  2014).	  Some	  biosensors	  are	  wired	  
into	   an	   electronic	   circuit	   in	   order	   to	   directly	   convert	   the	   detected	   signal	   to	   an	   electronic	  
impulse	   (Das	   et	   al,	   2015).	   In	   other	   cases,	   the	   detection	   of	   the	   signal	   triggers	   a	   biological	  
reaction,	   that	   can	   be	   subsequently	   measured,	   for	   example	   the	   expression	   of	   fluorescent	  
markers.	   Biosensors	   often	   allow	   the	   in	   vivo	   study	   of	   cellular	   processes	   that	  were	   until	   then	  
impossible	  to	  detect.	  An	  example	  is	  the	  recent	  study	  of	  Fosque	  et	  al,	  2015.	  They	  applied	  a	  Ca2+-­‐
sensitive,	  fluorescence-­‐based	  biosensor	  to	  enable	  the	  real-­‐time,	  in	  vivo	  study	  of	  how	  behavior	  
change	  manifests	  in	  brain	  cells.	  Without	  the	  use	  of	  a	  biosensor,	  an	  in	  vivo	  real-­‐time	  study	  was	  





the	   trigger	   was	   applied,	   making	   them	   by	   far	   less	   meaningful	   or	   reliable.	   Even	   though	  
numerous,	  different	  biosensors	  have	  been	  published	  in	  the	  recent	  years,	  the	  development	  of	  
new	  biosensors	  can	  still	  be	  time	  consuming	  and	  laborious.	  	  
1.1.1 The	  concept	  of	  genetically	  encoded	  biosensors	  
Recent	   developments	   in	   synthetic	   biology	   allow	   the	   affordable	   construction	   of	   diverse,	  
engineered	  cell	   libraries	   (Goodman	  et	  al,	  2013;	  Kosuri	  &	  Church,	  2014;	  Cavaleiro	  et	  al,	  2015;	  
Gibson,	   2014;	   Bonde	   et	   al,	   2015;	   Jiang	   et	   al,	   2013).	   These	   capabilities	   enable	   a	   deeper	  
understandings	  of	  biological	  processes	  and	  regulation	  (Bonde	  et	  al,	  2016;	  Kosuri	  et	  al,	  2013),	  
as	  well	  as	  facilitate	  more	  rapid	  and	  efficient	  cell	  factory	  and	  protein	  engineering	  (Wang	  et	  al,	  
2009).	  Similarly,	  inexpensive	  deep	  sequencing	  simplifies	  the	  identification	  of	  beneficial	  genetic	  
variants,	   often	   by	  multiplexing	   (Kosuri	   et	   al,	   2013).	   This	   also	   enables	   rapid	   identification	   of	  
specific	   genetic	   changes	   in	   microorganism,	   which	   evolutionary	   adopted	   to	   a	   defined	  
environment	   as	   in	   adaptive	   laboratory	   evolution	   (ALE)	   experiments	   (Portnoy	   et	   al,	   2011;	  
LaCroix	   et	   al,	   2015).	   Nevertheless,	   the	   development	   of	   new	   biotechnologically	   relevant	  
production	  pathways	   is	   still	   challenging.	  The	  modern	   research	   is	   confronted	  with	   the	   task	   to	  
identify	   those	   candidates	   out	   of	   the	   abundance	   of	   different	   variants	   that	   have	   a	   desired	  
characteristic.	   In	   certain	   case,	   as	   for	   example	   the	   expression	   of	   a	   colored	   compound,	   the	  
identification	  can	  be	  straight	  forward,	  but	  in	  many	  cases	  it	  is	  more	  challenging.	  
	  
Genetically	  encoded	  biosensors	  enable	  to	  link	  the	  expression	  of	  a	  reporter	  molecule	  to	  the	  
concentration	   of	   a	   certain	   molecule	   or	   other	   environmental	   trigger.	   By	   coupling	   the	  
intracellular	   concentration	   of	   a	   small	   molecule	   to	   the	   read	   out	   of	   a	   fluorescent	   protein,	  
differences	  in	  intracellular	  concentrations	  can	  be	  easily	  identified	  at	  the	  single	  cell	  level	  (Binder	  
et	  al,	  2012a).	  Biosensors	  have	  been	  applied	   in	   several	  high-­‐throughput	   screens	  proving	   their	  
relevance	  to	  enzyme	  engineering	  and	  cell	  factory	  optimization	  (Binder	  et	  al,	  2013;	  Mustafi	  et	  
al,	   2012;	  Michener	  et	   al,	   2012;	   Schendzielorz	  et	   al,	   2014;	   Siedler	  et	   al,	   2014b;	   Raman	  et	   al,	  
2014;	   Taylor	   et	   al,	   2015).	   In	   Table	   I,	   a	   selection	   of	   highly	   relevant	   and	   successfully	   applied	  
biosensors	  is	  listed,	  sorted	  by	  the	  kind	  of	  application.	  As	  this	  table	  shows,	  there	  have	  already	  
been	   a	   number	   of	   different	   areas	   of	   application	   for	   biosensors	   from	   the	   screening	   for	  
improved	  enzymes	  (Siedler	  et	  al,	  2014a;	  Tang	  et	  al,	  2013;	  Binder	  et	  al,	  2012b;	  Schendzielorz	  et	  
al,	   2014)	   or	   production	   pathways	   (Tang	   &	   Cirino,	   2011;	   Dietrich	   et	   al,	   2013)	   from	   a	  





Mahr	  et	  al,	  2015;	  Yang	  et	  al,	  2013).	  It	  has	  also	  been	  shown	  that	  biosensors	  can	  be	  applied	  to	  
identify	   novel	   enzymes	   with	   a	   desired	   function	   from	   for	   example	   metagenomic	   libraries	  
(Uchiyama	   &	   Miyazaki,	   2010;	   Genee	   et	   al,	   2016).	   One	   of	   the	   most	   promising	   advances	   in	  
biosensor	   design	   for	   biotechnology	   is	   the	   successful	   development	   of	   dynamic	   pathway	  
controls.	   These	   synthetic	   fed	   forward	   or	   negative	   feedback	   loops	   enable	   the	   dynamic	   auto-­‐
tuning	  of	  a	  pathway	  in	  response	  to	  the	  actual	  intracellular	  concentration	  of	  a	  precursor	  or	  for	  
example	  a	  toxic	  intermediate	  	  (Zhang	  et	  al,	  2012;	  Liu	  et	  al,	  2015;	  Xu	  et	  al,	  2014).	  
	  
	  
Table	  I)	  A	  list	  of	  highlights	  of	  successfully	  applied	  biosensors	  for	  different	  purposes.	  Proof	  of	  
principle	  studies	  are	  excluded	  from	  this	  table	  but	  mentioned	  in	  the	  further	  chapters.	  
Sensed	  molecule	   Sensor	   Output	   Reference	  
Improving	  enzymes	  
NADPH	   SoxR	   eYFP	   (Siedler	  et	  al,	  2014a)	  
Triacetic	  acid	  lactone	  (TAL)	   AraC	   LacZ	   (Tang	  et	  al,	  2013)	  
L-­‐Arg/L-­‐Lys/L-­‐His	   LysG	   eYFP	   (Binder	  et	  al,	  2012b;	  
Schendzielorz	  et	  al,	  2014)	  
Identification	  novel	  enzymes	  







(Genee	  et	  al,	  2016)	  
Pathway	  optimization	  
Mevalonate	   AraC	   LacZ	   (Tang	  &	  Cirino,	  2011)	  
Butanol	   BmoR	   TetR-­‐GFP	   (Dietrich	  et	  al,	  2013)	  
Dynamic	  pathway	  control	  
Acetyl-­‐CoA	   FadR	   Synthetic	  fed	  
forward	  activation	  
(Zhang	  et	  al,	  2012)	  
Malonyl-­‐CoA	   FapR	   Synthetic	  negative	  
feedback	  loop	  
(Liu	  et	  al,	  2015;	  Xu	  et	  al,	  2014)	  
Improving	  adaptive	  evolution	  
IPP	  (isopentenyl	  diphosphate)	   Ing/AraC	  
chimera	  
RFP	   (Chou	  et	  al,	  2013)	  
L-­‐Lys	   Lrp	   eYFP	   (Mahr	  et	  al,	  2015)	  
L-­‐Lys	   Lys	  riboswitch	   TetA	   (Yang	  et	  al,	  2013)	  
	  
	  





1.1.2 Output	  systems	  
The	  genetically	  encoded	  biosensors	  offer	  a	  modular	  output	  system	  that	  can	  be	  changed	  to	  
meet	  the	  requirements	  of	  the	  application.	  	  
The	  most	  commonly	  used	  output	  is	  fluorescence.	  The	  expression	  of	  a	  fluorescent	  protein	  
like	  GFP	  (Prasher	  et	  al,	  1992)	  is	  controlled	  by	  the	  biosensor.	  Since	  it	  is	  established	  that	  there	  is	  
a	  close	  correlation	  between	  the	  GFP	  expression	  and	  the	  fluorescent	  signal	  (Albano	  et	  al),	  the	  
signal	   can	   be	   used	   as	   a	   reporter	   for	   the	   biosensor	   activity.	   Different	   instruments	   offer	   the	  
option	   to	   screen	   for	   fluorescence,	   enabling	   many	   different	   screening	   methods,	   e.g.	  
fluorescence	  microscopy,	   plate	   reader	   analysis,	  microfluidics	   or	   flow	   cytometry/FACS.	   These	  
methods	  offer	  different	  resolutions,	  throughputs	  and	  costs,	  making	  it	  possible	  to	  use	  the	  same	  
biosensor	   construct	   in	   different	   stages	   of	   the	   experiment,	   from	   broad	   screens	   to	   individual	  
strain	  characterizations.	  
Another	  very	   interesting	  possible	  output	  system	   is	  selection.	  The	  biosensor	   is	  coupled	  to	  
the	   expression	   of	   a	   protein	   that	   either	   enables	   survival	   under	   certain	   conditions,	   like	   the	  
expression	  of	  antibiotic	  resistance	  genes	  or	  toxin/antitoxin	  pairs,	  or	  they	  lead	  to	  cell	  death,	  as	  
for	   example	   the	   expression	   of	   a	   lytic	   protein.	   Selection	   systems	   can	   achieve	   very	   high	  
throughput	  rates	  of	  more	  than	  109	  variants	  per	  day	  (Dietrich	  et	  al,	  2010)	  and	  colony	  formation	  
assays	  can	  be	  carried	  without	  the	  need	  for	  additional	  instruments.	  Selection	  systems	  also	  offer	  





A)	  Transcription	  factor-­‐based	  biosensor	  

















B)	  Riboswitch-­‐based	  biosensor	  


































	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
Figure	   1.1)	   Schematic	   overview	   of	   the	   functional	   mechanism	   of	   genetically	   encoded	  
biosensors.	  (A)	  Biosensor	  based	  on	  a	  repressing	  transcription	  factor	  (TF).	  In	  the	  given	  example	  
is	   the	   transcription	   factor	  bound	   to	   the	  DNA	   in	  absence	  of	  an	  effector	  molecule	   (red	   circle).	  
This	   inactivates	   the	  promoter	   and	  no	   reporter	  molecule	   (green	   star)	   can	  be	   transcribed	   and	  
translated.	  Upon	  binding	  of	   the	  effector,	   the	  TF	   looses	  DNA	  binding	  affinity	  and	  releases	   the	  
promoter.	  The	  gene	  can	  be	  transcribed	  and	  translated	  to	  the	  reporter	  molecule.	  (B)	  Biosensor	  
based	  on	  a	   riboswitch	   (RS).	  The	  gene	   is	   transcribed	   independent	  of	   the	  presence	  of	  effector	  
molecules.	  In	  the	  shown	  example	  is	  the	  ribosome-­‐binding	  site	  (RBS)	  on	  the	  mRNA	  accessible	  in	  
absence	   of	   effectors	   and	   thus	   the	   gene	   can	   be	   translated.	   In	   presence	   of	   the	   effector,	   the	  
conformation	  of	  the	  mRNA	  changes	  and	  masks	  the	  RBS.	  Therefore,	  the	  mRNA	  can	  no	  longer	  be	  
translated.	   (C)	   Biosensor	   based	   on	   a	   two-­‐component	   system.	   The	   two-­‐component	   system	  
consists	  of	  a	  sensor	  histidine	  kinase	  (SHK),	  located	  in	  the	  outer	  membrane,	  and	  an	  intracellular	  
response	  regulator	  (RR).	  The	  SHK	  is	  inactive	  in	  absence	  of	  an	  effector,	  but	  gets	  activated	  upon	  
binding,	   which	   leads	   to	   the	   phosphorylation	   of	   the	   RR.	   The	   RR	   is	   activated	   by	   the	  
phosphorylation	   and	   acts	   as	   an	   activator	   in	   this	   example,	   stimulating	   the	   expression	   of	   the	  





1.1.2.1 Transcription	  factors	  based	  biosensors	  
Transcription	   factors	   (TFs)	   are	   regulating	   proteins.	   In	  microorganism,	   fifty-­‐nine	   different	  
classes	   of	   transcription	   factors	   are	   known,	   which	   all	   have	   specific	   structures	   and	  modes	   of	  
action.	  The	  unifying	  characteristic	  is	  that	  all	  of	  them	  have	  at	  least	  a	  DNA-­‐binding	  domain	  and	  a	  
sensor	   domain.	   TFs	   change	   the	   expression	   rate	   of	   regulated	   genes	   upon	   stimulation	   in	   the	  
sensor	  domain,	  generally	  by	  a	  small	  effector	  molecule	  (Figure	  1.1A).	  Transcription	  factors	  can	  
be	  divided	  in	  three	  main	  categories,	  namely	  repressors,	  activators	  and	  dual	  regulators.	  When	  a	  
repressor	  or	  activator,	  respectively,	  binds	  to	  its	  DNA	  binding	  site	  in	  the	  promoter	  region	  of	  the	  
controlled	  gene,	  it	  either	  represses	  or	  activates	  the	  expression.	  A	  dual	  regulator	  can	  have	  both	  
effects.	  
The	  bacterial	  genome	  with	  the	  most	  thoroughly	  studied	  regulation	  network	  is	  Escherichia	  
coli.	   By	   today,	   there	   is	   experimental	   evidence	   for	   184	   different	   transcription	   factors	   in	   the	  
E.	  coli	   genome	   (Gama-­‐Castro	   et	   al,	   2016).	   Furthermore,	   there	   is	   a	   large	   number	   of	   thus	   far	  
uncharacterized	   proteins	   that	   are	   classified	   as	   possible	   transcription	   factors.	   Current	  
predictions	  anticipate	  that	  120	  additional	  transcription	  factors	  are	  part	  of	  the	  E.	  coli	  regulatory	  
network	  with	  so	  far	  unknown	  stimuli	  and	  binding	  sites.	  Including	  the	  transcription	  factors	  from	  
other	   microbial	   genomes,	   a	   total	   of	   11,790	   transcription	   factors	   are	   known	   so	   far	   (Gama-­‐
Castro	  et	  al,	  2016).	  
The	   known	   TFs	   are	   responsive	   to	   at	   least	   308	   different	   stimuli,	   not	   including	   protein-­‐
protein	  interactions	  (Table	  S	  I)	  (Novichkov	  et	  al,	  2013).	  The	  stimuli	  are	  often	  small	  molecules	  or	  
ions,	   including	  for	  example	  amino	  acids,	  cofactors,	  different	  carbohydrates	  and	  other	  organic	  
and	   inorganic	   chemicals,	   but	   there	   are	   also	   TFs	   reacting	   to	   physical	   changes	   of	   e.g.	   pH,	  
osmolarity	  or	  temperature.	  Other	  transcription	  factors	  are	  activated	  or	  deactivated	  by	  protein-­‐
protein	   interactions	   or	   protein	   modifications	   like	   phosphorylation.	   The	   interaction	   with	   the	  
effector	   results	   in	  a	  conformational	  change	  of	   the	  TF	  and	  thereby	  a	  change	  of	   the	  affinity	  of	  
the	  DNA-­‐binding	  domain	  for	  their	  DNA-­‐binding	  site	  (Schleif,	  2013).	  It	  is	  possible	  that	  a	  TF	  either	  
gets	   activated	   or	   deactivated	   by	   these	   changes	   respectively	   gains	   or	   looses	   the	   ability	   to	  
interact	  with	  the	  DNA.	  
	  A	   TF	   can	   have	   different	   effects	   on	   the	   DNA	   and	   the	   transcription	   level.	   The	   simplest	  
effects	  of	  TFs	  are	  repression	  and	  de-­‐repression	  of	  transcription.	  These	  two	  effects	  occur	  when	  
the	  DNA	  binding	  site	  of	  a	  TF	  is	  within,	  overlapping	  or	  close	  to	  the	  promoter	  region	  of	  a	  gene	  or	  
gene	  cluster.	  If	  the	  DNA	  affinity	  of	  the	  TF	  is	  increased	  upon	  stimulation,	  repression	  takes	  place.	  





prevention	  of	  the	  binding	  of	  the	  RNA-­‐polymerase,	  respectively	  the	  σ-­‐factor	  guiding	  the	  RNA-­‐
polymerase.	  As	  a	  result,	  the	  transcription	  is	  repressed	  (Figure	  1.1A).	  In	  the	  opposite	  case,	  de-­‐
repression,	  the	  DNA	  affinity	  decreases	  upon	  stimulation	  of	  the	  TF.	  The	  promoter	  gets	  released	  
by	   the	   now	   inactive	   TF	   and	   is	   again	   accessible	   for	   the	   RNA-­‐polymerase,	   which	   leads	   to	   an	  
increase	  of	  transcription.	  The	  most	  well-­‐known	  examples	  for	  a	  de-­‐repressor	  are	  the	  lac	  and	  the	  
tet	   transcription	   factors	   (LacI	   and	   TetR)	   (Gilbert	   &	   Müller-­‐Hill,	   1966).	   The	   opposite	   effect,	  
repression,	  can	  be	  observed	  with	  the	  tryptophan	  repressor	  (Trp).	  The	  repressor	  is	  inactive	  and	  
soluble	  until	  tryptophan	  binds.	  The	  binding	  of	  tryptophan	  increases	  the	  DNA	  affinity,	  Trp	  binds	  
downstream	  of	  the	  promoter	  and	  prevents	  the	  RNA-­‐polymerase	  from	  binding.	  	  
Repression	  can	  also	  take	  place	  when	  the	  binding	  of	  the	  TF	  causes	  conformational	  changes	  
in	  the	  DNA.	  In	  the	  case	  of	  AraC	  (Lutz,	  1997),	  the	  active	  form	  induces	  the	  formation	  of	  a	   loop	  
with	  the	  DNA,	  which	  blocks	  the	  promoter.	  Interestingly,	  AraC	  is	  a	  dual	  regulator	  that	  can	  also	  
activate	   transcription	   in	   its	   active	   form	   when	   arabinose	   is	   present	   by	   recruiting	   the	   RNA-­‐
polymerase.	   Another	   way	   of	   activating	   transcription	   is	   by	   bending	   the	   DNA,	   widening	   the	  
groove	   and	  making	   the	   promoter	  more	   accessible	   for	   the	   RNA-­‐polymerase.	   This	  mechanism	  
can	  be	  observed	  with	  the	  Cra-­‐activated	  ppsA	  promoter	  (Nègre	  et	  al,	  1998).	  
	  
The	  possible	  interactions	  and	  effects	  of	  TFs	  are	  even	  more	  complex,	  as	  one	  gene	  or	  gene	  
cluster	  is	  typically	  controlled	  by	  several	  TFs	  with	  often	  opposing	  effects.	  Furthermore,	  TFs	  can	  
also	   interact	   with	   each	   other,	   altering	   their	   activities	   and	   affinities.	   Cyclic-­‐AMP	   receptor	  
protein	  (CRP),	  formally	  known	  as	  catabolite	  activator	  protein	  (CAP),	  is	  a	  good	  example	  for	  the	  
complexity	   of	   the	   transcriptional	   regulation	   network.	   CRP	   is	   one	   of	   the	   most	   well	   studied,	  
globally	  acting	  transcription	  factors,	  controlling	  the	  activation	  of	  more	  than	  100	  genes	   in	  the	  
E.	  coli	  genome	  in	  response	  to	  the	  intracellular	  cAMP	  concentration	  (Keseler	  et	  al,	  2013).	  CPR	  is	  
a	  dual	  regulator	  that	  either	  activates	  (e.g.	  gapA)	  or	  represses	  (e.g.	  gdhA)	  the	  expression	  and	  in	  
most	  cases,	   it	   interacts	  with	  a	  number	  of	  other	  TF	   in	  order	   to	   fine-­‐tune	   the	  metabolism	  and	  
adjust	  it	  to	  the	  current	  environment	  (Busby	  &	  Ebright,	  1999;	  Shimada	  et	  al,	  2011a;	  Green	  et	  al,	  
2014).	   CRP	   is	   additionally	   controlling	   the	   expression	   of	   several	   other	   TF,	   for	   example	   AraC,	  
adding	  another	  level	  of	  complexity.	  Furthermore,	  the	  native	  DNA-­‐binding	  sites	  rarely	  resemble	  
the	   DNA	   sequence	   of	   the	   highest	   affinity	   of	   the	   TF,	   but	   instead	   consist	   of	   slightly	   changed	  
sequences	  (Novichkov	  et	  al,	  2013).	  This	  is	  a	  way	  in	  which	  the	  strength	  of	  transcription	  control	  
is	  adjusted	  to	  modulate	  and	  fine-­‐tune	  the	  transcription	  levels	  of	  different	  genes,	  controlled	  by	  
one	  TF.	  Another	  factor	  that	  can	  influence	  the	  efficiency	  of	  a	  TF	  is	  the	  position	  of	  its	  binding	  site	  






As	   this	   very	   brief	   overview	   suggests,	   the	   transcriptional	   regulation	   network,	   even	   only	  
regarding	  transcription	  factors,	  is	  highly	  complex	  and	  still	  far	  from	  being	  fully	  understood.	  The	  
possibilities	  of	   identifying	   and	   testing	  new	  TF	  binding	   sites	   is	   steadily	   improving	  with	   in	   vivo	  
(Boeva,	  2016)	  and	   in	  vitro	  (Shimada	  et	  al,	  2011b;	  Franco-­‐Zorrilla	  &	  Solano,	  2016)	  screens	  and	  
also	   the	   reliability	   of	   in	   silico	   predictions	   increases	   steadily	  with	   advanced	  machine	   learning	  
tools	  (Li	  et	  al,	  2015).	  Nevertheless,	  it	  is	  thus	  far	  still	  impossible	  to	  reliably	  predict	  the	  effect	  or	  
strength	  of	  an	  uncharacterized	  TF	  binding	  site.	  
1.1.2.2 Transforming	  TF	  to	  biosensors	  
Regardless	  of	   the	  obstacles	  of	   identifying	   the	   full	  effects	  and	  regulation	  networks	  of	  TFs,	  
there	   are	   several	   characteristics	   that	   make	   TFs	   particularly	   interesting	   targets	   for	   the	  
development	   of	   novel	   biosensors.	   As	   TFs	   comprise	   of	   a	   protein	   as	   well	   as	   a	   targeted	   DNA	  
component,	   there	   are	   several	   options	   to	   tweak,	   alter	   and	   optimize	   TFs	   in	   order	   to	   convert	  
them	  to	  applicable	  biosensors.	  	  
In	  certain	  cases,	  it	  is	  sufficient	  to	  choose	  a	  transcription	  factor	  with	  the	  desired	  sensitivity	  
and	  clone	  a	  native	  promoter	  containing	  the	  respective	  TF	  binding	  site	  upstream	  of	  a	  reporter	  
gene	  in	  order	  to	  generate	  a	  functional	  biosensor	  (Siedler	  et	  al,	  2014a).	  Oftentimes,	  though,	  the	  
native	  TF/binding-­‐site	  pair	  has	  not	  yet	   the	  required	  characteristics	   to	  be	  used	  as	  a	  biosensor	  
and	  requires	  optimization	  or	  de	  novo	  development,	  if	  there	  is	  no	  suitable	  native	  TF	  available.	  
	  
The	   qualities	   of	   a	   biosensor	   are	   defined	   by	   its	   specificity	   to	   the	   ligand	   of	   interest,	   its	  
sensitivity	   range	   for	   this	   ligand,	   its	  dynamic	   range	  of	  output	  between	  ON	  and	  OFF	   state	  and	  
the	   general	   “leakiness”	   during	   the	   OFF	   state,	   meaning	   the	   baseline	   expression	   rate	   of	   the	  
reporter	   protein.	   Furthermore,	   there	   are	   often	   host	   incompatibilities	   when	   a	   biosensor	   is	  
transferred	  from	  one	  organism	  to	  another	  (Blazeck	  &	  Alper,	  2013;	  Zhang	  et	  al,	  2015;	  Skjoedt	  et	  
al,	  2016).	  Depending	  on	  the	  desired	  application,	  different	  qualities	  can	  be	  important.	  	  
If	   the	  biosensor	  should	  be	  applied	   in	  a	  production	  pathway,	   the	  sensitivity	   for	   the	  target	  
usually	   needs	   to	   be	   decreased.	   In	   a	   product	   strain,	   the	   expected	   yield	   is	   exceeding	   the	  
physiological	   concentrations	   of	   the	   respective	   product	   and	   therefore	   saturates	   at	  
concentrations	  below	  the	  expected	  or	  desired	  concentrations.	   In	  the	  case	  that	  the	  biosensor	  





is	   essential.	   A	   biosensor	   with	   a	   broad	   dynamic	   range	   is	   important,	   when	   a	   very	   sensitive	  
feedback	  is	  necessary.	  
In	   the	   recent	   years,	   a	   number	   of	   functional	   biosensors	   have	   been	   published	   that	   were	  
tuned	   with	   modern	   technologies	   of	   protein	   engineering	   and	   synthetic	   biology	   in	   order	   to	  
overcome	  these	  problems.	  As	  an	  example,	  in	  a	  recent	  study	  by	  Taylor	  et	  al.,	  they	  successfully	  
applied	  a	  range	  of	  protein	  and	  DNA	  engineering	  methods	  in	  order	  to	  change	  the	  specificity	  of	  
LacI	  to	  novel	  ligands	  with	  a	  similar	  specificity	  and	  inducability	  compared	  to	  the	  wild	  type	  LacI	  
and	  its	  inducer	  isopropyl	  β-­‐D-­‐1-­‐thiogalactopyranoside	  (IPTG)	  (Taylor	  et	  al,	  2016).	  
The	  next	  section	  gives	  a	  more	  details	  overview	  on	  how	  TF	  biosensors	  can	  be	  changes	  and	  
the	  reasons	  why	  these	  adaptations	  are	  necessary	  to	  transform	  the	  TF	  to	  a	  biosensor.	  
	  
Target	  specificity	  
A	  biosensor	  needs	   to	  have	  a	  high	  specificity	   for	   the	  desired	  effector	  molecule.	   In	  certain	  
cases,	   there	   is	   no	   native	   biosensor	   available	   for	   a	   specific	   effector	   in	   the	   host	   strain.	   By	  
applying	  either	  randomizing	  approaches	  or	  very	  targeted	  changes,	  the	  change	  in	  specificity	  of	  
a	  biosensor	  to	  a	  new	  molecule	  could	  be	  achieved.	  
AraC	  (arabinose	  operon	  regulatory	  protein)	  is	  a	  very	  well	  studied	  transcription	  factor	  and	  
has	   also	   been	   the	   basis	   for	   several	   biosensor	   developments.	   Native	   AraC	   is	   sensitive	   to	   L-­‐
arabinose,	   but	   Tang	   et	   al.	   have	   successfully	   applied	   saturation	   mutagenesis	   in	   order	   to	  
manipulate	   the	   specificity	   of	   AraC.	   In	   an	   initial	   study	   in	   2008,	   Tang	   et	   al.	   could	   generate	   an	  
AraC	  mutant	   with	   an	   altered	   specificity	   for	   D-­‐	   instead	   of	   L-­‐arabinose	   (Tang	   et	   al,	   2008).	   In	  
further	   studies,	   it	   was	   demonstrated	   that	   the	   specificity	   could	   also	   be	   tailored	   towards	  
mevalonate	  (Tang	  &	  Cirino,	  2011),	  TAL	  (Triacetic	  Acid	  Lactone)	  (Tang	  et	  al,	  2013)	  and	  ectoine	  
(Chen	   et	   al,	   2015).	   Chou	   and	   Keasling	   also	   used	   AraC	   for	   the	   development	   of	   a	   chimeric	  
transcription	   factor.	   The	   modular	   construction	   of	   TFs	   of	   individual	   domains	   and	   the	   high	  
conservation	  of	  these	  domains	  makes	  them	  perfect	  targets	  for	  the	  building	  of	  chimeras.	  They	  
created	   a	   novel	   biosensor	   with	   sensitivity	   for	   isoprenoids	   and	   the	   well	   characterized	   AraC	  
regulation	  by	   fusing	   the	   sensor	  domain	  of	   Idi	   (IPP	   isomerase)	   to	   the	  DNA	  binding	  domain	  of	  
AraC	   (Chou	   et	   al,	   2013).	   Similar	   chimeric	   transcription	   factors	   have	   also	   been	   successfully	  
developed	   in	   the	   GalR-­‐LacI	   family	   of	   transcription	   factors	   (Meinhardt	   et	   al,	   2012).	   Chimeric	  
receptors	  are	  additionally	  highly	  interesting,	  as	  they	  can	  facilitate	  in	  the	  creation	  of	  functional	  
logic	  gates	  that	  enable	  input	  of	  several	  signals	  in	  parallel	  without	  requiring	  several	  different	  TF	  







The	  detection	  range	  of	  a	  transcription	  factor	  or	  biosensor	  is	  defined	  here	  as	  the	  affinity	  of	  
a	  biosensor	   to	   its	   ligand,	  which	   is	   classically	  described	  by	   the	  dissociation	  constant	  Kd	  of	   the	  
sensor	  for	  the	  respective	  ligand.	  	  
	  
Dynamic	  range	  
The	  dynamic	   range	  of	  a	  biosensor	  describes	   the	  difference	   in	   signal	  output	  between	   the	  
ON	  and	   the	  OFF	   state,	   respectively	  when	   the	  biosensor	   is	   fully	   active	  and	   fully	   inactive.	   The	  
optimization	   of	   the	   dynamic	   range	   is	   important,	   as	   the	   output	   strength	   needs	   to	  match	   the	  
detection	  system,	  for	  example	  the	  respective	  detection	  spectrum	  of	  a	  flow	  cytometer.	  
TF	  based	  biosensors	  offer	  the	  possibility	  of	  fine-­‐tuning	  their	  dynamic	  range	  by	  a	  number	  of	  
different	  approaches,	  including	  changing	  promoter	  sequences,	  the	  position,	  amount	  (Ang	  et	  al,	  
2013)	  and	  sequence	  of	  the	  TF	  binding	  site	  and	  the	  RBS	  (Alper	  et	  al,	  2005;	  Bonde	  et	  al,	  2016;	  
Hammer	  et	   al,	   2006;	   Rogers	  et	   al,	   2015;	   Zhang	  et	   al,	   2012).	  Modern	  DNA	   synthesis	   enables	  
quick,	   reliable	   and	   affordable	   de	   novo	   design	   of	   DNA	   fragments	   and	   novel	   seamless	   DNA	  
assembly	   techniques	   like	   USER	   cloning	   (Nørholm,	   2010;	   Cavaleiro	   et	   al,	   2015)	   or	   Gibson	  
assembly	   (Gibson,	   2011)	   facilitate	   a	   nearly	   restriction	   free	   creation	   of	   DNA	   sequences.	   One	  
example	  of	  a	  biosensor	  with	  a	  highly	  increased	  dynamic	  range	  is	  FadR.	  By	  switching	  the	  native	  
FadR	   binding	   promoter	   with	   phage	   promoters	   containing	   two	   FadR	   binding	   sites	   and	  
combining	   it	   with	   an	   inducible	   LacI	   promoter,	   the	   dynamic	   range	   could	   be	   increased	  
drastically.	   The	   optimized	   biosensor	   enabled	   the	   successful	   selection	   of	   production	  mutants	  
with	  an	  increased	  biofuel	  yield	  (Zhang	  et	  al,	  2012).	  
	  
Orthogonality	  
A	  common	  obstacle	  in	  the	  development	  of	  novel	  biosensors	  is	  the	  transferability	  between	  
different	   hosts.	   Due	   to	   differences	   in	   for	   example	   codon	   usage,	   promoter	   design	   and	  
expression	   systems,	   especially	   between	   bacteria	   and	   yeast,	   it	   is	   often	   difficult	   to	   transfer	   a	  
functional	  TF	  or	  biosensor	  from	  one	  organism	  to	  another.	  Although,	  particularly	  the	  transfer	  of	  
biosensors	   from	   bacteria	   to	   yeast	   is	   interesting	   for	   biotechnology,	   as	   yeast	   is	   a	   common	  
production	   host,	   but	   only	   encodes	   a	   small	   number	   of	   TF	   by	   itself.	   Consequently,	   the	  
application	  of	  biosensors	  in	  yeast	  is	  relaying	  to	  a	  huge	  extend	  on	  the	  possibility	  to	  orthogonal	  
transfer	  biosensors	  (Skjoedt	  et	  al,	  2016).	  
It	  is	  generally	  considerably	  easier	  to	  transfer	  a	  repressor	  between	  different	  hosts,	  as	  their	  





Because	   of	   this,	   there	   have	   already	   been	   several	   examples	   of	   bacterial	   repressors	   in	   yeast	  
(Wang	  et	  al,	  2016;	  Teo	  &	  Chang,	  2015).	  Only	  in	  a	  recent	  study	  by	  Skjoedt	  and	  co-­‐workers,	  they	  
were	  able	  create	  functional	  activating	  biosensors	  with	  bacterial	  origin	  in	  yeast.	  They	  chose	  to	  
test	   several	   members	   of	   the	   LysR-­‐type	   transcriptional	   regulators	   (LTTRs).	   Based	   on	   current	  
knowledge	  of	  the	  mechanism	  of	  LTTSs	  and	  the	  construction	  of	  yeast	  promoters,	  they	  rational	  
decided	  on	  2	  different	   sites	   in	   the	   yeast	   promoter,	  where	   they	   introduced	   the	   LTTR	  binding	  
sequences.	   This	  way,	   they	  were	   also	   able	   to	   create	  one	  platform,	   that	   could	  be	  used	   for	   all	  
tested	  LTTRs	  by	  simply	  changing	  the	  TF	  binding	  site	  sequence	   in	  the	  promoter	  (Skjoedt	  et	  al,	  
2016).	  
	  
1.1.2.3 Biosensor	  applications	  
As	   already	   shown	   in	   Table	   I,	   biosensors	   have	   already	   been	   applied	   in	   a	   wide	   range	   of	  
different	  applications.	  They	  have	  been	  applied	  to	  successfully	  rise	  the	  titers	  in	  the	  production	  
of	  compounds	  like	  amino	  acids	  (Binder	  et	  al,	  2012a;	  Mustafi	  et	  al,	  2012),	  succinate	  (Dietrich	  et	  
al,	  2013),	  butanol	  (Dietrich	  et	  al,	  2013)	  and	  secondary	  metabolites	  (Siedler	  et	  al,	  2014b)	  to	  just	  
name	   a	   few	   examples,	   by	   either	   sensing	   the	   end	   product	   itself,	   identify	   new	   enzymes	   or	  
facilitating	  pathway	  balancing.	  	  
A	   particularly	   interesting	   area	   of	   biosensor	   applications	   though	   is	   the	   development	   of	  
novel	  circuits.	  In	  many	  cases	  of	  pathway	  development,	  an	  intermediate	  can	  be	  toxic	  to	  the	  cell	  
in	   high	   concentrations.	   In	   these	   cases,	   TF	   offer	   the	   possibility	   to	   dynamically	   control	   the	  
pathway	  by	   synthetic	   feedback	   loops.	  Dhal	  et	   al.	  were	  able	   to	   construct	  a	  dynamic	  pathway	  
regulation	   to	   avoid	   the	   accumulation	   of	   toxic	   farnesyl	   pyrophosphate	   (FPP)	   during	   the	  
production	  of	  amorphadiene,	  resulting	  in	  a	  two-­‐fold	  increase	  in	  production	  (Dahl	  et	  al,	  2013).	  
A	   similar	   approach	   was	   used	   to	   improve	   fatty	   acid	   synthesis	   in	   E.	   coli.	   An	   acetyl-­‐CoA	   or	   a	  
malonyl-­‐CoA	   biosensor	  were	   applied	   regulates	   the	   expression	   levels	   of	   pathway	   enzymes	   in	  
order	  to	  balance	  it,	  according	  to	  the	  current	  intracellular	  availability	  of	  acetyl-­‐CoA	  or	  malonyl-­‐
CoA,	  respectively.	  In	  all	  cases,	  highly	  increased	  yields	  could	  be	  achieved	  (Xu	  et	  al,	  2014;	  Liu	  et	  
al,	  2015;	  Zhang	  et	  al,	  2012).	  
Dynamic	   pathway	   control	   is,	   as	   shown	   in	   these	   two	   examples,	   a	   very	   strong	   tool	   for	  
biotechnology,	   as	   they	   enable	   the	   individual	   pathway	   adjustment	   of	   each	   single	   cell	   in	   a	  





enzymes	   before	   the	   precursor	   is	   added	   to	   the	   fermentation	   process,	   which	   could	   possible	  
make	  external	  inducer	  molecules	  redundant.	  	  
	  
1.1.2.4 Two-­‐component	  systems	  as	  biosensors	  
Bacterial	   two-­‐component	   systems	   (TCSs)	   are	   related	   to	   TFs	   and	   should	   be	   briefly	  
mentioned.	  TCSs	  comprise	  of	  two	  separate	  proteins.	  The	  response	  regulator	  (RR)	  has	  the	  same	  
mechanism	  of	  binding	  to	  promoter	  and	  activating	  or	  inhibiting	  transcription	  as	  TF.	  In	  contrast	  
to	   TFs,	   TCSs	   do	   not	   bind	   or	   sense	   the	   effector	   themselves.	   A	   separate	   receptor	   unit	   that	   is	  
located	  in	  the	  cell	  membrane	  senses	  the	  effector,	  which	  is	  often	  an	  extracellular	  stimulus,	  and	  
transmits	  the	  information	  by	  phosphorylation	  of	  the	  response	  regulator	  (Figure	  1.1C).	  	  
Biosensors	  based	  on	  TCS	  offer	  the	  possibility	  to	  sense	  for	  effectors	  outside	  of	  the	  cell.	  This	  
could	  be	  of	   great	   advantage,	   for	   example	  when	   the	  bacterium	   shall	   be	  used	  as	   a	  whole-­‐cell	  
biosensor	   for	   sensing	   toxins	   or	   other	   effectors	   in	   the	   environment	   or	   for	   co-­‐cultivation	  
experiments	   in	  metabolic	  engineering	   (Meyer	  et	  al,	  2015;	  Tsai	  et	  al,	  2015;	  Luka	  et	  al,	  2015).	  
The	   sensor	   domain	   in	   the	   periplasm	   allows	   detecting	   an	   effector	   that	   cannot	   cross	   the	  
membrane.	   The	   receptor	   proteins	   contain	   a	   very	   conserved	   structure	   in	   the	   DNA	   spanning	  
domain	   and	   the	   phosphorylation	   domain.	   This	   enables	   the	   creation	   of	   chimeric	   receptor	  
proteins	  by	  using	  different	  effector	  binding	  domains	  with	  only	  one	  phosphorylation	  domain.	  
The	   phosphorylation	   domain	   will	   then	   phosphorylate	   the	   same	   well-­‐characterized	   response	  
regulator,	  but	  upon	  addition	  of	  different	  effector	  molecules.	  Creating	  a	  platform	  of	   chimeric	  
receptors	   opens	   to	   a	   wide	   range	   of	   possible	   novel	   biosensors	   (Yusuf	   &	   Draheim,	   2015;	  
Nørholm	  et	  al,	  2015).	  	  





1.1.2.5 Riboswitches	  	  
The	  other	  major	  native	  expression	  control	  system	  that	  is	  target	  of	  biosensor	  development	  
is	  riboswitches.	  As	  this	  thesis	  focuses	  on	  transcription	  factor	  based	  biosensors,	  this	  chapter	  will	  
only	   provide	   a	   brief	   overview	   of	   the	   mechanisms	   of	   riboswitches	   in	   eukaryotes,	   the	  
possibilities	   to	   synthetically	   create	   them	   and	   successful	   examples	   of	   riboswitch	   based	  
biosensors.	  	  
In	  contrast	  to	  transcription	  factors,	  riboswitches	  are	  intrinsic	  parts	  of	  the	  mRNA	  coding	  for	  
the	  reporter	  protein	   (Figure	  1.1B).	  Upon	  binding	  of	  an	  effector	  molecule,	   the	  mRNA	  changes	  
conformation.	  The	  change	  of	  conformation	  either	  allows	  the	  ribosome-­‐binding	  site	  (RBS)	  to	  be	  
accessible	  or	   to	  be	   folded	  and	  therefor	   inaccessible.	  The	  direct	  and	  fast	   regulation	  that	  does	  
not	  need	  any	   interaction	  with	   another	  molecule	   than	   the	  effector	  make	   riboswitches	   a	   very	  
appealing	   target	   for	   biosensor	   development.	  Hence,	   there	   is	   only	   a	   small	   number	   of	   known	  
natural	  riboswitches	  available,	  for	  example	  for	  thiamine	  pyrophosphate	  (TPP)	  (Muranaka	  et	  al,	  
2009)	  or	  adenosylcobalamin	  (Nou	  &	  Kadner,	  2000).	  
Consequently,	  current	  research	  is	  aiming	  for	  the	  development	  of	  synthetic,	  custom-­‐made	  
riboswitches	   for	  any	  desired	  product.	  A	  common	  approach	   is	  systematic	  evolution	  of	   ligands	  
by	  exponential	  enrichment	  (SELEX),	  in	  which	  a	  large	  library	  of	  RNA	  molecules	  is	  created	  to	  fish	  
for	   aptamers	   with	   the	   right	   specificity.	   The	   effector	   of	   interest	   is	   often	   bound	   to	   a	   solid	  
membrane	  or	  beads,	  enabling	  washing	  steps	  and	  thereby	  removing	  RNA	  sequences	  with	  lower	  
affinities.	  The	  binding	  and	  washing	  cycles	  need	  to	  be	  repeated	  several	  times,	  which	   is	  a	  time	  
consuming	  procedure	  and	  a	  drawback	  of	  this	  technology.	   Instead	  of	  starting	  with	  a	   library	  of	  
unknown	   sequences,	   it	   is	   also	   possible	   to	   alter	   the	   specificity	   of	   a	   known	   aptamer	   by	  
introducing	  mutations	  in	  the	  sequence.	  There	  are	  a	  few	  successful	  developments	  of	  synthetic	  
riboswitches	  e.g.	   tetracycline	   (Hanson	  et	  al,	  2003)	  and	  theophylline	   (Suess	  et	  al,	  2004).	  Even	  
though,	   the	   transfer	   of	   in	   vitro	   derived	   aptamers	   to	   in	   vivo	   functional	   riboswitches	   is	  
challenging	  (Berens	  et	  al,	  2015).	  
Nevertheless,	   riboswitches	   as	   biosensors	   offer	   a	   range	   of	   advantages	   over	   TF	   based	  










1.2 Transcription	  factor	  and	  biosensor	  Cra	  
The	  catabolite	  repressor	  activator	  (Cra)	  was	  initially	  named	  fructose	  repressor	  (FruR),	  as	  it	  
was	  first	  described	  as	  a	  repressor	  of	  the	  fructose	  operon	  in	  Salmonella	  typhimurium	  and	  E.	  coli	  
(Geerse	  et	  al,	  1986;	  Chin	  et	  al,	  1987).	  Later	  on,	  it	  was	  shown	  that	  Cra	  has	  a	  way	  larger	  role	  in	  
the	  bacterial	  metabolism	  in	  some	  bacteria,	  regulating	  a	  large	  number	  of	  genes	  involved	  in	  the	  
central	  carbon	  metabolism	  and	  beyond	  (Bledig	  et	  al,	  1996a;	  Saier	  &	  Ramseier,	  1996;	  Shimada	  
et	  al,	  2005,	  2011b;	  Njoroge	  et	  al,	  2012).	  In	  E.	  coli	  and	  S.	  typhimurium,	  Cra	  is	  facilitating	  as	  the	  
major	   switch	   between	   glycolysis	   (Embden-­‐Meyerhof-­‐Parnas	   [EMP]	   pathway)	   and	  
gluconeogenesis	   (Ramseier	  et	  al,	  1993,	  1995),	   respectively,	   the	  metabolic	  and	  non-­‐metabolic	  
transcriptome	  (Kotte	  et	  al,	  2010).	  	  
Interestingly,	  it	  is	  omnipresent	  and	  highly	  conserved	  in	  gram-­‐negative	  bacteria	  (Leclerc	  et	  
al,	   1990;	   Vartak	   et	   al,	   1991),	   even	   in	   species	   that	   do	   not	   express	   the	   EMP	   pathway,	   e.g.	  
Pseudomonas	  putida.	  For	  those	  organisms,	  the	  role	  of	  Cra	  is	  yet	  to	  be	  discovered	  (Leclerc	  et	  al,	  
1990;	   Chavarría	   et	   al,	   2011,	   2014),	   but	   it	   highlights	   its	   importance	   and	   makes	   it	   a	   very	  
interesting	  target	  for	  further	  studies.	  	  
1.2.1 Structure	  and	  mechanism	  of	  action	  
Cra	  belongs	  to	  the	  GalR-­‐LacI	  family	  of	  transcription	  factors	  (Leclerc	  et	  al,	  1990;	  Weickert	  &	  
Adhya,	   1992a;	   Scarabel	  et	  al,	   1995;	   Penin	  et	  al,	   1997).	   In	   its	   soluble	   form,	   it	   forms	  a	  homo-­‐
tetramer	   (Cortay	   et	   al,	   1994)	   with	   a	   C-­‐terminal	   effector	   binding	   domain	   and	   an	   N-­‐terminal	  
helix-­‐turn-­‐helix	   (HTH)	   DNA	   binding	   domain	   (Vartak	   et	   al,	   1991;	   Weickert	   &	   Adhya,	   1992b;	  
Penin	   et	   al,	   1997).	   It	   is	   a	   pleiotropic	   transcription	   factor	   that	   binds	   to	   an	   imperfect,	   16-­‐	  
respectively	  18-­‐bp	  long	  palindromic	  sequence	  (Ramseier	  et	  al,	  1993,	  1995;	  Nègre	  et	  al,	  1996;	  
Shimada	  et	  al,	  2005,	  2011b).	  	  
When	   Cra	   is	   bound	   to	   the	   DNA,	   it	   can	   activate	   and	   repress	   the	   transcription	   of	  
downstream	  genes.	  The	  current	  state	  of	  knowledge	  suggests	  that	  the	  activating	  and	  repressing	  
effects	  depend	  on	  the	  positioning	  of	  the	  binding	  sites	  relatively	  to	  the	  transcription	  start	  site	  
(Shimada	  et	  al,	  2011b).	  They	  applied	  SELEX	   in	  order	   to	   identify	  new	  binding	  sites	  of	  Cra	  and	  
refine	   the	   consensus	   sequence	   (	   Figure	   1.2A),	   tested	   the	   response	   to	   Cra	   of	   the	   different	  
binding	  sites	  and	  created	  a	  map	  of	  activating	  respectively	  repressing	  activity	  in	  dependency	  of	  
the	   transcription	   initiation	   site	   (	   Figure	   1.2B).	   The	   general	   trend	   suggests	   that	   a	   positioning	  
downstream	  or	  overlapping	  with	  the	  promoter	  results	   in	   the	   inhibition	  of	   transcription	  start,	  









	  Figure	  1.2)	  Results	  of	   the	  SELEX	  study	  of	   the	  Cra	  binding	  sites	  by	  Shimada	  et	  al.	   (2011)	  (A)	  
Consensus	   sequence	   of	   the	   Cra	   binding	   site,	   computed	   based	   on	   the	   164	   binding	   sites	   that	  
were	   identified	   by	   SELEX.	   (B)	   Positioning	   of	   the	   Cra	   binding	   sites	   of	   all	   identified	   promoter	  




Cra	  is	  sensitive	  to	  the	  effectors	  fructose-­‐1,6-­‐bisphosphate	  (FBP)	  and	  fructose-­‐1-­‐phosphate	  
(F1P)	  that	  both	  bind	  to	  the	  effector	  binding	  domain	  of	  Cra.	  The	  structural	  conformation	  of	  Cra	  
when	   FBP	   or	   F1P	   are	   bound	   inhibits	   DNA-­‐binding,	   leading	   to	   a	   general	   inactivation	   of	   Cra	  








Figure	  1.3)	  Mechanism	  of	   the	   transcription	   factor	  Cra	   (blue:	  active,	  gray:	   inactive).	   In	  a	   low	  
glycolytic	  flux	  condition,	  the	  concentration	  of	  FBP	  (orange	  circles)	  is	  low	  and	  Cra	  active.	  Active	  
Cra	  binds	  to	  its	  binding	  site	  on	  the	  DNA	  and	  can	  either	  function	  as	  an	  activator	  or	  repressor.	  In	  
high	   flux	   conditions,	   the	   FBP	   concentration	   is	   high.	   FBP	   binds	   to	   Cra,	   which	   leads	   to	   a	  




The	   actual	   global	   function	   of	   Cra	   as	   a	   glycolytic	   flux	   sensor	   has	   been,	   and	   still	   is,	   a	  
controversial	  subject.	  One	  of	  the	  main	  reasons	  for	  this	  controversy	  is	  the	  considerably	  higher	  
Kd	   for	   binding	   of	   FBP	   compared	   to	   F1P,	   which	   are	   in	   the	   mM	   and	   µM	   range,	   respectively	  
(Ramseier	  et	  al,	  1993).	  The	  question	  has	  been	  raised,	  why	  a	  central	  flux	  sensor	  would	  have	  a	  
higher	  affinity	  to	  a	  metabolite	  of	  a	  branch	  pathway	  and	  even,	  whether	  the	  sensitivity	  for	  FBP	  
might	  have	  been	  an	  artifact	  in	  the	  measurement.	  
Two	   recent	   studies	  on	  Cra	   in	  different	  organism	  support	  an	  evolutionary	  explanation	   for	  
the	  differences	  in	  the	  Kds.	  Chavarría	  et	  al.	  (2014)	  could	  show	  that	  P.	  putida	  is	  solely	  sensitive	  to	  
F1P	  and	  does	  not	  respond	  to	  FBP,	  whereas	  Kochanowski	  et	  al.	  (2013b)	  could	  validate	  the	  FBP	  
sensitivity	   of	   Cra	   in	   E.	   coli.	   Considering	   these	   two	   findings	   and	   the	   omnipresence	   and	  
conservation	  of	  Cra	   in	  gram-­‐negative	  bacteria,	   it	  can	  be	  hypothesized	  that	  Cra	  adapted	  to	   its	  
different	   roles	   in	   the	   context	   of	   the	   different	   metabolism	   it	   faces	   in	   different	   organisms	  
(Chavarría	  et	  al,	  2011,	  2014).	  





1.2.2 Regulon	  and	  flux	  dependency	  
The	   regulation	   network	   has	   been	   expanded	   a	   lot	   since	   its	   initial	   characterization	   as	   a	  
regulator	  of	  the	  fructose	  operon	  (Geerse	  et	  al,	  1986;	  Chin	  et	  al,	  1987).	  With	  further	  research,	  
the	  pleiotropic	  properties	  and	  Cra’s	  importance	  for	  the	  regulation	  of	  carbon	  metabolism	  were	  
-­‐and	  still	  are-­‐	  revealed.	  
Already	  in	  the	  beginning	  of	  the	  research	  on	  Cra	  in	  the	  1990s,	  it	  became	  clear	  that	  it	  acts	  as	  
a	   major	   switch	   between	   sugar	   catabolism	   and	   gluconeogenesis	   (Ramseier	   et	   al,	   1993;	  
Ramseier,	  1996;	  Ramseier	  et	  al,	  1995;	  Saier	  &	  Ramseier,	  1996).	  In	  its	  active	  form,	  Cra	  represses	  
the	   transcription	   of	   core	   enzymes	   of	   the	   glycolytic	   pathway,	   like	   the	   genes	   for	   the	   6-­‐
phosphofructokinase	   I	   (pfkA)	  and	  the	  pyruvate	  kinase	   I	   (pykF).	  At	   the	  same	  time,	   it	  activates	  
the	   expression	   of	   gluconeogenic	   genes	   like	   the	   phosphoenolpyruvate	   synthetase	   (ppsA)	   and	  
the	   fructose-­‐1,6-­‐bisphosphatase	   I	   (fbp)	   (Chin	   et	   al,	   1989;	   Ramseier,	   1996).	   With	   the	  
development	   of	   new	   techniques	   to	   study	   protein-­‐DNA	   interactions,	   also	   the	   Cra-­‐regulation	  
network	  extended.	  In	  two	  SELEX	  studies,	  carried	  out	  by	  Shimada	  et	  al.	  (2005	  &	  2011),	  it	  could	  
be	   shown	   that	   Cra	   is	   actually	   involved	   in	   the	   regulation	   of	   far	   more	   enzymes	   of	   the	   core	  
metabolism,	   also	   outside	   of	   glycolysis	   and	   gluconeogenesis,	   as	   it	   is	   shown	   in	   Figure	   1.4.	  
Shimada	  et	  al.	   could	   for	  example	   show	   that	  besides	   repression	  of	   the	  genes	  pykA	  and	  pykF,	  
which	  both	  encode	  for	  the	  pyruvate	  kinase,	  also	  the	  three	  genes	  coding	  for	  the	  subunits	  of	  the	  
pyruvate	  dehydrogenase	  (PDH)	  complex,	  aceE	  (PDH	  decarboxylase	  component	  E1),	  aceF	  (PDH	  
dihydrolipoyltransacetylase	   component	   E2)	   and	   lpd	   (lipoamide	   dehydrogenase,	   PDH	  
component	  E3)	  are	   repressed.	  Hence,	  Cra	  does	  not	  only	   repress	   the	  glycolysis	   itself	  but	  also	  
the	   further	   downstream	   energy	   metabolism	   that	   follows.	   It	   also	   represses	   the	   key	   operon	  
cyoABCDE	  for	  the	  terminal	  electron	  transport	  system.	  Furthermore,	  Cra	  is	  also	  involved	  in	  the	  
repression	  of	  the	  gene	  zwf,	  which	  encodes	  for	  the	  glucose	  6-­‐phosphate-­‐1-­‐dehydrogenase,	  the	  
entry	  point	  to	  the	  pentose-­‐phosphate	  (PP)	  pathway	  (Rowley	  &	  Wolf,	  1991).	  Cra	  is	  furthermore	  
involved	   in	   the	   regulation	   of	   certain	   phosphotransferase	   systems	   (PTS)	   that	   enable	   the	  
transport	  of	  fructose,	  mannose,	  mannitol	  and	  to	  a	  certain	  extend	  glucose	  over	  the	  membrane	  
(Zubay	   et	   al,	   1970;	   Busby	   &	   Ebright,	   1999;	   Shimada	   et	   al,	   2011a).	   As	   recent	   ChiP-­‐exo	  
experiments	   in	  our	  group	   indicate,	   the	   regulation	  network	  of	  Cra	   is	  even	  more	  complex	  and	  
more	  sensitive	  to	  changes	  of	  the	  metabolic	  condition	  of	  the	  cell	  than	  currently	  known	  (Arkan	  
Vasie,	  unpublished	  data).	  	  
In	  a	  study	  from	  2012	  by	  Njoroge	  et	  al.	  was	  shown	  that	  additionally	  to	  the	  regulation	  on	  the	  





and	   that	   Cra	   is	   relevant	   in	   the	   virulence	   in	   pathogenic	   enterohemorrhagic	   Escherichia	   coli	  
(EHEC)	  (Njoroge	  et	  al,	  2012).	  	  
	  
	  	  	  	  	  	  	  	  	   	  
	  
	  
Figure	  1.4)	  Cra	  regulon	  described	  by	  Shimada	  et	  al.	  (2011).	  The	  genes	  in	  blue	  boxes	  are	  under	  
the	   control	   of	   Cra,	   although	   the	   genes	   in	   purple	   are	   not	   yet	   experimentally	   validated.	  
Important	   irreversible,	   respectively	   rate-­‐controlling,	   steps	   are	   highlighted	   by	   a	   red	   box.	   This	  
metabolic	   map	   gives	   an	   overview	   of	   the	   importance	   of	   Cra	   in	   the	   metabolic	   regulation	   in	  





1.2.3 Cra	  as	  a	  glycolytic	  flux	  biosensor	  	  
In	  a	   recent	  study	  by	  Kochanowski	  et	  al.,	   they	  could	  show	  that	  Cra’s	   function	   is	  beyond	  a	  
simple	  metabolite	   sensor,	   but	   actually	   capable	   of	   being	   a	  metabolic	   flux	   sensor.	   They	   could	  
show	  a	  clear,	   linear	  correlation	  between	  the	  FBP	  concentration,	  respectively	  Cra	  activity,	  and	  
the	   glycolytic	   flux	   (Figure	   1.5).	   By	   using	   a	  modeling	   approach,	   they	   could	   explain	   the	   linear	  
dependency	  of	  Cra	  activity	  on	  the	  glycolytic	  flux	  by	  the	  FBP	  induced	  feedforward	  activation	  of	  
the	   pyruvate	   kinase	   (Pyk).	   Pyk	   is	   under	   allosteric	   control	   of	   FBP	   and	   gets	   activated	   upon	   its	  
binding	  (Valentini	  et	  al,	  2000).	  The	  activated	  Pyk	  catalyzes	  the	  last	  and	  irreversible	  step	  in	  the	  
glycolysis,	   the	   conversation	   from	   phosphoenolpyruvate	   (PEP)	   to	   pyruvate.	   Due	   to	   this	  
feedforward	   activation,	   the	   correlation	   between	   the	   FBP	   concentration	   and	   the	   actual	  
glycolytic	  flux	  stays	  linear,	  even	  when	  the	  concentration	  of	  FBP	  is	  higher	  than	  the	  Km	  of	  the	  FBP	  
aldolase	  (Kochanowski	  et	  al,	  2013).	  
	  
A	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Figure	   1.5)	   Cra	   activity	   and	   fructose-­‐1,6-­‐bisphosphate	   concentration	   in	   dependency	   of	  
glycolytic	   flux.	   The	   study	   of	   Kochanowski	   et	   al.	   (2013)	   explored	   the	   correlations	   between	  
glycolytic	   flux,	  Cra	  activity	  and	  FBP	  concentration.	  (A)	  The	  measured	  glycolytic	   flux,	  triggered	  
by	  different	  glucose	  concentrations	  and	  different	  carbon	  sources,	  correlates	  with	  the	  activity	  
of	  Cra.	  A	  higher	  glucose	  concentration	  showed	  as	  well	  a	  higher	  glycolytic	  flux	  as	  a	  decrease	  in	  
Cra	   activity.	   The	   other	   carbon	   sources,	  which	   all	   induce	   different	   glycolytic	   fluxes,	   show	   the	  
same	   correlation	   between	   flux	   and	   Cra	   activity,	   indicating	   that	   the	   effect	   is	   not	   substrate	  
specific.	  (B)	  The	  intracellular	  FBP	  concentration	  is	  depending	  on	  the	  glycolytic	  flux.	  Figure	  from	  
Kochanowski	  et	  al.	  (2013).	  
	  
	  
Furthermore,	  Kochanowski	  et	  al.	  developed	  an	  initial	  Cra-­‐based	  glycolytic	  flux	  biosensor	  by	  
fusing	   the	   Cra	   dependent	   promoter	   region	   of	   the	   pyruvate	   kinase	   gene	   (pykF)	   to	   gfp.	   In	   a	  
second	  construct,	  the	  Cra	  binding	  site	  was	  removed	  from	  the	  pykF	  promoter	  region,	  resulting	  
in	   a	   constitutive	   expression	   of	   GFP.	   The	   expression	   of	   GFP	   in	   the	   two	   different	   strains	   was	  






Recent	   technological	   advances	  as	   for	   example	   low	  cost	  DNA	   synthesis	  of	   short	  DNA	  and	  
RNA	   oligonucleotides	   as	   well	   as	   full	   gene	   sequences,	   next	   generation	   sequencing	   (NGS),	  
bacterial	   fluorescent	   activated	   cell	   sorting	   (FACS)	   and	   the	   application	   of	   robotic	   systems	   in	  
order	  to	  generate	  diversity	  facilitate	  faster	  and	  more	  efficient	  developments	  in	  biotechnology.	  
The	  current	  bottleneck,	  however,	  is	  the	  screening	  for	  interesting	  candidates	  in	  the	  abundance	  
of	  variants.	  The	  promise	  of	  biosensors	  is	  that	  they	  will	  eventually	  offer	  cheap	  and	  customizable	  
in	  vivo	  analysis	  tools.	  
An	  thus	  far	  unexplored	  area	  of	  applications	  is	  the	  use	  of	  biosensors	  in	  physiological	  studies	  
in	  vivo.	  A	  new	  the	  current	  biosensor	  offers	  the	  possibility	  to	  reliably	  measure	  the	  glycolytic	  flux	  
over	  a	  very	  broad,	  physiologically	  relevant	  range	  and	  convert	  the	  information	  into	  a	  cheap	  and	  
easily	  detectable	  fluorescent	  output.	  
1.4 Aim	  of	  this	  project	  
Despite	  the	  broad	  range	  of	  applications	  of	  biosensors	  for	  biotechnological	  purposes,	  there	  
has	   not	   yet	   been	   much	   interest	   in	   applying	   biosensors	   for	   studying	   the	   physiology	   or	  
regulation	   networks	   in	   bacteria	   in	   a	   large-­‐scale	   approach.	   Most	   biosensors	   are	   also	   very	  
limited	   in	   their	   application	   spectrum,	   as	   their	   effector	   molecule	   limits	   the	   versatility	   and	  
changing	   the	   specificity.	   Even	   though	   this	   is	   possible	   as	   shown	   in	   several	   examples,	   it	  
ultimately	   means	   the	   development	   of	   a	   novel	   biosensor,	   including	   optimization	   and	  
verification.	  
The	   aim	   of	   this	   PhD	   project	   is	   to	   develop	   a	   glycolytic	   flux	   biosensor	   suitable	   for	   high-­‐
throughput	   genotype	   to	   phenotype	   association	   studies.	   Besides	   verifying	   its	   applicability	   for	  
possible	   biotechnology	   setups,	   it	   will	   be	   used	   to	   characterize	   the	   effect	   of	   thousands	   of	  
individual	  E.	  coli	  gene	  knockouts	  on	  the	  glycolytic	  flux.	  
A	  biosensor	  of	  this	  kind	  would	  have	  versatile	  possible	  applications,	  ranging	  from	  improving	  
the	   development	   speed	   for	   new	  production	   pathways,	   characterizing	   the	  metabolic	   state	   of	  
different	  genotypes	  or	  build	  a	  genetic	  circuit	  in	  combination	  with	  product	  sensors	  in	  order	  to	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Appendix	  –	  Chapter	  1	  	  
	  
Table	   S	   I)	   Comprehensive	   list	   of	   known	   stimuli	   for	   transcription	   factors	   and	   riboswitches.	  
Source:	  RegPrecise	  (Novichkov	  et	  al,	  2013)	  




(regulons)	   Genomes	  
Amino	  Acids	   	   	   	  
4-­‐hydroxyproline	   11	  (37)	   0	  (0)	   11	  (11)	   103	  
Arginine	   29	  (239)	   0	  (0)	   29	  (29)	   249	  
Asparagine	   1	  (5)	   0	  (0)	   1	  (1)	   11	  
Betaine	   3	  (11)	   0	  (0)	   3	  (3)	   46	  
Branched-­‐chain	  amino	  acids	   3	  (33)	   0	  (0)	   3	  (3)	   33	  
Choline	   1	  (5)	   0	  (0)	   1	  (1)	   11	  
cis-­‐Urocanic	  acid	   19	  (117)	   0	  (0)	   19	  (19)	   172	  
Glutamate	   3	  (15)	   0	  (0)	   3	  (3)	   18	  
Glycine	   3	  (35)	   18	  (145)	   21	  (21)	   188	  
Histidine	   8	  (55)	   0	  (0)	   8	  (8)	   55	  
Homocysteine	   17	  (134)	   0	  (0)	   17	  (17)	   171	  
L-­‐citrulline	   1	  (8)	   0	  (0)	   1	  (1)	   11	  
L-­‐glutamine	   0	  (0)	   1	  (9)	   1	  (1)	   14	  
LL-­‐2,6-­‐Diaminopimelate	   1	  (12)	   0	  (0)	   1	  (1)	   12	  
Lysine	   1	  (4)	   10	  (102)	   11	  (11)	   134	  
O-­‐acetyl-­‐L-­‐serine	   4	  (43)	   0	  (0)	   4	  (4)	   33	  
Ornithine	   1	  (8)	   0	  (0)	   1	  (1)	   11	  
Phenylalanine	   8	  (67)	   0	  (0)	   8	  (8)	   70	  
Proline	   12	  (42)	   0	  (0)	   12	  (12)	   122	  
S-­‐adenosylhomocysteine	   10	  (70)	   9	  (67)	   19	  (19)	   151	  
S-­‐adenosylmethionine	   8	  (74)	   16	  (130)	   24	  (24)	   222	  
Tryptophan	   10	  (59)	   0	  (0)	   10	  (10)	   83	  
Tyrosine	   8	  (67)	   0	  (0)	   8	  (8)	   70	  
Aminoacyl-­‐tRNAs	   	   	   	  
Ala-­‐tRNA	   0	  (0)	   5	  (62)	   5	  (5)	   68	  
Arg-­‐tRNA	   0	  (0)	   3	  (26)	   3	  (3)	   46	  
Asn-­‐tRNA	   0	  (0)	   5	  (43)	   5	  (5)	   68	  
Asp-­‐tRNA	   0	  (0)	   4	  (24)	   4	  (4)	   61	  
Cys-­‐tRNA	   0	  (0)	   4	  (32)	   4	  (4)	   53	  
Gly-­‐tRNA	   0	  (0)	   7	  (64)	   7	  (7)	   78	  
His-­‐tRNA	   0	  (0)	   3	  (13)	   3	  (3)	   50	  
Ile-­‐tRNA	   0	  (0)	   9	  (92)	   9	  (9)	   95	  
Leu-­‐tRNA	   0	  (0)	   4	  (53)	   4	  (4)	   53	  
Lys-­‐tRNA	   0	  (0)	   3	  (8)	   3	  (3)	   46	  
Met-­‐tRNA	   0	  (0)	   5	  (45)	   5	  (5)	   68	  
Phe-­‐tRNA	   0	  (0)	   6	  (70)	   6	  (6)	   73	  








(regulons)	   Genomes	  
Pro-­‐tRNA	   0	  (0)	   4	  (31)	   4	  (4)	   51	  
Ser-­‐tRNA	   0	  (0)	   6	  (62)	   6	  (6)	   73	  
Thr-­‐tRNA	   0	  (0)	   6	  (70)	   6	  (6)	   73	  
Trp-­‐tRNA	   0	  (0)	   6	  (66)	   6	  (6)	   73	  
Tyr-­‐tRNA	   0	  (0)	   4	  (46)	   4	  (4)	   53	  
Val-­‐tRNA	   0	  (0)	   7	  (66)	   7	  (7)	   78	  
Antibiotics	   	   	   	   	  
3,3'-­‐neotrehalosadiamine	   1	  (3)	   0	  (0)	   1	  (1)	   11	  
Bacillibactin	   1	  (5)	   0	  (0)	   1	  (1)	   11	  
Chloramphenicol	   1	  (5)	   0	  (0)	   1	  (1)	   12	  
Distamycin	   1	  (4)	   0	  (0)	   1	  (1)	   7	  
Fe-­‐Bacillibactin	   1	  (5)	   0	  (0)	   1	  (1)	   11	  
Methicillin	   1	  (1)	   0	  (0)	   1	  (1)	   7	  
Penicillin	  G	   1	  (1)	   0	  (0)	   1	  (1)	   7	  
Ramoplanin	   1	  (7)	   0	  (0)	   1	  (1)	   11	  
Tetracycline	   1	  (5)	   0	  (0)	   1	  (1)	   12	  
Carbohydrates	   	   	   	  
2-­‐deoxy-­‐5-­‐keto-­‐D-­‐gluconate	  6-­‐
phosphate	   2	  (5)	   0	  (0)	   2	  (2)	   26	  
2-­‐keto-­‐3-­‐deoxy-­‐6-­‐phosphogluconate	   13	  (95)	   0	  (0)	   13	  (13)	   110	  
2-­‐keto-­‐3-­‐deoxygluconate	   6	  (33)	   0	  (0)	   6	  (6)	   64	  
2-­‐keto-­‐D-­‐gluconate	   4	  (19)	   0	  (0)	   4	  (4)	   34	  
5-­‐dehydro-­‐D-­‐gluconate	   1	  (4)	   0	  (0)	   1	  (1)	   12	  
6-­‐phosphogluconate	   1	  (13)	   0	  (0)	   1	  (1)	   15	  
Aldotetraouronic	  acid	   1	  (4)	   0	  (0)	   1	  (1)	   11	  
Allolactose	   1	  (5)	   0	  (0)	   1	  (1)	   12	  
Allose-­‐6-­‐phosphate	   2	  (3)	   0	  (0)	   2	  (2)	   19	  
Alpha-­‐galactosides	   2	  (8)	   0	  (0)	   2	  (2)	   21	  
Alpha-­‐glucoside	   2	  (12)	   0	  (0)	   2	  (2)	   30	  
Alpha-­‐mannans	   3	  (6)	   0	  (0)	   3	  (3)	   11	  
Arabinan	   1	  (6)	   0	  (0)	   1	  (1)	   11	  
Arabinogalactan	  oligosaccharides	   1	  (1)	   0	  (0)	   1	  (1)	   11	  
Arabinose	   7	  (47)	   0	  (0)	   7	  (7)	   84	  
Ascorbate-­‐6-­‐phosphate	   7	  (26)	   0	  (0)	   7	  (7)	   47	  
Beta-­‐galactosides	   8	  (29)	   0	  (0)	   8	  (8)	   67	  
Beta-­‐glucoside	   16	  (52)	   0	  (0)	   16	  (16)	   103	  
Beta-­‐glucoside-­‐6-­‐phosphate	   4	  (15)	   0	  (0)	   4	  (4)	   34	  
Cellobiose	   5	  (22)	   0	  (0)	   5	  (5)	   39	  
Cellobiose-­‐6-­‐phosphate	   7	  (26)	   0	  (0)	   7	  (7)	   37	  
Chitobiose	   1	  (8)	   0	  (0)	   1	  (1)	   11	  
Chondroitin	  sulphate	   1	  (7)	   0	  (0)	   1	  (1)	   11	  
D-­‐allose	   1	  (2)	   0	  (0)	   1	  (1)	   12	  
D-­‐galactose-­‐6-­‐phosphate	   2	  (15)	   0	  (0)	   2	  (2)	   30	  








(regulons)	   Genomes	  
D-­‐gluconate	   2	  (7)	   0	  (0)	   2	  (2)	   11	  
D-­‐glucono-­‐delta-­‐lactone	   1	  (3)	   0	  (0)	   1	  (1)	   11	  
D-­‐glycerate	   8	  (28)	   0	  (0)	   8	  (8)	   66	  
D-­‐mannonate	   3	  (10)	   0	  (0)	   3	  (3)	   39	  
Deoxyribose-­‐5-­‐phosphate	   2	  (10)	   0	  (0)	   2	  (2)	   26	  
Ethanolamine	   5	  (21)	   0	  (0)	   5	  (5)	   59	  
Fructose	   2	  (12)	   0	  (0)	   2	  (2)	   25	  
Fructose-­‐1,6-­‐bisphosphate	   3	  (41)	   0	  (0)	   3	  (3)	   30	  
Fructose-­‐1,6-­‐diphosphate	   9	  (66)	   0	  (0)	   9	  (9)	   75	  
Fructose-­‐1-­‐phosphate	   13	  (55)	   0	  (0)	   13	  (13)	   125	  
Fructose-­‐6-­‐phosphate	   5	  (44)	   0	  (0)	   5	  (5)	   56	  
Fucose	   2	  (9)	   0	  (0)	   2	  (2)	   21	  
Galactarate	   1	  (2)	   0	  (0)	   1	  (1)	   11	  
Galactobiose	   1	  (6)	   0	  (0)	   1	  (1)	   10	  
Galactonate	   2	  (7)	   0	  (0)	   2	  (2)	   24	  
Galactosamine-­‐6-­‐phosphate	   7	  (18)	   0	  (0)	   7	  (7)	   57	  
Galactose	   11	  (61)	   0	  (0)	   11	  (11)	   128	  
Galactose-­‐6-­‐phosphate	   1	  (4)	   0	  (0)	   1	  (1)	   7	  
Galacturonate	   7	  (25)	   0	  (0)	   7	  (7)	   88	  
Galacturonate	  oligosaccharides	   1	  (8)	   0	  (0)	   1	  (1)	   11	  
Gluconate	   19	  (80)	   0	  (0)	   19	  (19)	   192	  
Glucosamine-­‐6-­‐phosphate	   10	  (54)	   6	  (44)	   16	  (16)	   147	  
Glucose	   7	  (25)	   0	  (0)	   7	  (7)	   22	  
Glucuronate	   13	  (38)	   0	  (0)	   13	  (13)	   132	  
Heparin	   1	  (4)	   0	  (0)	   1	  (1)	   11	  
Hyaluronan	   1	  (7)	   0	  (0)	   1	  (1)	   11	  
Hyaluronate	  oligosaccharide	  phosphate	   1	  (6)	   0	  (0)	   1	  (1)	   15	  
Kojibiose	   3	  (9)	   0	  (0)	   3	  (3)	   23	  
L-­‐fuculose-­‐1-­‐phosphate	   3	  (7)	   0	  (0)	   3	  (3)	   42	  
L-­‐galactose	   1	  (6)	   0	  (0)	   1	  (1)	   11	  
L-­‐gulonate	   3	  (10)	   0	  (0)	   3	  (3)	   39	  
L-­‐idonate	   2	  (11)	   0	  (0)	   2	  (2)	   27	  
L-­‐talarate	   3	  (5)	   0	  (0)	   3	  (3)	   29	  
L-­‐xylulose	   1	  (1)	   0	  (0)	   1	  (1)	   10	  
Lactose	   2	  (15)	   0	  (0)	   2	  (2)	   25	  
Maltose	   23	  (126)	   0	  (0)	   23	  (23)	   154	  
Maltose-­‐6-­‐phosphate	   3	  (10)	   0	  (0)	   3	  (3)	   18	  
Mannitol	   2	  (5)	   0	  (0)	   2	  (2)	   31	  
Mannose	   8	  (22)	   0	  (0)	   8	  (8)	   55	  
Mannose-­‐6-­‐phosphate	   1	  (1)	   0	  (0)	   1	  (1)	   6	  
N-­‐acetylgalactosamine	   3	  (17)	   0	  (0)	   3	  (3)	   30	  
N-­‐acetylgalactosamine-­‐6-­‐phosphate	   8	  (20)	   0	  (0)	   8	  (8)	   59	  
N-­‐acetylglucosamine	   16	  (71)	   0	  (0)	   16	  (16)	   134	  








(regulons)	   Genomes	  
N-­‐acetylglucosamine-­‐6-­‐phosphate	   11	  (80)	   0	  (0)	   11	  (11)	   106	  
N-­‐acetylmannosamine-­‐6-­‐phosphate	   3	  (8)	   0	  (0)	   3	  (3)	   29	  
N-­‐acetylmuramate-­‐6-­‐phosphate	   5	  (18)	   0	  (0)	   5	  (5)	   60	  
N-­‐acetylneuraminic	  acid	   4	  (30)	   0	  (0)	   4	  (4)	   46	  
Nigerose-­‐6-­‐phosphate	   2	  (3)	   0	  (0)	   2	  (2)	   30	  
O-­‐glycans	   2	  (2)	   0	  (0)	   2	  (2)	   11	  
Pectic	  galactan	   2	  (9)	   0	  (0)	   2	  (2)	   11	  
Psicose	   1	  (4)	   0	  (0)	   1	  (1)	   15	  
Raffinose	   1	  (4)	   0	  (0)	   1	  (1)	   12	  
Rhamnose	   15	  (56)	   0	  (0)	   15	  (15)	   125	  
Rhamnulose-­‐1-­‐phosphate	   1	  (5)	   0	  (0)	   1	  (1)	   11	  
Rhamogalacturonate	  oligosaccharides	   3	  (13)	   0	  (0)	   3	  (3)	   38	  
rhizopine	   1	  (5)	   0	  (0)	   1	  (1)	   15	  
Ribitol	   1	  (1)	   0	  (0)	   1	  (1)	   15	  
Ribose	   25	  (121)	   0	  (0)	   25	  (25)	   222	  
Sialic	  acid	   1	  (3)	   0	  (0)	   1	  (1)	   10	  
Sorbitol	   3	  (13)	   0	  (0)	   3	  (3)	   41	  
Sorbitol-­‐6-­‐phosphate	   1	  (5)	   0	  (0)	   1	  (1)	   12	  
Sorbose	   1	  (1)	   0	  (0)	   1	  (1)	   12	  
Sucrose	   13	  (57)	   0	  (0)	   13	  (13)	   127	  
Sucrose-­‐6-­‐phosphate	   10	  (43)	   0	  (0)	   10	  (10)	   90	  
Tagatose-­‐6-­‐phosphate	   2	  (5)	   0	  (0)	   2	  (2)	   30	  
Trehalose	   8	  (36)	   0	  (0)	   8	  (8)	   85	  
Trehalose-­‐6-­‐phosphate	   14	  (66)	   0	  (0)	   14	  (14)	   115	  
Xylitol	   3	  (5)	   0	  (0)	   3	  (3)	   40	  
Xylose	   10	  (57)	   0	  (0)	   10	  (10)	   86	  
Coenzymes	   	   	   	   	  
Adenosylcobalamin	   4	  (23)	   21	  (197)	   25	  (25)	   230	  
Biotin	   28	  (222)	   0	  (0)	   28	  (28)	   252	  
Flavin	  mononucleotide	   8	  (44)	   36	  (247)	   44	  (44)	   377	  
Heme	   3	  (32)	   0	  (0)	   3	  (3)	   39	  
NAD	   1	  (11)	   0	  (0)	   1	  (1)	   12	  
NADH	   18	  (156)	   0	  (0)	   18	  (18)	   138	  
Niacin	   7	  (57)	   0	  (0)	   7	  (7)	   77	  
Pre-­‐queuosine	   0	  (0)	   2	  (17)	   2	  (2)	   30	  
Pre-­‐queuosine1	   0	  (0)	   7	  (51)	   7	  (7)	   92	  
Pyridoxal-­‐5-­‐phosphate	   61	  (161)	   0	  (0)	   61	  (61)	   337	  
Tetrahydrofolate	   0	  (0)	   3	  (22)	   3	  (3)	   50	  
Thiamine	  phosphate	   4	  (28)	   0	  (0)	   4	  (4)	   28	  
Thiamine	  pyrophosphate	   0	  (0)	   40	  (365)	   40	  (40)	   380	  
Heterocyclic	  Compounds	   	   	   	  
Bis-­‐indoles	   1	  (4)	   0	  (0)	   1	  (1)	   7	  
Catechin	   1	  (2)	   0	  (0)	   1	  (1)	   11	  








(regulons)	   Genomes	  
Fisetin	   2	  (6)	   0	  (0)	   2	  (2)	   11	  
Flavonoids	   1	  (2)	   0	  (0)	   1	  (1)	   11	  
Paraquat	   18	  (85)	   0	  (0)	   18	  (18)	   164	  
Proflavin	   1	  (12)	   0	  (0)	   1	  (1)	   12	  
Quercetin	   2	  (6)	   0	  (0)	   2	  (2)	   11	  
Rhodamine	  6G	   1	  (12)	   0	  (0)	   1	  (1)	   12	  
Inorganic	  Chemicals	   	   	   	  
Arsenate	   5	  (30)	   0	  (0)	   5	  (5)	   38	  
Arsenite	   7	  (45)	   0	  (0)	   7	  (7)	   53	  
Cadmium,	  ion	  (Cd2+)	   25	  (156)	   0	  (0)	   25	  (25)	   215	  
Cobalt	  ion,	  (Co2+)	   5	  (36)	   0	  (0)	   5	  (5)	   49	  
Copper	  ion,	  (Cu+)	   27	  (156)	   0	  (0)	   27	  (27)	   228	  
Copper	  ion,	  (Cu2+)	   6	  (62)	   0	  (0)	   6	  (6)	   67	  
Hydrogen	  peroxide	   7	  (67)	   0	  (0)	   7	  (7)	   67	  
Inorganic	  phosphate	   3	  (32)	   0	  (0)	   3	  (3)	   35	  
Iron	  ion,	  (Fe2+)	   35	  (304)	   0	  (0)	   35	  (35)	   268	  
Lead	  ion,	  (Pb2+)	   18	  (96)	   0	  (0)	   18	  (18)	   170	  
Magnesium	  ion,	  (Mg2+)	   0	  (0)	   9	  (44)	   9	  (9)	   100	  
Manganese	  ion,	  (Mn2+)	   24	  (173)	   0	  (0)	   24	  (24)	   171	  
Mercury	  ion,	  (Hg2+)	   13	  (32)	   0	  (0)	   13	  (13)	   129	  
Molybdate	   29	  (126)	   0	  (0)	   29	  (29)	   221	  
Molybdenum	   1	  (7)	   16	  (81)	   17	  (17)	   175	  
Nickel	  ion,	  (Ni2+)	   20	  (88)	   0	  (0)	   20	  (20)	   193	  
Nitrate	   5	  (46)	   0	  (0)	   5	  (5)	   53	  
Nitric	  oxide	   45	  (240)	   0	  (0)	   45	  (45)	   254	  
Nitrite	   8	  (70)	   0	  (0)	   8	  (8)	   88	  
Oxygen	   13	  (115)	   0	  (0)	   13	  (13)	   119	  
Potassium	  ion	   2	  (27)	   0	  (0)	   2	  (2)	   28	  
Silver	  ion,	  (Ag+)	   5	  (37)	   0	  (0)	   5	  (5)	   37	  
Sulfate	   5	  (20)	   0	  (0)	   5	  (5)	   42	  
Sulfite	   2	  (10)	   0	  (0)	   2	  (2)	   19	  
Tetrathionate	   4	  (14)	   0	  (0)	   4	  (4)	   47	  
Thiosulfate	   4	  (37)	   0	  (0)	   4	  (4)	   37	  
Tungsten	   4	  (23)	   0	  (0)	   4	  (4)	   30	  
Zinc	  ion,	  (Zn2+)	   60	  (446)	   0	  (0)	   60	  (60)	   362	  
Lipids	  and	  Fatty	  Acids	   	   	   	  
Gamma-­‐linolenic	  acid	   2	  (8)	   0	  (0)	   2	  (2)	   26	  
Linoleate	   2	  (8)	   0	  (0)	   2	  (2)	   26	  
Long-­‐chain	  acyl-­‐ACP	   2	  (24)	   0	  (0)	   2	  (2)	   30	  
Oleate	   14	  (84)	   0	  (0)	   14	  (14)	   136	  
Oleoyl-­‐CoA	   7	  (71)	   0	  (0)	   7	  (7)	   73	  
Palmitoyl-­‐CoA	   7	  (71)	   0	  (0)	   7	  (7)	   73	  
Phytanate	   2	  (8)	   0	  (0)	   2	  (2)	   26	  








(regulons)	   Genomes	  
Unsaturated	  acyl-­‐ACP	   12	  (78)	   0	  (0)	   12	  (12)	   90	  
Unsaturated	  acyl-­‐CoA	   12	  (78)	   0	  (0)	   12	  (12)	   90	  
Nucleotides	  and	  Nucleosides	   	   	  
5-­‐phosphoribosyl	  1-­‐pyrophosphate	   4	  (48)	   0	  (0)	   4	  (4)	   48	  
Adenine	   0	  (0)	   8	  (69)	   8	  (8)	   105	  
Adenosine	   1	  (4)	   0	  (0)	   1	  (1)	   15	  
Adenosine	  diphosphate	  ribose	   26	  (97)	   0	  (0)	   26	  (26)	   263	  
Cyclic	  3',5'-­‐AMP	   4	  (49)	   0	  (0)	   4	  (4)	   50	  
Cyclic	  diguanylate	   0	  (0)	   9	  (50)	   9	  (9)	   104	  
Deoxyinosine	   1	  (4)	   0	  (0)	   1	  (1)	   12	  
Deoxyribonucleotides	   43	  (363)	   0	  (0)	   43	  (43)	   378	  
Guanine	   3	  (31)	   8	  (69)	   11	  (11)	   126	  
Guanosine	  3',5'-­‐bis(diphosphate)	   1	  (10)	   0	  (0)	   1	  (1)	   12	  
Guanosine	  triphosphate	   2	  (26)	   0	  (0)	   2	  (2)	   26	  
Hypoxanthine	   3	  (31)	   0	  (0)	   3	  (3)	   31	  
Pyrimidine	  nucleoside	   2	  (6)	   0	  (0)	   2	  (2)	   6	  
Uracil	   19	  (95)	   0	  (0)	   19	  (19)	   118	  
Xanthine	   1	  (3)	   0	  (0)	   1	  (1)	   6	  
Xanthosine	   1	  (4)	   0	  (0)	   1	  (1)	   12	  
Organic	  Chemicals	   	   	   	  
2,4-­‐Dinitrophenol	   1	  (12)	   0	  (0)	   1	  (1)	   12	  
2-­‐Acetolactate	   2	  (28)	   0	  (0)	   2	  (2)	   28	  
2-­‐aminoethylphosphonate	   6	  (14)	   0	  (0)	   6	  (6)	   43	  
2-­‐methylcitrate	   10	  (60)	   0	  (0)	   10	  (10)	   88	  
2-­‐oxoglutarate	   4	  (29)	   0	  (0)	   4	  (4)	   32	  
3-­‐hydroxybenzoate	   1	  (2)	   0	  (0)	   1	  (1)	   8	  
4,5-­‐dihydroxypentan-­‐2,3-­‐dione	   1	  (6)	   0	  (0)	   1	  (1)	   12	  
4-­‐hydroxyphenylpyruvate	   2	  (17)	   0	  (0)	   2	  (2)	   24	  
Acetate	   1	  (4)	   0	  (0)	   1	  (1)	   11	  
Acetohydroxybutyrate	   1	  (16)	   0	  (0)	   1	  (1)	   16	  
Acetoin	   1	  (6)	   0	  (0)	   1	  (1)	   11	  
Allantoin	   1	  (2)	   0	  (0)	   1	  (1)	   12	  
Carbonyl	  cyanide	  m-­‐
chlorophenylhydrazone	   1	  (12)	   0	  (0)	   1	  (1)	   12	  
Choline	   1	  (7)	   0	  (0)	   1	  (1)	   12	  
Citrate	   7	  (41)	   0	  (0)	   7	  (7)	   41	  
Cumene	  hydroperoxide	   1	  (8)	   0	  (0)	   1	  (1)	   11	  
Deoxyfructosyl	  glutamine	   1	  (3)	   0	  (0)	   1	  (1)	   15	  
Diamide	   13	  (42)	   0	  (0)	   13	  (13)	   119	  
Ethidium	  bromide	   1	  (12)	   0	  (0)	   1	  (1)	   12	  
Ferulic	  acid	   4	  (12)	   0	  (0)	   4	  (4)	   49	  
Formaldehyde	   2	  (14)	   0	  (0)	   2	  (2)	   26	  
Formate	   7	  (29)	   0	  (0)	   7	  (7)	   64	  








(regulons)	   Genomes	  
Fructoselysine	  6-­‐phosphate	   1	  (2)	   0	  (0)	   1	  (1)	   11	  
Galangin	   1	  (4)	   0	  (0)	   1	  (1)	   11	  
Gamma-­‐aminobutyric	  acid	   12	  (39)	   0	  (0)	   12	  (12)	   88	  
Gentisate	   1	  (2)	   0	  (0)	   1	  (1)	   8	  
Glycerate	   2	  (20)	   0	  (0)	   2	  (2)	   28	  
Glycerol	  3-­‐phosphate	   2	  (16)	   0	  (0)	   2	  (2)	   22	  
Glycolate	   8	  (25)	   0	  (0)	   8	  (8)	   85	  
Glyoxylate	   1	  (10)	   0	  (0)	   1	  (1)	   12	  
Homogentisate	   1	  (5)	   0	  (0)	   1	  (1)	   8	  
L-­‐lactate	   22	  (100)	   0	  (0)	   22	  (22)	   210	  
L-­‐malate	   2	  (17)	   0	  (0)	   2	  (2)	   30	  
Lactate	   1	  (6)	   0	  (0)	   1	  (1)	   10	  
Malonyl-­‐CoA	   2	  (18)	   0	  (0)	   2	  (2)	   18	  
Mannopine	   1	  (3)	   0	  (0)	   1	  (1)	   15	  
Methylglyoxal	   1	  (8)	   0	  (0)	   1	  (1)	   15	  
p-­‐aminobenzoyl-­‐glutamate	   1	  (4)	   0	  (0)	   1	  (1)	   12	  
p-­‐Coumaric	  acid	   3	  (10)	   0	  (0)	   3	  (3)	   41	  
Phenylacetyl-­‐CoA	   17	  (80)	   0	  (0)	   17	  (17)	   138	  
Protocatechuate	   1	  (2)	   0	  (0)	   1	  (1)	   8	  
Putrescine	   1	  (9)	   0	  (0)	   1	  (1)	   11	  
Pyruvate	   7	  (65)	   0	  (0)	   7	  (7)	   65	  
Quinate	   1	  (2)	   0	  (0)	   1	  (1)	   8	  
Quinone	   1	  (9)	   0	  (0)	   1	  (1)	   11	  
Salicylate	   2	  (8)	   0	  (0)	   2	  (2)	   23	  
Shikimate	   1	  (2)	   0	  (0)	   1	  (1)	   8	  
Tamarixetin	   1	  (4)	   0	  (0)	   1	  (1)	   11	  
Taurine	   9	  (26)	   0	  (0)	   9	  (9)	   89	  
tert-­‐Butyl	  hydroperoxide	   1	  (8)	   0	  (0)	   1	  (1)	   11	  
Vanillate	   10	  (28)	   0	  (0)	   10	  (10)	   83	  
Other	  factors	   	   	   	  
Blue	  light	   4	  (21)	   0	  (0)	   4	  (4)	   45	  
DNA	  damage	   41	  (327)	   0	  (0)	   41	  (41)	   339	  
Heat	  shock	   45	  (374)	   0	  (0)	   45	  (45)	   339	  
Iron-­‐sulfur	  cluster	  redox	  state	   26	  (216)	   0	  (0)	   26	  (26)	   223	  
New	  effector	   4	  (11)	   0	  (0)	   4	  (4)	   40	  
Peptides,	  and	  Proteins	   	   	   	  
BceS,	  sensor	  histidine	  kinase	  
(bacitracin)	   1	  (7)	   0	  (0)	   1	  (1)	   11	  
BlaR,	  sensor	  histidine	  kinase	  (beta-­‐
lactam	  antibiotics)	   1	  (4)	   0	  (0)	   1	  (1)	   7	  
CelB,	  cellobiose-­‐specific	  PTS	  
component	  EIIB	   2	  (10)	   0	  (0)	   2	  (2)	   30	  
ComP,	  sensor	  histidine	  kinase	  (ComX)	   1	  (4)	   0	  (0)	   1	  (1)	   11	  
CssS,	  sensor	  histidine	  kinase	   1	  (5)	   0	  (0)	   1	  (1)	   11	  








(regulons)	   Genomes	  
CysK,	  cysteine	  synthetase	   2	  (18)	   0	  (0)	   2	  (2)	   18	  
Feedback-­‐inhibited	  GlnA,	  glutamine	  
synthetase	   3	  (28)	   0	  (0)	   3	  (3)	   18	  
GlnK,	  sensor	  histidine	  kinase	  
(glutamine)	   1	  (6)	   0	  (0)	   1	  (1)	   11	  
GlnK-­‐AMP,	  signal	  transduction	  protein	   5	  (16)	   0	  (0)	   5	  (5)	   39	  
GutB,	  sorbitol-­‐specific	  PTS	  EIIB	  
component	   2	  (7)	   0	  (0)	   2	  (2)	   30	  
HPr,	  phosphocarrier	  protein	   19	  (131)	   0	  (0)	   19	  (19)	   59	  
HssS,	  sensor	  histidine	  kinase	  (heme)	   1	  (7)	   0	  (0)	   1	  (1)	   7	  
KdpS,	  sensor	  histidine	  kinase	   1	  (2)	   0	  (0)	   1	  (1)	   10	  
LiaS,	  sensor	  histidine	  kinase	  (bacitracin,	  
nisin,	  ramoplanin,	  vancomycin)	   1	  (11)	   0	  (0)	   1	  (1)	   11	  
LicB,	  lichenan-­‐specific	  enzyme	  IIB	  PTS	  
component	   1	  (5)	   0	  (0)	   1	  (1)	   11	  
MalK,	  sensor	  histidine	  kinase	  (malate)	   1	  (5)	   0	  (0)	   1	  (1)	   11	  
Malonyl-­‐ACP	   1	  (7)	   0	  (0)	   1	  (1)	   7	  
ManP,	  mannose-­‐specific	  enzyme	  IIBCA	  
PTS	  component	   2	  (7)	   0	  (0)	   2	  (2)	   18	  
MtlA,	  mannitol-­‐specific	  enzyme	  IICB	  
PTS	  component	   4	  (24)	   0	  (0)	   4	  (4)	   48	  
NreB,	  sensor	  histidine	  kinase	  (Nitrate,	  
Nitrite)	   1	  (6)	   0	  (0)	   1	  (1)	   7	  
NrgA,	  ammonium	  uptake	  protein	   1	  (10)	   0	  (0)	   1	  (1)	   11	  
NrgB,	  ammonium	  uptake	  protein	   1	  (10)	   0	  (0)	   1	  (1)	   11	  
Phosphorylated	  NtrB,	  signal	  histidine	  
kinase	   21	  (193)	   0	  (0)	   21	  (21)	   207	  
PspA	  regulatory	  protein	   1	  (5)	   0	  (0)	   1	  (1)	   10	  
PyrR	   0	  (0)	   9	  (79)	   9	  (9)	   95	  
RocG,	  glutamate	  dehydrogenase	   2	  (9)	   0	  (0)	   2	  (2)	   11	  
SaeS,	  sensor	  histidine	  kinase	   1	  (4)	   0	  (0)	   1	  (1)	   7	  
SdpI,	  signal	  transduction	  protein	   1	  (8)	   0	  (0)	   1	  (1)	   11	  
SgaB,	  ascorbate-­‐specific	  PTS	  system	  
EIIB	  component	   1	  (11)	   0	  (0)	   1	  (1)	   15	  
SgaB2,	  ascorbate-­‐specific	  PTS	  system,	  
EIIB	  component	   1	  (8)	   0	  (0)	   1	  (1)	   15	  
SinI,	  antirepressor	  protein	   1	  (7)	   0	  (0)	   1	  (1)	   11	  
Trx,	  thioredoxin	  protein	   1	  (12)	   0	  (0)	   1	  (1)	   14	  
YvcQ,	  sensor	  histidine	  kinase	   1	  (4)	   0	  (0)	   1	  (1)	   11	  





































Measuring,	  understanding	  and	   influencing	  the	  metabolic	   flux	  of	  bacterial	  cells	  are	  crucial	  
for	   the	   development	   and	   optimization	   of	   production	   pathways.	   A	  metabolic	   flux	   sensor	   can	  
help	  to	  understand	  bacterial	  physiology	  as	  well	  as	  refining	   in	   silico	  metabolic	  modelling.	  This	  
chapter	   presents	   a	   novel,	   improved	   Cra-­‐based	   biosensor	   in	   E.	   coli	   with	   the	   characteristics	  
required	  for	  high-­‐throughput	  screenings	  in	  flow	  cytometry.	  In	  order	  to	  improve	  the	  qualities	  of	  
the	   original	   Cra	   biosensor	   by	   Kochanowski	   et	   al.,	   different	   native	   promoters	  were	   tested	   to	  
respond	   to	  different	   glycolytic	   fluxes.	   The	  best	   promoter	  of	  ppsA	  was	   chosen	   to	   control	  gfp	  
expression	  and	  a	  mutated	  version	  without	  the	  repressor	  binding	  site	  controlling	  rfp	  expression.	  
This	  allows	  constitutive	  expression	  of	  rfp	  and	  enables	  to	  correct	  for	  possible	  effects	  on	  protein	  
expression	   caused	   by	   different	   growth	   phases	   and	   doubling	   times.	   The	   glycolytic	   flux	  
dependency	  of	  the	  biosensor	  was	  validated	  for	  the	  range	  of	  physiologically	  relevant	  glycolytic	  
fluxes	  in	  a	  series	  of	  different	  carbon	  sources.	  Additionally,	  the	  sensitivity	  of	  this	  Cra-­‐biosensor	  
was	   tested	   during	   the	   expression	   of	   mevalonate	   from	   the	   pMevT	   production	   pathway,	  
developed	   by	  Martin	   et	   al,	   2003.	   It	   could	   be	   demonstrated	   that	   the	   dynamic	   range	   of	   this	  
biosensor	  exceeds	  the	  native	  range	  and	  therefore	  can	  also	  be	  applied	  in	  experimental	  setups	  
that	  aim	  for	  increasing	  the	  glycolytic	  flux.	  
2.2 Introduction	  
	  This	   chapter	   focuses	   on	   creating	   to	   use	   the	   already	   excising	   Cra	   based	   glycolytic	   flux	  
biosensor	  (Kochanowski	  et	  al,	  2013)	  and	  develop	  it	  further.	  The	  current	  sensor	  is	  based	  on	  the	  
Cra	  controlled	  pykF	  promoter	  region	  of	  the	  E.	  coli	  genome	  and	  was	  shown	  to	  give	  a	  reliable,	  
flux-­‐depended	  GFP	  expression	   in	   steady	   state	  measurements	   (Kochanowski	  et	  al,	   2013).	  The	  
aim	  of	  an	  improved	  biosensor	  is	  to	  be	  able	  to	  obtain	  a	  reliable,	  single	  cell	  signal	  output	  while	  
measuring	  only	  once,	  at	  one	  time	  point	  during	  exponential	  growth.	  These	  characteristics	  are	  
essential	  for	  the	  use	  of	  the	  biosensor	  in	  large-­‐scale	  screenings.	  Such	  large	  scales	  screenings	  are	  
needed	  to	  overcome	  bottlenecks	  in	  the	  identification	  of	  mutants	  with	  improved	  glycolytic	  flux,	  
which	   could	  be	   redirected	   towards	  production	  pathways.	   Furthermore,	   the	  ability	   to	  quickly	  
generate	   large	  datasets	   is	   also	   interesting	   for	   any	   kind	  of	   global	  network	   studies.	  A	  detailed	  
introduction	  including	  successful	  examples	  of	  applications	  of	  biosensors	  in	  biotechnology	  and	  






2.3 Materials	  and	  methods	  
2.3.1 Strains,	  plasmids	  and	  DNA-­‐primer	  
E.	  coli	  Top10	  and	  E.	  coli	  DH5a	  were	  used	  for	  the	  construction	  of	  pFlux.	  E.	  coli	  BW25113	  and	  
derived	  knockout	  strains	  from	  the	  KEIO	  collection	  (Baba	  et	  al,	  2006)	  were	  used	  for	  the	  further	  
characterization	   and	   application	   of	   pFlux.	   For	   clarifications,	   the	   Cra	   knockout	   strain	   E.	  coli	  
BW25113	   JW0078-­‐1	   is	   called	   ∆cra	  throughout	   this	   manuscript,	   even	   though	   it	   is	   originally	  
labeled	  ∆fruR	  in	  the	  KEIO	  collection	  due	  to	  old	  terminologies.	  
Primer	  were	  ordered	   from	   Integrated	  DNA	  Technologies	   and	  pMevT	  was	   constructed	  by	  
Martin	  et	  al,	  2003.	  
Strains,	  plasmids	  and	  primers	  are	  listed	  in	  Table	  SII	  and	  	  
Table	  SIII.	  
2.3.2 Cultivation	  and	  growth	  media	  
The	   growth	   media	   used	   in	   this	   study	   are	   Luria-­‐Bertani	   (LB)	   complex	   medium,	   Super	  
Optimal	   broth	   with	   Catabolite	   repression	   (SOC)	   medium	   and	   M9	   minimal	   medium	  
(Kochanowski	  et	  al,	  2013b)	  supplemented	  with	  filter-­‐sterile	  trace	  element	  solution,	  resulting	  in	  
a	  final	  concentration	  of	  6.3	  µM	  ZnSO4,	  7.0	  µM	  CuCl2,	  7.1	  µM	  MnSo4,	  7.6	  µM	  CaCl2	  and	  60	  µM	  
FeCl3).	  The	  M9	  medium	  contained	  5	  g/L	  of	  the	  respectively	  indicated	  carbon	  sources	  (fructose,	  
glucose,	   mannitol,	   sorbitol,	   galactose,	   glycerin,	   sodium	   pyruvate	   or	   sodium	   acetate).	   When	  
solid	  medium	  was	  required,	  the	  bacteria	  were	  grown	  on	  LB-­‐agar	  plates.	  Antibiotics	  were	  added	  
when	  required	  at	  the	  concentrations	  25	  µg/mL	  spectinomycin.	  
If	  not	  stated	  otherwise,	  the	  cells	  were	  cultured	  in	  5	  mL	  medium	  in	  15	  mL	  cultivation	  tubes	  
or	  2	  mL	  medium	  in	  24-­‐deep	  well	  plates.	  The	  cultivation	  tubes	  were	  incubated	  at	  37°C,	  190	  rpm	  
in	  a	  common	  shaking	  incubator	  and	  the	  24-­‐deep	  well	  plates	  at	  37°C	  and	  900	  rpm	  on	  a	  tabletop	  
plate	  shaker	  (Titramax	  1000	  incubator,	  Heidolph	  Instruments	  GmbH,	  Germany).	  
Strains	  were	  stored	  in	  15	  %	  v/v	  glycerol	  at	  -­‐80°C.	  
	  
2.3.3 Plasmid	  construction	  
All	   plasmids	  were	   assembled	   by	   USER	   cloning	   (Nour-­‐Eldin	   et	   al,	   2006).	   Phusion™	  U	   Hot	  
Start	   DNA	   Polymerase	   polymerase	   (Thermo	   Fisher	   Scientific)	   or	   in	   house	   synthesized	   PfuX	  





program,	   matching	   the	   Tm	  of	   the	   respective	   primers.	   Amplified	   PCR	   products	   were	   purified	  
with	  the	  NucleoSpin	  Gel	  and	  PCR	  Clean-­‐up	  kit	  (Macherey-­‐Nagel	  GmbH	  &	  Co.	  KG),	  digested	  with	  
DpnI	  FastDigest	  (Thermo	  Fisher	  Scientific)	  and	  the	  plasmid	  ligated	  with	  USER	  enzyme	  mix	  (New	  
England	  Biolabs)	  according	   to	   the	  protocols.	   The	   resulting	  plasmids	  were	   transformed	   in	   the	  
respective	  chemically	  competent	  E.	  coli	  strain.	  
The	   template	   for	   the	   pFlux	   backbones	   is	   pZA11MCS,	   which	   is	   a	   modular	   constructed	  
plasmid	   backbone	   from	   EXPRESSYS	   with	   a	   p15A	   origin,	   ampicillin	   resistance,	   a	   tetracycline	  
inducible	  promoter	  (PLtetO-­‐1)	  and	  multiple	  cloning	  site	  (MCS)	  (Lutz,	  1997).	  The	  promoter	  regions	  
were	   amplified	   directly	   from	   the	   E.	   coli	   BW25113	   genome.	   The	   gfp	   sequence	   derives	   from	  
Jensen	  et	  al.	   (unpublished	  data)	  and	  the	  rfp	  gene	  was	  obtained	  from	  the	  Standard	  European	  
Vector	   Architecture	   database	   (Silva-­‐Rocha	   et	   al,	   2013).	   As	   a	   spectomycin	   resistance	   was	  
desired	   and	   the	   respective	   EXPRESSYS	  was	   not	   available,	   the	   resistance	  was	   amplified	   from	  
another	  EXPRESSYS	  plasmid	  using	  the	  primer	  PC055/PC060	  for	  the	  spectomycin	  resistance	  and	  
PC055/PC070	   on	   pZA11MCS	   for	   the	   backbone	   creating	   the	   pZA41MCS	   plasmid.	   For	   the	  
assembly	  of	   the	  plasmids	  pGFPppsA,	  pGFPppc	  and	  pGFPpykF,	  pZA14MCS	  was	  amplified	  with	  
the	  primers	  PC004/PC031,	  eliminating	  the	  promoter	  region	  but	  maintaining	  the	  p15A	  origin	  of	  
replication	  and	   the	  spectinomycin	   resistance	  marker.	  The	  different	  natural	  promoter	   regions	  
were	   obtained	   by	   colony	   PCR	   from	  E.	  coli	  BW25113,	   using	   the	   primer	   pairs	   PC001/PC002,	  
PC003/PC004	  and	  PC005/PC006	  and	  gfp	  with	  the	  primers	  PC019/PC021.	  
In	   order	   to	   generate	   the	   constitutive	  ppsA	   promoter	  with	   a	   scrambled	   Cra	   binding	   site,	  
pGFPppsA	  was	   amplified	  with	   the	   primer	   pair	   PC063/PC064.	   This	   constitutive	   promoter	  was	  
subsequently	   amplified	   with	   PC033/PC065,	   rfp	   with	   PC069/PC070.	   The	   pGFPppsA	   backbone	  
was	   amplified	   with	   PC071/PC072,	   resulting	   in	   an	   opening	   of	   the	   backbone	   downstream	   of	  
the	  gfp	  gene.	   The	   PCR	   products	   were	   ligated	   and	   transformed	   as	   described.	   The	   obtained	  
plasmid	  is	  pFlux.	  
A	   list	   of	   the	   plasmids,	   primer	   and	   promoter	   sequences	   and	   a	   plasmid	  map	   of	   pFlux	   are	  
provided	  in	  Appendix	  –	  Chapter	  2.	  	  
2.3.4 Flow	  cytometry	  
To	  measure	  the	  fluorescence	  signals	  of	  the	  pFlux	  plasmid,	  the	  different	  E.	  coli	  strains	  were	  
initially	  grown	  over	  night	  in	  LB	  medium	  at	  37°C	  and	  190	  rpm.	  Minimal	  medium	  with	  5	  g/l	  of	  the	  
respective	   carbon	   source	   (fructose,	   glucose,	  mannitol,	   sorbitol,	  mannose,	   galactose,	  malate,	  





cultures	  in	  minimal	  medium	  were	  incubated	  over	  night	  at	  37°C	  and	  190	  rpm	  and	  subsequently	  
used	  to	  inoculate	  fresh	  minimal	  medium	  (1:200)	  and	  grown	  under	  the	  same	  conditions	  for	  four	  
hours.	  The	  cells	  were	  diluted	  in	  FACSFlow	  (BD)	  in	  order	  to	  prepare	  them	  for	  screening	  on	  the	  
FACSAria	  (BD),	  equipped	  with	  a	  488	  nm	  and	  561	  nm	  LASER.	  To	  collect	  the	  GFP	  and	  RFP	  signals,	  
the	  FITC	  (530/30)	  and	  PE-­‐Texas	  Red	  (610/20)	  filter	  were	  used.	  
	  In	   order	   to	   maintain	   comparability	   between	   several	   runs	   on	   different	   days,	   the	   E.	   coli	  
strain	  BW25113	  was	  aligned	  with	   the	  diagonal	  between	   the	  FITC	  and	  PE-­‐Texas	  Red-­‐channel.	  
The	  obtained	  data	  was	  analyzed	  with	  FlowJo	  (FlowJo	  LLC,	  Oregon,	  US).	  
2.3.5 Validation	  in	  a	  mevalonate	  production	  strain	  
The	   E.	   coli	   BW25113	   strain	   containing	   the	   pFlux	   plasmid	  was	   subsequently	   transformed	  
with	   pMevT	   (Martin	   et	   al,	   2003)	   or	   pZA1	   and	   grown	   in	   medium	   containing	   25	   ng/mL	  
spectinomycin	   and	   25ng/mL	   chloramphenicol.	   For	   mevalonate	   production,	   the	   cells	   were	  
grown	  in	  M9	  medium	  containing	  5	  g/L	  glucose.	  When	  transferring	  the	  cultures	  from	  the	  pre-­‐
culture	  to	  fresh	  medium,	  they	  were	  induced	  with	  0.05	  mM	  IPTG.	  Fluorescence	  was	  determined	  
5	  hours	  after	  induction	  by	  flow	  cytometry.	  





2.4 Results	  and	  Discussion	  
2.4.1 Identification	  of	  flux	  dependent	  promoters	  regions	  
To	  generate	  a	  flux	  dependent	  biosensor	  that	  can	  be	  applied	  in	  high-­‐throughput	  screening	  
approaches,	   we	   tested	   three	   different	   promoter	   regions	   (pykF,	   ppsA	   and	   ppc).	   All	   three	  
promoters	   are	   thus	   far	   known	   to	   be	   regulated	   exclusively	   by	   Cra	   (Keseler	   et	   al,	   2013).	  
Promoter	  regions	  are	  often	  controlled	  by	  a	  number	  of	  different	  activators	  and	  repressors	  that	  
give	  feedback	  of	  a	  variety	  of	   intra-­‐	  and	  extracellular	  signals	  (Keseler	  et	  al,	  2013).	  By	  choosing	  
promoter	   regions	   that	   are	   regulated	  by	  only	  one	   transcription	   factor,	   potential	   bias	   through	  
cross-­‐interactions	  with	  other	  effectors	  and	  regulators	  is	  reduced.	  	  
We	   tested	   one	   promoter	   region	   that	   gets	   activated	   (ppsA)	   by	   Cra	   and	   two	   that	   get	  
repressed	  (pykF,	  ppc)	   (Table	  SIV).	  The	  promoters	  were	  cloned	   in	   front	  of	  gfp	  to	  enable	  a	  Cra	  
dependent	   regulation	   of	   GFP	   output	   fluorescence	   (Figure	   2.1A)	   The	   fluorescent	   signal	   was	  
measured	  at	   the	   single	   cell	   level	  during	  exponential	   growth	  phase	   in	   various	   carbon	   sources	  
using	  flow	  cytometry.	  The	  uptake	  of	  the	  used	  carbon	  sources	  as	  well	  as	  their	  entry	  point	  in	  the	  
glycolysis	   differ	   and	   these	   differences	   generate	   distinct	   fluxes	   for	   the	   FBP	   conversion,	  
depending	  on	  the	  carbon	  source	  the	  bacterium	  is	  utilizing.	  	  
The	  expression	  levels	  of	  the	  two	  repressing	  promoter	  regions	  turned	  out	  to	  be	  not	  suitable	  
for	  the	  high-­‐throughput	  biosensor	  approach.	  The	  pykF	  promoter	  showed	  a	  too	  low	  expression	  
level	  for	  reliable	  discrimination	  in	  a	  high-­‐throughput	  approach	  and	  the	  changes	  in	  expression	  
between	  high	  and	  low	  flux	  state	  was	  too	  small	  in	  the	  case	  of	  the	  ppc	  promoter	  (Figure	  2.1B).	  In	  
the	  case	  of	  ppsA	  the	  promoter	  is	  activated	  under	  low	  flux	  conditions.	  After	  correcting	  for	  the	  
background	  signal	  and	  differences	   in	  OD600,	  a	  16-­‐fold	   induction	  of	   the	   fluorescent	  signal	  was	  
detected	   after	   growth	   on	   acetate	   (15318	   ±	   168	   a.u.)	   compared	   to	   glucose	   (830	   ±	   103	   a.u.).	  
When	  E.	  coli	  is	  grown	  on	  glucose,	  the	  expression	  of	  GFP	  is	  furthermore	  very	  low,	  indicating	  the	  
low	  leakiness	  of	  the	  promoter	  in	  absence	  of	  active	  Cra	  molecules.	  	  The	  ppsA	  promoter	  region	  








    
 
 



























Figure	   2.1	   Construction	   of	   the	  
initial	   screening	   approach	   (A)	  
Different	   Cra	   regulated	   promoter	  
regions	   (ppsA,	   ppc	   and	   pykF)	   are	  
cloned	   in	   front	  of	  gfp,	   generating	  
three	   different	   reporter	   plasmids	  
(B)	   The	   fluorescence	   of	   E.	   coli	  
KEIO	   wild	   type	   strain	   BW25113	  
with	   the	   different	   flux	   sensor	  
constructs	  was	  measured	  by	   flow	  
cytometry.	   The	   cells	   grew	   in	  
minimal	  media	   containing	   carbon	  
sources	   inducing	   high	   glycolytic	  
flux	   (glucose/gray),	   medium	   flux	  
(galactose/dark	   green)	   and	   low	  
flux	   (acetate,	   light	   green).	   By	  
applying	  a	  gate	  in	  the	  FSC/SSC	  dot	  
plot,	   the	   bacterial	   cells	   could	   be	  
separated	  from	  background	  noise.	  
The	   bars	   represent	   the	   mean	  
fluorescent	   signal	   of	   the	   bacteria	  
population	   in	   the	   FITC	   channel.	  
The	   standard	   deviations	   were	  







2.4.2 Design	  and	  characterization	  of	  a	  robust	  biosensor	  
A	  robust	  biosensor	  needs	  to	  provide	  a	  reliable	  output	  even	  in	  changing	  conditions.	  This	  is	  
of	  especial	   importance	   in	  the	  case	  of	  a	  flux	  biosensor,	  as	  the	  use	  of	  different	  carbon	  sources	  
does	  not	   only	   lead	   to	   changes	   in	   the	   glycolytic	   flux	   but	   also	   in	   the	   growth	   rate.	   The	   growth	  
rate,	  subsequently,	  has	  a	  not	  negligible	  influence	  on	  protein	  maturation	  rate,	  which	  can	  give	  a	  
bias	   in	  the	  GFP	  per	  cell	  density	  ratio.	   In	  order	  to	  generate	  a	  biosensor	  with	  reduced	  noise,	  a	  
two-­‐color	   approach	   was	   implemented	   (Kosuri	   et	   al,	   2013).	   The	   final	   biosensor	   construct	  
contains	  the	  native	  ppsA	  promoter	  with	  a	  Cra	  binding	  site	  as	  well	  as	  a	  second	  promoter	  with	  a	  
variant	  of	  the	  ppsA	  promoter	  with	  the	  Cra	  binding	  site	  sequence	  scrambled.	  The	  native	  ppsA	  
promoter	   regulates	   the	   expression	   of	   GFP	   whereas	   the	   altered	   ppsA	   promoter	   with	   the	  
scrambled	  Cra	  binding	   site	  controls	   the	  expression	  of	  a	   red	   fluorescent	  protein	   (RFP)	   (Figure	  
2.2A,	  Table	  SV).	  The	  expression	  levels	  of	  both,	  GFP	  and	  RFP,	  are	  equally	  affected	  by	  the	  protein	  
maturation	   bias	   during	   the	   growth	   on	   different	   carbon	   sources.	   As	   Cra	   controls	   only	   the	  
promoter	  upstream	  of	  gfp,	  the	  information	  about	  the	  glycolytic	  flux	  is	  solely	  conveyed	  into	  the	  
intensity	   of	   the	  GFP	   signal,	   but	   not	   the	   RFP	   signal.	   Therefore,	   relative	   glycolytic	   flux	   can	   be	  
obtained	  by	  calculating	  the	  ratio	  of	  the	  fluorescence	  intensities	  of	  GFP	  and	  RFP.	  	  
In	  order	   to	  conform	  the	  assumption	   that	   this	   construct	   is	  actually	   capable	  of	  eliminating	  
possible	  growth	  defects	  but	  also	  show	  a	  Cra	  depended	  expression	  pattern,	  the	  construct	  was	  
tested	  in	  a	  wild	  type	  E.	  coli	  W25113	  strain	  and	  an	  E.	  coli	  W25113	  ∆cra	  deletion	  strain.	  The	  two	  
strains	  were	  grown	   in	  M9	  medium	  with	  either	  glucose	   (dark	  gray)	  or	  pyruvate	   (light	  gray)	  as	  
the	  sole	  carbon	  source	  and	  samples	  measured	  during	  exponential	  growth.	  Figure	  2.2B	  shows	  
the	  dot	  plots	  of	   the	  ∆cra	   strain.	   The	  overlay	  of	   the	   cells	   grown	   in	  presence	  of	   glucose	   (dark	  
gray)	  and	  pyruvate	  (light	  gray)	  is	  clearly	  visible	  in	  this	  plot.	  The	  growth	  of	  the	  wild-­‐type	  strain	  
in	  the	  same	  conditions	  results	  in	  a	  distinct	  shift	  of	  the	  two	  populations	  towards	  a	  higher	  signal	  
in	   the	   green	   channel.	  However,	   the	   fluorescent	   intensity	   of	   the	   bacteria	   grown	  on	  pyruvate	  
(light	   gray)	   is	   a	   magnitude	   higher	   than	   on	   glucose	   (dark	   gray),	   resulting	   in	   two	   easily	  
distinguishable	  populations	  in	  the	  dot	  plot	  (Figure	  2.2C).	  
In	  order	  to	  test	  if	  the	  Cra	  biosensor	  is	  also	  sensitive	  enough	  to	  give	  a	  feedback	  on	  a	  variety	  
of	   different	   fluxes	   in	   between	   the	   highest	   (glucose)	   and	   lowest	   (pyruvate)	   physiologically	  
relevant	  fluxes,	  a	  range	  of	  other	  carbon	  sources	  was	  tested.	  These	  carbon	  sources	  have	  various	  
entry	   points	   into	   the	   glycolysis	   and	   also	   are	   taken	   up	   and	   converted	   in	   different	   rates,	  
consequently	  resulting	  in	  different	  glycolytic	  fluxes.	  The	  GFP/RFP	  ratios	  follow	  the	  trend	  that	  is	  





Furthermore,	   the	   flux	   sensor	   provides	   a	   large	   dynamic	   range	   with	   a	   ratio	   of	   2.49	   ±	   0.28	  
GFP/RFP	   fluorescence	   on	   fructose	   and	   17.83	  ±	   0.59	   on	   acetate.	   The	   expression	   level	   in	   the	  
∆cra	   strain	  on	  different	   carbon	  sources	   is	  not	   following	   the	   trend	   towards	  a	  higher	  GFP/RFP	  
signal	  with	  lower	  fluxes	  as	  observed	  in	  the	  wild-­‐type	  strain	  as	  it	  was	  to	  be	  expected.	  There	  is	  
even	  a	   small	  decrease	  noticeable,	   caused	  by	  a	   slight	   shift	   towards	  a	  higher	   red	   signal	   in	   the	  








Figure	  2.2)	  Construct	  and	  evaluation	  of	  pFlux.	  (A)	  Schematic	  map	  of	  pFlux.	  The	  transcription	  
of	  gfp	   is	   controlled	   by	   a	   Cra	   dependent	   ppsA	   promoter,	   whereas	   the	   transcription	   of	   rfp	   is	  
controlled	  by	  a	  ppsA	  promoter	  with	  a	  scrambled	  Cra	  binding	  site.	  (B)	  Dot	  plot	  of	  the	  GFP	  and	  
RFP	   expression	   of	   the	  E.	   coli	   ∆cra	   strain	   during	   growth	   on	   glucose	   (dark	   gray)	   and	   pyruvate	  
(light	   gray).	   (C)	  Dot	  plot	  of	   the	  GFP	  and	  RFP	  expression	  of	  E.	  coli	   BW25113	  wild	   type	  during	  
growth	  on	  glucose	   (dark	  blue)	  and	  pyruvate	   (light	  blue).	  The	  fluorescence	  signals	  of	  GFP	  and	  



























Figure	  2.3)	  GFP/RFP	  emission	  ratios	  for	  E.	  coli	  W25113	  wild	  type	  (blue	  bars)	  and	  ∆cra	   (gray	  
bars)	   when	   grown	   on	   different	   carbon	   sources,	   inducing	   different	   glycolytic	   fluxes.	   The	  
fluorescent	  signals	  of	  GFP	  and	  RFP	  where	  obtained	  with	  flow	  cytometry.	  The	  signal	  of	  the	  ∆cra	  
strain	  grown	  on	  glucose	  is	  used	  as	  a	  reference	  point	  in	  the	  measurements	  and	  was	  positioned	  
on	  the	  diagonal	  between	  the	  green	  and	  red	  channel.	  The	  mean	  value	  of	  the	  green	  (GFP)	  and	  
red	  (RFP)	  channels	  was	  obtained	  and	  the	  ratio	  calculated.	  The	  average	  and	  standard	  deviation	  
of	  three	  individual	  experiments	  are	  shown.	  	  
	  
2.4.3 Validation	  of	  pFlux	  in	  different	  E.	  coli	  strains	  
In	  order	  to	  validate	  the	  versatility	  of	  pFlux,	  it	  was	  transformed	  into	  different	  E.	  coli	  strains.	  
The	  selected	  six	  E.	  coli	  strains	  are	  common	  laboratory	  strains	  and	  comprise	  K-­‐	  as	  well	  as	  1	  B-­‐
strain	   (BL21)	   in	   order	   to	   test	   the	   biosensor	   in	   a	   variety	   of	   genetic	   backgrounds.	   The	   strains	  
were	  grown	  in	  presence	  of	  glycolytic	  and	  gluconeogenic	  carbon	  sources	  and	  the	  GFP	  and	  RFP	  
signals	  measured	  by	  flow	  cytometry.	  As	  shown	  in	  Figure	  2.4,	  all	  E.	  coli	  strains	  follow	  the	  same	  
pattern	  as	  previously	  observed	  for	  E.	  coli	  BW25113.	  E.	  coli	  Crooks	  showed	  a	  generally	  higher	  
GFP/RFP	  ratio	  which	  correlates	  to	  the	  generally	  lower	  fluorescent	  signals	  in	  the	  GFP	  as	  well	  as	  
the	  RFP	  channel	  compared	  to	  the	  other	  E.	  coli	  strains,	  causing	  a	  numerical	  bias.	  Even	  though	  
the	  actual	  expression	  levels	  and	  subsequent	  ratios	  slightly	  differ	   in	  all	  strains,	  this	  should	  not	  
have	  an	  impact	  on	  the	  usability	  of	  pFlux,	  as	  the	  trends	  in	  flux	  response	  were	  comparable	  in	  all	  
tested	  E.	  coli	  strains.	  	  
There	  was	  no	  growth	  of	  BL21	  in	  M9	  medium	  containing	  galactose	  as	  sole	  carbon	  source,	  as	  






Figure	  2.4)	  GFP/RFP	  ratios	  of	  six	  commonly	  used	  E.	  coli	   strains.	  The	  cells	  were	  grown	  in	  M9	  
minimal	  medium	  with	  different	  carbon	  sources.	  The	  fluorescence	  signals	  of	  GFP	  and	  RFP	  were	  
measured	  by	  flow	  cytometry	  for	  10,000	  cells	  per	  run.	  The	  bars	  show	  the	  average	  of	  the	  mean	  
GFP	  per	  RFP	  values	  of	  three	  independent	  experiments.	  	  
Abbreviations:	  Fru:	  Fructose,	  Glu:	  Glucose,	  Mnol:	  Mannitol;	  Sor:	  Sorbitol;	  Gal:	  Galactose;	  Gly:	  
Glycerin;	  Pyr:	  Sodiumpyruvate;	  Ace:	  Sodiumacetate.	  	  
*)	  BL21	  (DE3)	  is	  unable	  to	  grow	  on	  galactose.	  	  
	  
2.4.4 Applying	  pFlux	  in	  a	  mevalonate	  production	  strain	  
After	   testing	   the	   sensitivity	   of	   the	   Cra	   biosensor	   to	   different	   fluxes	   and	   its	   function	   in	   a	  
variety	  of	  E.	  coli	  backgrounds,	  its	  applicability	  in	  a	  production	  strain	  was	  assessed.	  One	  of	  the	  
most	   important	   possible	   applications	   for	   the	   glycolytic	   flux	   biosensor	   is	   in	   the	   development	  
and	  optimization	  of	  production	  strains.	  The	  example	  that	  was	  chosen	  for	  the	  evaluation	  is	  the	  
mevalonate	   production	   via	   the	   improved	  mevalonate	   pathway	   from	  Martin	  et	   al,	   2003.	   The	  
mevalonate	   pathway	   is	   a	   very	   suitable	   example,	   as	   an	   increase	   in	   mevalonate	   production	  
causes	  a	  drain	  of	  acetyl-­‐CoA,	  resulting	  in	  an	  increase	  of	  the	  glycolytic	  flux.	  The	  pMavT	  plasmid	  
(Martin	  et	  al,	  2003)	  was	  transformed	  to	  the	  E.	  coli	  BW25113	  wild	  type	  and	  Δcra	  strain	  together	  
with	  pFlux.	  As	  a	  control,	  we	  used	  the	  empty	  plasmid	  pZA1.	  The	  GFP	  per	  RFP	  ratio	  dropped	  in	  
wild	   type	   cells	   grown	   in	   glucose	   expressing	   the	   genes	   of	   the	   mevalonate	   pathway	   to	   70%	  
indicating	  a	  higher	   flux	   through	  glycolysis,	  while	   the	  GFP	  per	  RFP	  ratio	  did	  not	  change	   in	   the	  
Δcra	  mutant	  (Figure	  2.5).	  This	  result	  demonstrates	  that	  pFlux	  can	  be	  applied	  for	  glycolytic	  flux	  































The	  integration	  of	  novel	  or	  enhanced	  biotechnologically	  relevant	  pathways	  often	  causes	  a	  
change	   in	   the	  metabolic	   flux	   as	   for	   this	   example	  of	  mevalonate	  production.	  However,	   lower	  
glycolytic	   flux	   rates	   can	   also	   be	   found	   in	   production	   strains.	   For	   instance	   during	   lysine	  
production	   the	   carbon	   flux	   directed	   through	   the	   pentose	   phosphate	   pathway	   leading	   to	   a	  
reduced	  glycolytic	  flux	  (Kiefer	  et	  al,	  2004).	  	  
	  This	  characteristic	  of	  production	  altering	  glycolytic	  flux	  enables	  a	  broad	  range	  of	  possible	  
applications	   for	   this	   glycolytic	   flux	   sensor,	   as	   the	  monitoring	   of	   flux	   changes	  might	   indicate	  
higher	   production,	   in	   case	   no	   product	   sensor	   is	   yet	   available,	   or	   it	   could	   otherwise	   be	  
integrated	  in	  a	  synthetic	  pathway	  control	  mechanism	  (Xu	  et	  al,	  2014).	  	  
2.5 Summary	  
By	  changing	  the	  promoter	  region	  compared	  to	  the	  initial	  study	  of	  Kochanowski	  et	  al.	  and	  
combining	  the	  Cra-­‐controlled	  and	  constitutive	  expression	  of	  a	  reporter	  on	  one	  plasmid	  via	  two	  
different	  fluorescent	  proteins,	  it	  was	  possible	  create	  a	  glycolytic	  flux	  sensor	  that	  can	  be	  used	  to	  
compare	  the	  metabolic	  flux	  of	  different,	  individual	  cells	  via	  flow	  cytometry.	  Growing	  E.	  coli	   in	  
presence	   of	   different	   carbon	   sources	   and	  measuring	   the	  GFP/RFP	   signal	   ratio	   demonstrated	  
the	  dynamic	  range	  of	  the	  biosensor	  over	  the	  physiologically	  relevant	  range.	  By	  introducing	  the	  
pMevT	   plasmid,	   it	   could	   furthermore	   be	   shown,	   that	   pFlux	   can	   also	   be	   used	   to	   measure	  
glycolytic	  fluxes	  above	  the	  flux	  occurring	  during	  the	  growth	  on	  glucose.	  















Figure	   2.5)	  The	   GFP	   per	   RFP	   ratios	   obtained	  
by	   flow	   cytometry	   in	   absence	   (pZA41)	   and	  
presence	   of	   the	   mevalonate	   pathway	  
(pMevT).	  The	  cells	  were	  grown	  in	  M9	  medium	  
containing	  5	  g/L	  glucose.	  The	  wild	  type	   (gray)	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Appendix	  –	  Chapter	  2	  
Table	  SII)	  DNA	  oligo	  sequences	  for	  cloning.	  	  
Abbreviations:	  -­‐p:	  promoter	  region;	  BSsc:	  scrambled	  Cra-­‐binding	  sit	  
Promoter	  regions	   	  
PC028	   AACCATUAATACCGCCATTTGG	   pfkA-­‐p	  forw	  
PC029	   AGTTCTTCTCCUTTGCTCATGACTACCTCTGAACTTTG	   pfkA-­‐p	  rev	  
PC033	   AACCATUCAACGCTGGGATC	   ppsA-­‐p	  forw	  
PC048	   AGTTCTTCTCCUTTGCTCATCGAACAATCCTTTTGTG	   ppsA-­‐p	  rev	  
PC035	   AACCATUGACGTAAATTCCTG	   ppc-­‐p	  forw	  
PC049	   AGTTCTTCTCCUTTGCTCATATTACCCCAGACACC	   ppc-­‐p	  rev	  
PC063	   ATTACTGGGUCGACGTTTTTTTCATCCGGT	   ppsA-­‐p	  BSsc	  forw	  
PC064	   ACCCAGTAAUAGTCATATATTTTTTTACTTTTTAAGAC	   ppsA-­‐p	  BSsc	  rev	  
Genes	   	   	  
PC019	   AGGAGAAGAACUTTTCACTGGAG	   gfp	  forw	  
PC021	   ATTTGUAGAGCTCATCCATGCC	   gfp	  rev	  
PC069	   ACGACCUGCAGGGAGCAG	   mCherry	  w	  term	  rev	  
PC070	   ATGGTTUCCAAGGGCGAG	   mCherry	  forw	  
Backbone	  assembly	   	  
PC004	   AATGGTUTCTTAGACGTC	   p15A	  rev	  1	  
PC031	   ACAAAUGATAGAGGCATCA	   p15A	  forw	  1	  
PC055	   ACTCTUCCTTTTTCAATATT	   p15A	  forw	  2	  
PC073	   AACTGUACAACTTATATCGTATGGG	   p15A	  forw	  2	  
PC057	   AAGAGUATGCCTCGGGCA	   Sm/Sp	  resist.	  forw	  
PC060	   ACAGTUATTTGCCGACTAC	   Sm/Sp	  resist.	  rev	  
PC065	   AAACCAUCGAACAATCCTTTTGTG	   p15A	  forw	  3	  
PC071	   AGGTCGUGTCCTACTCAGGAG	   p15A	  rev	  3	  
PC072	   AATGGTUGCGCTAGCGGAG	   p15A	  forw	  4	  
	  
	  
Table	  SIII)	  Plasmid	  list.	  
Abbreviations:	  -­‐p:	  promoter	  region;	  BSsc:	  scrambled	  Cra-­‐binding	  site	  
Name	   Description	   Source	  
pZA11MCS	   p15A	  ori;	  ampicillin	  res.	  (amp),	  PLtetO-­‐1	  promoter,	  MCS	   (Lutz,	  1997)	  
pZA14MCS	   p15A	  ori;	  spectinomycin	  res.	  (spec),	  PLtetO-­‐1	  promoter,	  MCS	   this	  study	  
pGFPppsA	   pZA4	  +	  ppsA-­‐p_gfp	   this	  study	  
pGFPppc	   pZA4	  +	  ppc-­‐p_gfp	   this	  study	  
pGFPpykF	   pZA4	  +	  pykF-­‐p_gfp	   this	  study	  
pFlux	   pZA4	  +	  ppsA-­‐p_gfp	  +	  ppsA-­‐BSsc_mCherry	   this	  study	  
pMevT	   Mevalonate	  production	  pathway	   (Martin	  et	  al,	  2003)	  
	  




Table	   SIV)	  DNA	   sequences	   of	   the	   promoter	   regions.	   The	   Cra	   binding	   site	   is	   highlighted	   in	  
green,	  the	  -­‐35	  region	  in	  dark	  gray,	  the	  -­‐10	  region	  in	  light	  gray	  and	  the	  transcription	  start	  site	  in	  
blue.	  
ppsA	  promoter	  region	  
CAACGCTGGGATCAGTCTTAAAAAGTAAAAAAATATATTTGCTTGAACGATTCACCGTTTTTTTCATCCGGTTAAATATGCAAAGATAAATGC
GCAGAAATGTGTTTCTCAAACCGTTCATTTATCACAAAAGGATTGTTCG	  
ppc	  promoter	  region	  
GACGTAAATTCCTGCTATTTATTCGTTTGCTGAAGCGATTTCGCAGCATTTGACGTCACCGCTTTTACGTGGCTTTATAAAAGACGACGAAAA
GCAAAGCCCGAGCATATTCGCGCCAATGCGACGTGAAGGATACAGGGCTATCAAACGATAAGATGGGGTGTCTGGGGTAAT	  



























	   	  












	   	  




	   	  





Understanding	  the	  genetic	  factors	  that	  influence	  the	  metabolic	  flux	  of	  bacterial	  cells	   is	  of	  
fundamental	   importance	   to	   bacterial	   physiology	   as	  well	   as	   in	   silico	  modelling	   and	  metabolic	  
engineering.	   In	  this	  chapter,	  the	  novel	  genetically	  encoded	  glycolytic	   flux	  biosensor	  based	  on	  
the	   ppsA	   promoter	   of	   E.	   coli	   is	   applied	   to	   screen	   for	   metabolic	   flux	   changes	   in	   a	   fast	   and	  
parallelizable	  way.	  FlowSeq,	  the	  combination	  of	  fluorescence	  activated	  cell	  sorting	  (FACS)	  and	  
deep	   sequencing,	   enabled	   the	   analysis	   of	   a	   library	   of	   2,126	   gene	   knockouts	   in	   E.	   coli.	  On	   a	  
single	   cell	   level	   their	   individual	   effects	   on	   the	   glycolytic	   flux	   during	   the	   growth	  on	   galactose	  
were	   studied.	   FACS	  was	   used	   to	   select	   for	   sub-­‐populations	   of	   the	   full	  mutant	   library	  with	   a	  
particular	   high	   or	   low	   flux	   phenotype,	   respectively.	   The	   subsequent	   deep	   sequencing	   gave	  
detailed	  information	  of	  the	  distributions	  of	  individual	  deletion	  mutants	  in	  the	  subpopulations,	  
linking	  the	  glycolytic	  flux	  phenotype	  to	  the	  genotype.	  After	  filtering	  and	  analysing	  the	  obtained	  
data,	   one	   mutant	   (ΔrpiA)	   with	   a	   high-­‐flux	   phenotype	   and	   158	   mutants	   with	   a	   low-­‐flux	  
phenotype	  were	   identified.	  The	  genes	  with	   the	   low	   flux	  phenotypes	   comprised	  genes	  of	   the	  
glyoxylate	   cycle,	   galactitol	   metabolism	   and	   flagella	   synthesis.	   The	   glycolytic	   flux	   biosensor	  
enhances	  our	  understanding	  of	  microbial	  physiology	  and	  can	  be	  applied	  to	  improve	  microbial	  
cell	  factories.	  
3.2 Introduction	  
Biosensors	  have	  been	  applied	   in	  several	  high-­‐throughput	  screens	  proving	   their	   relevance	  
to	  enzyme	  engineering	  and	  cell	   factory	  optimization	   (Binder	  et	  al,	  2013;	  Mustafi	  et	  al,	  2012;	  
Michener	  et	  al,	  2012;	  Schendzielorz	  et	  al,	  2014;	  Siedler	  et	  al,	  2014b;	  Raman	  et	  al,	  2014;	  Taylor	  
et	  al,	  2015).	  However,	  biosensors	  have	  not	  yet	  been	  used	  to	  study	  cellular	  states	  such	  as	  the	  
glycolytic	  flux	  state	  of	  the	  cell.	  In	  the	  previous	  chapter,	  it	  could	  be	  shown	  that	  the	  novel	  pFlux	  
Cra	  biosensor	  is	  capable	  of	  sensing	  the	  glycolytic	  flux	  over	  a	  physiologically	  relevant	  range	  and	  
even	  above,	  as	  was	  shown	  in	  the	  example	  of	  the	  artificial	  mevalonate	  pathway.	  
In	   this	   chapter,	   the	   Cra	   biosensor	   is	   applied	   in	   a	   large-­‐scale	   screen	   for	   single	   gene	  
knockouts,	  which	  have	  a	  glycolytic	   flux	  altering	  effect	   in	  E.	  coli.	  With	  established	  techniques,	  
like	  13C	  measurements	  the	  obtained	  fluxes	  are	  very	  precise	  and	  give	  a	  detailed,	  global	  picture	  
of	   the	   metabolism,	   but	   it	   is	   not	   scalable	   to	   a	   whole	   genome	   screen	   (Zamboni	   et	   al,	   2009;	  
Fischer	  et	  al,	  2004;	  Haverkorn	  van	  Rijsewijk	  et	  al,	  2011).	  The	  aim	  of	  this	  genome-­‐wide	  screen	  is	  
to	  identify	  genes	  with	  flux-­‐regulating	  properties	  that	  have	  not	  been	  identified	  yet.	   	  




3.3 Materials	  and	  methods	  
3.3.1 Strains,	  plasmids	  and	  DNA-­‐oligos	  
Strains,	  plasmids	  and	  primers	  are	  listed	  in	  Table	  SII	  and	  	  
Table	  SIII.	  In	  the	  experimental	  setup,	  the	  used	  E.	  coli	  wild	  type	  and	  knockout	  strains	  derive	  
from	  the	  KEIO	  collection	   (Baba	  et	  al,	  2006).	  Primers	  and	  other	  oligos	  were	  ordered	  from	  IDT	  
and	  were	  optimized	   for	  USER	  cloning.	  The	  adapters	  and	  primers	   for	   the	   Illumina	  sequencing	  
were	   additionally	   HPLC	   purified	   and	   contained	   in	   the	   case	   of	   the	   UAD_tail	   a	   3'-­‐
phosphorothioate	  bond	  and	  a	  5’-­‐phosphate	  for	  the	  barcoded	  sequencing	  adapters.	  
3.3.2 Cultivation	  and	  growth	  media	  
The	   growth	   media	   used	   in	   this	   study	   are	   Luria-­‐Bertani	   (LB)	   complex	   medium,	   Super	  
Optimal	   broth	   with	   Catabolite	   repression	   (SOC)	   medium	   and	   M9	   minimal	   medium	  
(Kochanowski	  et	  al,	  2013)	  supplemented	  with	  filter-­‐sterile	  trace	  element	  solution,	  resulting	  in	  
a	  final	  concentration	  of	  6.3	  µM	  ZnSO4,	  7.0	  µM	  CuCl2,	  7.1	  µM	  MnSo4,	  7.6	  µM	  CaCl2	  and	  60	  µM	  
FeCl3).	   The	   M9	   medium	   contained	   5	   g/L	   of	   galactose.	   The	   LB	   and	   M9	   media	   were	  
supplemented	   with	   either	   50	   µg/mL	   kanamycin	   for	   the	   library	   preparation	   or	   25	  µg/mL	  
spectomycin	  after	  transformation	  with	  pFlux.	  
If	  not	  stated	  otherwise,	  the	  cells	  were	  cultured	  in	  5	  mL	  medium	  in	  15	  mL	  cultivation	  tubes	  
or	   2	  mL	   in	   24-­‐deep	  well	   plates.	   The	   cultivation	   tubes	  were	   incubated	   at	   37°C,	   190	   rpm	   in	   a	  
common	   shaking	   incubator	   and	   the	   24-­‐deep	  well	   plates	   at	   37°C	   and	  900	   rpm	  on	   a	   tabletop	  
plate	  shaker	  (Titramax	  1000	  incubator,	  Heidolph	  Instruments	  GmbH,	  Germany).	  
Strains	  were	  stored	  in	  15	  %	  v/v	  glycerol	  at	  -­‐80°C.	  
3.3.3 KEIO	  library	  generation	  and	  plasmid	  transformation	  
For	  the	  library	  screen,	  the	  KEIO	  collection	  was	  pooled.	  In	  order	  to	  obtain	  the	  best	  possible	  
coverage,	   the	   individual	   strains	   were	   plated	   from	   the	   glycerol	   stock	   on	   LB	   agar	   plates	   with	  
50	  µg/mL	  kanamycin.	  The	  plates	  were	   incubated	  over	  night	  at	  37°C	  and	  the	  colonies	  washed	  
off	  with	  1	  ml	  liquid	  LB	  medium	  without	  antibiotics.	  100	  µl	  of	  each	  cell	  suspension	  was	  used	  to	  
inoculate	  150	  mL	  LB	  medium	  containing	  50	  µg/mL	  kanamycin	  in	  one	  500	  mL	  shaking	  flask.	  The	  
resulting	   inoculation	   volume	   for	   the	  150	  mL	  medium	  was	   in	  5.6	  ml	   in	   total.	   The	   flasks	  were	  
incubated	   at	   37°	   C,	   190	   rpm	   until	   OD	   0.5	   was	   reached.	   In	   order	   to	   prepare	   the	   cells	   for	  
electroporation	   and	   to	   remove	   all	   traces	   of	   salts,	   the	   cells	   were	   pre-­‐chilled	   on	   ice	   for	   10	  




minutes	  and	  afterwards	  washed	  three	   times	  with	   ice-­‐cold	  10	  %	   (v/v)	  glycerol.	  Between	  each	  
washing	  step,	  the	  cells	  were	  pelleted	  for	  5	  minutes	  at	  4000	  rpm	  and	  0°C	  and	  the	  supernatant	  
discarded.	  The	  first	  two	  washing	  step	  were	  carried	  out	  in	  a	  50	  ml	  Falcon	  tube	  with	  50	  ml	  and	  
25	  ml	   cell	   suspension,	   respectively.	  The	   last	  washing	   step	  was	  carried	  out	   in	  a	  2	  ml	   reaction	  
tube	  and	  pelleted	  in	  a	  pre-­‐chilled	  tabletop	  centrifuge.	  The	  pellet	  was	  resuspended	  in	  200	  µl	  of	  
the	  ice-­‐cold	  10	  %	  (v/v)	  glycerol.	  50	  µl	  of	  this	  cell	  suspensions	  were	  transferred	  to	  a	  pre-­‐chilled	  
1	  mm	  electroporation	  cuvette	  and	  100	  ng	  of	  pFlux	  added.	  The	  cells	  were	  electroporated	  at	  1.8	  
kV	  and	  resuspended	   in	  950	  µL	  pre-­‐warmed	  SOC	  medium.	  After	  transferring	  them	  to	  a	  1.5	  ml	  
reaction	   tube,	   they	   recovered	   for	  1	  h	  at	  37°C	  and	  500	  rpm.	  The	  cell	   suspension	  was	  used	   to	  
inoculate	  50	  ml	  LB	  medium	  (additionally	  added	  0.5	  mM	  MgSO4	  and	  25	  µg/ml	  kanamycin)	  in	  a	  
250	   ml	   shaking	   flasks.	   The	   cultures	   grew	   over	   night	   at	   37°C	   and	   190	   rpm.	   700	   µl	   of	   the	  
overnight	  culture	  were	  diluted	  to	  15	  %	  glycerol	  stocks	  and	  stored	  at	  -­‐80°C	  until	  use.	  
3.3.4 Fluorescence	  Activated	  Cell	  Sorting	  (FACS)	  
For	  the	  individual	  cell	  sorting	  rounds,	  50	  ml	  LB	  medium	  containing	  25	  ng/mL	  spectomycin	  
were	  inoculated	  with	  1	  ml	  of	  the	  KEIO	  cryo	  stocks	  in	  order	  to	  maintain	  diversity.	  The	  cultures	  
were	   incubated	  at	  37°C,	  190	   rpm	  over	  night.	   50	  ml	  M9	  medium	  containing	  5	  g/L	   glucose	  or	  
galactose	  and	  the	  respective	  antibiotics	  were	  inoculated	  from	  the	  LB	  precultures	  to	  an	  OD600	  of	  
0.01.	   The	   cultures	   were	   incubated	   at	   37°C,	   190	   rpm	   over	   night.	   Fresh	   M9	   medium	   was	  
inoculated	  to	  an	  OD600	  of	  0.05.	  After	  4	  hours	  of	  shaking	   incubation,	  samples	  were	  taken	  and	  
diluted	  in	  FACSFlow	  (BD)	  in	  order	  to	  prepare	  them	  for	  sorting	  FACSAria	  (BD)	  with	  a	  488	  nm	  and	  
561	   nm	   LASER.	   To	   collect	   the	   GFP	   and	   RFP	   signals,	   the	   FITC	   (530/30)	   and	   PE-­‐Texas	  Red	  
(610/20)	  filter	  were	  used.	  The	  individual	  cells	  were	  sorted	  according	  to	  their	  signal	  in	  the	  FITC	  
(GFP	  fluorescence)	  and	  PE-­‐Texas	  Red	  (RFP	  fluorescence)	  channels.	  One	  percent	  of	  the	  outliers	  
towards	  a	  higher,	  respectively	  lower	  FITC	  per	  PE-­‐Texas	  Red	  signal	  ratio	  were	  collected	  (Figure	  
3.1).	  The	  cells	  were	  sorted	  into	  12	  cm	  FACS	  tubes	  with	  1	  ml	  LB	  medium	  (25	  ng/ml	  spectomycin)	  
and	  grown	  at	  37°C,	  190rpm	  over	  night.	  The	  cells	  were	  pelleted	  at	  4,500	  rpm	  and	  stored	  at	   -­‐
20°C.	  
3.3.5 Genome	  purification,	  amplification	  and	  sequencing	  
Library	   preparation	   and	   validation	   closely	   followed	   the	   TnSeq	   protocol	   of	   Lennen	   et	   al.	  
(Lennen	  &	  Herrgård,	   2014).	   To	   adjust	   the	  protocol	   to	   the	  KEIO	   strains,	   the	  biotinolated	  PCR	  
primer	  was	  designed	  to	  match	  the	  19	  base	  pair	  long	  FTR	  scar	  (GAAGCAGCTCCAGCCTACA)	  that	  




was	  left	  from	  the	  deletion	  process	  to	  generate	  the	  knockout	  library	  (Baba	  et	  al,	  2006).	  In	  order	  
to	   amplify	   the	   respective	   knockout	   regions	   a	   biotinolated	   primer	  
(/5BiotinTEG/AATGATACGGCGACCACCGAGATCTACACTCTTTCCCTACACGACGCTCTTCCGATCTGA
AGCAGCTCCAGCCTACA)	   and	   a	   standardized	   UAD-­‐tail	   primer	  
(GATCTACACTCTTTCCCTACACGACG)	   was	   used.	   The	   barcoded	   adapter	   matched	   the	   Illumina	  
NexTera	  platform.	  The	  sequencing	  was	  performed	  on	  an	  Illumina	  miSeq,	  150	  bp,	  running	  1	  pM	  
of	  DNA	  per	  sample.	  
3.3.6 Data	  analysis	  
In	   order	   to	   analyze	   the	   obtained	   sequence	   reads	   from	   the	  miSeq,	  we	   run	   a	   customized	  
script,	   consisting	   of	   data	   preparation,	   quality	   check,	   creating	   database	   of	   quality	   reads,	  
searching	  for	  E.	  coli	  genes	  using	  their	  bar	  codes	  and	  summarize	  the	  results	  in	  a	  table.	  
The	   PCR	   amplification	   of	   the	   region	   following	   the	   FRT	   scar	   allows	   evaluating	   the	  
occurrence	   of	   a	   deletion	   mutant	   in	   the	   different	   pools	   without	   mapping	   it	   to	   the	   entire	  
genome.	  Instead,	  it	  can	  be	  simply	  matched	  to	  the	  list	  of	  primers	  Baba	  et	  al.	  (Baba	  et	  al,	  2006)	  
used	  to	  generate	  the	  knockout	  strains.	  The	  circumventing	  of	   the	  mapping	  results	   in	   less	  bias	  
and	  a	  clear	  output	  list	  of	  each	  gene	  and	  the	  number	  of	  annotated	  reads.	  
In	  the	  data	  preparation	  process,	  the	  short-­‐read	  .fastq	  files	  were	  converted	  into	  .fasta	  files	  
and	  a	  blast	  database	  build	  for	  each	  experiment	  as	  well	  as	  a	  tabular	  file	  with	  reads	  indexed	  by	  
their	  read	  identification	  number.	  The	  quality	  check	  assured	  that	  only	  reads	  that	  began	  with	  the	  
FRT	   specific	   DNA	   sequence	   GAAGCAGCTCCAGCCTACA	   were	   taken	   into	   consideration	   and	  
blasted	   (blastn)	   considering	   the	   parameters	   given	   in	   Supplementary	   Table	   SII	   to	   search	   for	  
small	   sequences.	  We	   then	  extract	   the	   reads	   that	  have	  at	   least	   80%	  coverage	  of	   the	  primers	  
with	   a	  maximum	  of	   two	  mismatches	   and	  discard	   those	   that	  do	  not	  meet	   these	   criteria.	   The	  
extracted	  reads	  form	  the	  blast	  database	  that	  is	  used	  to	  search	  for	  the	  barcodes.	  The	  barcode	  
list	  is	  based	  on	  the	  reverse	  primers	  that	  were	  used	  by	  Baba	  et	  al.	  (Baba	  et	  al,	  2006)	  to	  delete	  
the	   respective	  genes.	  For	  each	  barcode,	   corresponding	   to	  one	  gene	  deletion,	   the	  number	  of	  
reads	  in	  the	  blast	  database	  is	  counted	  they	  match,	  allowing	  a	  maximum	  of	  three	  mismatches.	  
In	  order	  to	  reduce	  possible	  bias	   in	  the	  analysis,	  we	  normalized	  the	  reads	   in	  two	  steps.	   In	  
the	  first	  step,	  the	  numbers	  of	  reads	  for	  every	  gene	  in	  each	  sequencing	  run	  was	  normalized	  on	  
the	  over-­‐all	  number	  of	  reads	  of	  the	  run	  to	  make	  the	  results	  of	  the	  different	  sequencing	  runs	  
comparable.	  In	  the	  second	  step,	  the	  number	  of	  reads	  of	  the	  sorted	  population	  was	  divided	  by	  
the	  number	  of	  reads	  of	  the	  unsorted	  population,	  which	  was	  grown	  under	  the	  same	  conditions.	  




The	   second	   normalization	   step	  was	   performed	   to	   reduce	   the	   bias	   of	   unlike	   growth	   rates	   of	  
different	  mutants	  and	   to	  obtain	   the	   fold	  enrichment	  of	   the	  different	  pools	   compared	   to	   the	  
not	  enriched	  population.	  The	  threshold	  for	  consideration	  of	  a	  gene	  was	  set	  to	  a	  minimum	  of	  10	  
annotated	  reads	  in	  the	  library.	  	  
3.3.7 Clustering	  and	  GO	  analysis	  
The	  enrichment	  and	  depletion	  of	  the	  individual	  genes	  in	  the	  different	  pools	  were	  clustered	  
by	  their	  likeliness,	  generating	  ten	  clusters	  (Figure	  SIII;	  Table	  SVII;	  Table	  SVIII;	  Table	  SIX).The	  ten	  
clusters	  were	  subsequently	  grouped	  into	  three	  groups.	  Clusters	  with	  genes	  enriched	  in	  the	  low	  
flux	   pools	   and	   depleted	   in	   high	   flux	  were	   grouped,	   as	   well	   as	   all	   clusters	   with	   no	   apparent	  
enrichment	  profiles.	  In	  case	  of	  a	  high	  flux	  phenotype,	  there	  was	  only	  one	  cluster	  where	  genes	  
would	   be	   enriched	   in	   the	   high	   flux	   pools	   and	   depleted	   in	   the	   low	   flux	   pools.	   A	   GO	   analysis	  
based	  on	  their	  biological	  function	  was	  performed	  with	  the	  genes	  of	  the	  group	  with	  a	  low	  flux	  
phenotype	  (Ashburner	  et	  al,	  2000;	  The	  Gene	  Ontology	  Consortium,	  2014).	  
3.3.8 Growth	  rate	  characterization	  
The	  gene	  deletions	   that	   showed	  an	   interesting	  phenotype	   in	   the	   flux	  data	  analysis	  were	  
tested	  individually	  on	  their	  growth	  rate.2	  ml	  of	  LB	  medium	  (25	  nm/ml	  Kanamycin)	  in	  a	  24-­‐deep	  
well	  plate	  was	  inoculated	  with	  strains	  from	  a	  cryo	  stock	  and	  grown	  at	  37°C	  and	  1000	  rpm	  in	  a	  
tabletop	  plate	  shaker	  (Titramax	  1000	  incubator,	  Heidolph	  Instruments	  GmbH,	  Germany)	  until	  
exponential	   or	   stationary	   phase.	   The	   cells	   were	   subsequently	   diluted	   1:50	   in	   M9	   medium	  
containing	  either	  5	  g/L	  glucose	  or	  5	  g/L	  galactose	  and	  grown	  at	  the	  same	  conditions	  over	  night.	  
The	  cells	  were	  diluted	  1:200	  in	  fresh	  M9	  media	  containing	  the	  respective	  carbon	  source.	  200	  µl	  
of	  the	  fresh	  culture	  were	  transferred	  to	  a	  micro	  titer	  plate.	  The	  plate	  was	  sealed	  with	  Breathe-­‐
Easy	   sealing	   membrane	   (Sigma-­‐Aldrich).	   The	   OD630	   was	   measured	   in	   a	   plate	   reader	   over	   a	  
period	  of	  16	  h	  and	  the	  growth	  rate	  determined.	  
	   	  




3.4 Results	  and	  discussion	  
The	   glycolytic	   flux	   biosensor	   plasmid	   pFlux	   was	   transformed	   into	   a	   library	   of	   the	   KEIO	  
collection,	   a	   collection	   of	   non-­‐lethal	   single	   gene	   deletions	   in	   E.	   coli	   (Baba	   et	   al,	   2006).	   The	  
library	   of	   knockout	   strains	   was	   grown	   in	   M9	   minimal	   media	   containing	   5	   g/L	   galactose.	  
Galactose	  was	   chosen	  as	   carbon	   source,	   as	   it	   takes	   the	   same	  glycolytic	   route	  as	  glucose	  but	  
with	  a	   lower	   flux	   rate	   (Haverkorn	  van	  Rijsewijk	  et	  al,	  2011).	  As	   it	  was	  shown	   in	   the	  previous	  
chapter,	  galactose	  as	  a	  carbon	  source	  enables	  to	  show	  as	  well	  an	  increase	  in	  signal	  as	  well	  as	  a	  
decrease,	  respectively	  indicate	  a	  higher	  and	  lower	  glycolytic	  flux	  (Figure	  2.3).	  During	  growth	  on	  
glucose,	  Cra	  is	  furthermore	  mostly	  inactive,	  thus	  we	  assume	  that	  choosing	  galactose	  as	  carbon	  
source	  also	  offers	  the	  possibility	  to	  give	  a	  better	  sensitivity	  for	  changes	  towards	  higher	  flux.	  
	  
Single	   cells	  were	   sorted	   according	   to	   their	   flux	   phenotype	  by	   fluorescence	   activated	   cell	  
sorting	   (FACS).	   After	   recovery	   in	   LB	   medium,	   the	   gene	   regions	   downstream	   of	   the	   flippase	  
recognition	   target	   (FTR)	   sequence	   was	   amplified	   and	   sequenced	   (Figure	   3.1A,B).	   Each	   gene	  
knockout	  of	  the	  KEIO	  collection	  still	  harbors	  the	  last	  21	  bases	  of	  the	  deleted	  gene,	  enabling	  an	  
easy	   and	   rather	   straightforward	   possibility	   of	   matching	   the	   amplified	   gene	   regions	   to	   the	  
respective	  gene	  deletions.	  The	  biological	  replicates	  showed	  a	  good	  agreement	  (R2	  0.87	  –	  0.99)	  
(Figure	  SII)	  and	  the	  1%	  and	  5%	  pools	  on	  each	  side	  of	  the	  dot	  plot	  have	  a	  huge	  overlap	  (Figure	  
3.2).	   A	   total	   of	   2,126	   individual	   deletion	  mutants	   were	   found	   in	   the	   library	   after	   growth	   in	  
minimal	   medium	   with	   galactose,	   which	   resembles	   more	   than	   56	   %	   of	   the	   whole	   KEIO	  
collection.	   We	   assume	   that	   those	   knockout	   mutants	   that	   do	   not	   appear	   in	   the	   library	   had	  
either	  not	  been	  transformed	  with	  pFlux	  or	  had	  too	  high	  fitness	  defect	  and	  were	  outcompeted	  
by	  the	  other	  strains	  during	  the	  initial	  growth	  of	  the	  cell	  library	  (Cao	  et	  al,	  2014).	  After	  coverage	  
and	  quality	  filtering,	  which	   is	  explained	  in	  chapter	  3.3.6,	  504	  genes	  remained.	  The	  504	  genes	  
were	   analyzed	   according	   to	   the	   similarity	   of	   their	   enrichment	   and	   depletion	   patterns	   in	   the	  
different	  pools	  compared	  to	  the	  total,	  unsorted	  library	  (Figure	  3.2).	  3	  gene	  deletions	  (∆ompC,	  
∆rpiA	  and	  ∆ynfH)	  were	  at	  least	  two	  times	  enriched	  in	  the	  high	  flux	  pools,	  while	  also	  depleted	  in	  
the	  low	  flux	  pool	  (Table	  SIX).	  OmpC	  is	  a	  porin	  in	  the	  outer	  membrane	  and	  forms	  non-­‐specific	  
pores,	  which	   allow	   the	   diffusion	   of	   small	   hydrophilic	  molecules	   across	   the	   outer	  membrane	  
(Heller	  &	  Wilson,	  1981)	  whereas	  YnfH	  is	  considered	  a	  subunit	  of	  a	  putative	  selenite	  reductase	  
(Guymer	  et	  al,	  2009).	  The	  deletions	  of	  ompC	  and	  ynfH	  have	  been	  shown	  to	  give	  E.	  coli	  a	  growth	  
benefit	   compared	   to	   the	   wild	   type	   in	   presence	   of	   antibiotics.	   In	   the	   case	   of	   OmpC,	   it	   was	  
tested	   with	   antibiotics	   of	   the	   ß-­‐lactam	   family	   (Liu	   et	   al,	   2012)	   and	   in	   the	   case	   of	   ∆ynfH	  




spectomycin	  directly	   (Vlasblom	  et	  al,	  2015).	  Hence,	  the	  higher	  flux	  phenotype	  of	  ∆ompC	  and	  
∆ynfH	  mutants	  in	  the	  presence	  of	  antibiotics	  compared	  to	  the	  overall	  knockout	  library	  and	  the	  





















Figure	  3.1)	  FlowSeq	  workflow.	   (A)	  Overview	  of	  the	  FACSSeq	  procedure.	   In	  the	  first	  step,	   the	  
deletion	  library	  is	  transformed	  with	  pFlux,	  followed	  by	  FACS	  and	  recovery	  in	  LB	  medium.	  In	  the	  
last	  step,	  the	  purified	  and	  enriched	  gene	  knockout	  regions	  are	  sequenced.	  (B)	  Dot	  plot	  of	  the	  
RFP	  and	  GFP	  signals	  of	  the	  KEIO	  library	  grown	  in	  5	  g/L	  galactose.	  The	  four	  shown	  gates	  were	  
used	  to	  sort	  the	  cells	  for	  their	  flux	  phenotype,	  sorting	  100,000	  cells	  into	  the	  1%	  and	  5%	  gates.	  
Additionally,	  a	  sample	  of	  1,000,000	  cells	  was	  collected,	  to	  determine	  the	  genetic	  composition	  










            	  

















	   	  
Figure	   3.2)	   Clustered	   heatmap	   of	  
the	   enriched	   and	   deprived	   genes	  
of	   the	   different	   glycolytic	   flux	  
phenotype	  pools,	  compared	  to	  the	  
total	   knockout	   library.	   Enrichment	  
is	   shown	   in	   red	   and	   depletion	   in	  
blue.	   The	   genes	   are	   sorted	  
according	   to	   their	   similarity	   in	  
enrichment	  and	  depletion	  patterns,	  
resulting	   in	   the	   cluster	   tree	   shown	  
on	   the	   left.	   The	   dotted	   line	  
indicates	   the	   complexity	   level	   that	  
was	  used	   in	   the	   further	  analysis	  as	  
the	   definition	   point	   for	   the	  
different	  clusters.	  	  
5%	   5%	  1%	   1%	  
low	  flux	  high	  flux	  




The	  remaining	  gene	  knockout	  strain	  with	  a	  significant	  high	  flux	  phenotype	  is	  ∆rpiA,	  which	  
encodes	   for	   the	   ribose-­‐5-­‐phosphate	   isomerase	   A.	   RpiA	   catalyzes	   the	   first	   step	   of	   the	   non-­‐
oxidative	   phase	   of	   the	   pentose	   phosphate	   pathway	   (PPP)	   and	   hence	   the	   step	   towards	   the	  
biosynthesis	  of	  nucleotides	  and	  aromatic	  amino	  acids	  (Skinner	  &	  Cooper,	  1971).	  We	  compared	  
the	  growth	  rates	  in	  a	  plate	  reader	  of	  ∆rpiA	  and	  the	  wild	  type	  strain	  on	  minimal	  medium	  with	  
glucose	  or	  galactose	  supplemented	  and	  could	  detect	  a	  significant	  growth	  difference	  between	  
∆rpiA	  and	  the	  wild	  type	  on	  galactose	  (∆rpiA	  0.308	  ±	  0.005	  h-­‐1	  and	  wt	  0.223	  ±	  0.006	  h-­‐1),	  and	  a	  
still	  observable	  advantage	  on	  glucose	  ((∆rpiA	  0.416	  ±	  0.052	  h-­‐1	  and	  wt	  0.362	  ±	  0.007	  h-­‐1).	  These	  
findings	  are	  surprising	  as	  a	  ∆rpiA	  mutant	  should	  not	  be	  able	  to	  grow	  on	  glucose	  (Sørensen	  &	  
Hove-­‐Jensen,	   1996)	   and	   possibly	   not	   on	   galactose.	   It	   is	   known	   that	   the	   isoenzyme	   RpiB	   is	  
capable	  of	  supplementing	  RpiA	  in	  a	  deletion	  strain,	  but	  the	  expression	  needs	  to	  be	  induced	  by	  
e.g.	  ribose	  and	  had	  been	  shown	  to	  be	  not	  active	  on	  glucose	  (Sørensen	  &	  Hove-­‐Jensen,	  1996).	  It	  
was	  generally	  considered	  a	  substituting	  enzyme	  of	  minor	  function,	  but	  recent	  studies	  of	  ∆rpiB	  
deletion	  strains	  have	   found	  surprisingly	  strong	  effects	  on	  biomass	  production.	  Kim	  and	  Reed	  
found	  that	  the	  ∆rpiB	  mutant	  had	  a	  30	  %	  decrease	  in	  biomass	  yield	  compared	  to	  the	  parental	  
strain	  (Kim	  &	  Reed,	  2012).	  In	  regard	  to	  our	  findings,	  this	  could	  mean	  that	  the	  ∆rpiA	  mutant	  has	  
an	  up-­‐regulation	  of	  RpiB	  expression,	   resulting	   in	   thus	   far	  uncharacterized	  positive	  effects	  on	  
the	   glycolytic	   flux.	   This	   hypothesis	   will	   need	   experimental	   evidence,	   but	   it	   makes	   the	  
isoenzymes	   RpiA	   and	   RpiB	   very	   interesting	   targets	   for	   further	   research	   on	   glycolytic	   flux	  
control	  and	  optimization.	  
To	   conclude,	   only	   one	   of	   the	   three	  most	   prominent	   knockout	  mutants	   with	   a	   high	   flux	  
phenotype	  could	  actually	  be	  an	   interesting	   candidate	   for	   further	   flux	   studies.	   The	  other	   two	  
candidates	  are	  having	  higher	  resistance	  against	  spectinomycin	  and	  hence	  a	  growth	  advantage	  
compared	   to	   the	  other	   strains.	   In	   total	  158	  genes	  were	   found	   to	  be	  connected	   to	  a	   low	   flux	  
phenotype,	   significantly	   depleted	   in	   the	   high	   GFP/RFP	   fraction	   and	   enriched	   in	   the	   low	  
GFP/RFP	   fraction	   (Figure	   3.2,	   Table	   SVIII)	   We	   could	   identify	   the	   deletion	   mutants	   of	   the	  
transcriptional	  regulators	  GalR	  and	  GalS	  in	  this	  fraction	  as	  positive	  controls.	  GalR	  and	  GalS	  take	  
part	   in	   the	   regulation	   of	   operons	   involved	   in	   transport	   and	   catabolism	   of	   D-­‐galactose	   in	  
presence	  of	  high	  galactose	  concentrations	  and	  under	  glucose	   limitation	   (Semsey	  et	  al,	   2007;	  
Weickert	  &	  Adhya,	  1992a).	   It	   is	   expected	   that	   the	  deletion	  of	   these	  genes	   leads	   to	  a	  drastic	  
reduction	   of	   the	   glycolytic	   flux	   when	   grown	   on	   galactose	   and	   therefore	   can	   be	   seen	   as	   a	  
validation	  of	  the	  applicability	  of	  the	  glycolytic	  flux	  biosensor	  in	  this	  experimental	  setup.	  
Additionally,	  a	  GO	  analysis	  of	  the	  158	  genes	  with	  the	  low	  flux	  phenotype	  was	  performed.	  A	  
GO	  analysis	  is	  helpful	  to	  give	  a	  global	  picture	  on	  which	  groups	  of	  genes	  with	  biologically	  related	  




functions	   are	   significantly	   enriched	   or	   depleted	   in	   a	   dataset,	   compared	   to	   the	   statistical	  
expectation.	  In	  detail,	  the	  corresponding	  data	  file	  for	  this	  GO	  analysis	  contains	  all	  genes	  of	  the	  
E.	   coli	   K12	   genome,	   grouped	   based	   on	   their	   biological	   function.	   An	   initial	   step	   uses	   the	  
observed	  gene	  coverage	   to	  calculate,	  how	  many	  genes	  are	  expected	  per	   functional	  group,	   if	  
the	  distribution	  was	  entirely	  random.	  In	  a	  second	  step,	  these	  expected	  numbers	  are	  compared	  
with	   the	   actual	   detected	   numbers	   of	   each	   group	   and	   the	   fold	   enrichment,	   compared	   to	  
expected	  count,	  and	   the	  statistical	   relevance	   is	   calculated.	   (Ashburner	  et	  al,	  2000;	  The	  Gene	  
Ontology	  Consortium,	  2014)	  	  
The	  GO	  analysis	  revealed	  that	  genes	  related	  to	  flagella	  machinery	  (7	  genes	  out	  of	  26)	  are	  
enriched	   more	   than	   five-­‐fold	   compared	   to	   what	   is	   expected	   (ρ	  =	  7.77x10-­‐06)	   in	   the	   low-­‐flux	  
phenotype	   clusters.	   Flagella	   are	   mainly	   responsible	   for	   chemotaxis	   and	   hence	   enable	   the	  
individual	  cells	  to	  move	  in	  direction	  of	  higher	  carbon	  source	  concentration	  (Eisenbach,	  2007).	  
Even	   though	   chemotaxis	   is	   necessary	   for	   the	   cells	   to	   obtain	   nutrients,	   this	   ability	   is	   not	   as	  
relevant	   in	   the	   continuous	   mixing	   conditions	   of	   this	   experiment.	   As	   flagella	   are	   a	   very	  
expensive	   machinery	   and	   compete	   with	   transporters	   for	   the	   proton	   gradient	   over	   the	   cell	  
membrane,	   it	  was	   shown	  previously	   that	   its	   expression	   is	   down	   regulated	   in	   glucose-­‐limited	  
fed-­‐batch	  cultivation	  (Lemuth	  et	  al,	  2008).	  Hence,	  deleting	  parts	  of	  the	  chemotaxis	  machinery	  
reduces	  the	  metabolic	  burden	  that	  is	  put	  upon	  the	  cell	  assumingly	  lowering	  the	  glucose	  drain	  
and	  hence	  the	  glycolytic	  flux	  (Martínez-­‐García	  et	  al,	  2014).	  	  
Another	  metabolic	  function	  significantly	  enriched	  was	  the	  galactitol	  metabolic	  pathway	  (4	  
genes	  out	  of	  7	   in	   the	  E.	  coli	   genome,	  ρ	  =	  4.63x10-­‐05).	  Gene	  deletions	   include	  gatA	   and	  gatC,	  
subunits	   of	   the	   galactitol/sorbitol	   PTS	   permease.	   Either,	   the	   transporter	   is	   also	   accepting	  
galactose	   to	   some	   extend	   and	   increasing	   the	   intracellular	   galactose	   concentration	   and	  
subsequently	   a	   deletion	   reduces	   the	   uptake	   and	   hence	   the	   flux,	   or	   galactitol,	   an	   alcohol	   of	  
galactose,	  is	  potentially	  present	  as	  a	  byproduct	  in	  the	  galactose	  solution	  taken	  up	  by	  the	  cells	  
and	  resulting	  in	  a	  higher	  overall	  flux.	  
The	  third	  enriched	  GO-­‐pathway	  was	  the	  glyoxylate	  pathway,	  including	  all	  necessary	  genes	  
(∆aceA,	  ∆aceB	  and	  ∆aceK)	  in	  the	  low	  flux	  phenotype.	  AceA	  and	  aceB,	  coding	  for	  isocitrate	  lyase	  
and	  malate	   synthase,	   respectively,	   are	   the	   two	   enzymes	   needed	   for	   a	   functional	   glyoxylate	  
pathway.	  AceK	  controls	  the	  branch	  point	  between	  the	  TCA	  cycle	  and	  the	  glyoxylate	  cycle,	  by	  
phosphorylation	   of	   the	   isocitrate	   dehydrogenase	   (ICD)	   and	   thereby	   modulation	   of	   the	   ICD	  
activity	  (LaPorte	  &	  Koshland,	  1982;	  Cortay	  et	  al,	  1988).	  A	  deletion	  of	  aceK	  results	   in	  constant	  
activation	  of	  the	  ICD	  and	  reduced	  glyoxylate	  pathway	  activity.	  As	  it	  was	  shown	  in	  previous	  13C	  
metabolic	   flux	  analysis	   (Haverkorn	  van	  Rijsewijk	  et	  al,	  2011),	   the	  glyoxylate	  shunt	   is	  having	  a	  




much	   stronger	   flux	   when	   E.	  coli	   is	   grown	   on	   galactose	   compared	   to	   glucose.	   The	   genes	  
involved	   in	   this	   process	   lead	   to	   an	   overall	   reduction	   of	   glycolytic	   flux	   when	   those	   cells	   are	  
grown	  on	  galactose.	  	  
It	   would	   be	   expected	   to	   find	   a	   large	   number	   of	   gene	   deletions	   related	   to	   the	   central	  
carbon	  metabolism,	  since	  many	  of	   these	  have	  a	  naturally	  huge	   impact	  on	   the	  glycolytic	   flux.	  
However,	   gene	   deletions	   in	   the	   central	   carbon	   metabolism	   are	   often	   lethal	   (e.g.	   eno,	   pgk,	  
gapA)	  and	  therefore	  not	  present	   in	   the	  KEIO	  collection	   (Baba	  et	  al,	  2006).	  Moreover,	  even	   if	  
the	  deletion	  is	  not	  directly	  lethal,	  it	  still	  results	  in	  a	  strong	  growth	  defect.	  Thus,	  those	  knockout	  
strains	  do	  not	  appear	  in	  the	  library	  (e.g.	  pgi,	  pfkA,	  tpiA),	  resulting	  in	  the	  decreased	  library	  size	  
and	  the	  low	  number	  of	  genes	  related	  to	  central	  metabolism	  appearing	  in	  the	  data	  sets.	  	  
Interestingly,	  many	  of	  the	  158	  gene	  deletion	  mutants	  in	  this	  low	  flux	  phenotype	  cluster	  are	  
either	   of	   unknown	   and	   putative	   functions	   or	   phage	   and	   prophage	   related.	   It	   is	   a	   very	  
remarkable	   finding	   that	   the	   deletion	   of	   phage	   and	   prophage	   genes	   results	   in	   an	   actual	  
decrease	  in	  glycolytic	  flux.	  It	  was	  previously	  shown	  that	  prophage	  genes	  are	  not	  always	  only	  a	  
silent	  cargo	  in	  the	  bacterial	  genome	  but	  can	  be	  highly	  expressed	  and	  change	  their	  expression	  
patterns	   in	   different	   conditions,	   especially	   in	   pathogens	   (Smoot	   et	   al,	   2001).	   This	   might	   be	  
related	   to	   the	   fact	   that	   prophage	   genes	   have	   been	   identified	   to	   give	   their	   host	   certain	  
advantages,	   even	   in	   the	   case	   of	   the	   laboratory	   strain	   E.	  coli	   K-­‐12	   (Barondess	   &	   Beckwith,	  
1990).	  The	  expression	  of	  the	  prophage	  gene	  bor	  significantly	  increases	  the	  survival	  of	  E.	  coli	  K-­‐
12	  on	  animal	  serum.	  Thus,	  it	  might	  very	  well	  be	  that	  these	  proteins	  give	  E.	  coli	  advantages	  that	  
are	  not	  yet	  described	  but	  would	  be	  very	   interesting	   to	  study	   further.	  The	  appearance	  of	   the	  
large	  number	  of	  genes	  with	  unknown	  and	  putative	  function	  is	  also	  interesting,	  as	  it	  highlights	  
again	   that	   there	   is	   still	   a	   large,	   so	   far	   uncharacterized,	   regulatory	   network	   in	   place.	   This	  
observation	  matches	  the	  recent	  findings	  of	  Hutchison	  et	  al.	  (2016).	  They	  could	  show	  that	  473	  
genes	  are	  required	  for	  a	  viable,	  synthetic	  minimal	  genome.	  Of	  those	  473	  genes,	  149	  genes	  are	  
of	   unknown	   function.	   Even	   though	   the	   exact	   function	   of	   these	   158	   gene	   knockouts	   is	   still	  
unknown,	  this	  list	  provides	  an	  interesting	  starting	  point	  for	  further,	  more	  targeted	  studies.	  
In	   regard	   to	   biotechnological	   applications,	   the	   identified	   gene	   knockouts	  with	   a	   low	   flux	  
phenotype	   are	   very	   interesting.	   These	   deletion	   strains	   showed	   a	   lower	   flux	   phenotype,	   but	  
were	  not	  outcompeted	  by	  growth	  rate.	  Therefore,	  these	  mutants	  could	  provide	  an	  additional	  
flux	  span	  that	  can	  be	  redirected	  towards	  the	  production	  process.	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Appendix	  –	  Chapter	  3	  
Table	  SVI)	  blastn	  parameters	  considered	  in	  the	  analysis	  of	  the	  FlowSeq	  data	  
Parameter	   Value	   Comment	  
word_size	   4	   To	  match	  small	  sequences	  
evalue	   1000	   To	  match	  small	  sequences	  
num_threads	   28	   To	  fully	  utilize	  the	  machine	  




Figure	  SII)	  Log	  scale	  dot	  plot	  of	  the	  individual	  gene	  coverage	  for	  the	  duplicates	  of	  the	  1	  %	  low	  
flux	   pool.	   Each	   dot	   represents	   one	   gene.	   The	   plot	   shows	   the	   raw	   numbers	   before	  
normalization.	  A	  linear	  regression	  line	  is	  presented	  with	  a	  R2	  of	  0.86699.	   	  
y	  =	  3.4922x	  +	  1.7496	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Figure	  SIII)	  Dendrogram	  of	   the	  different	  clusters.	  A	  threshold	  was	  set	   to	   identify	  10	  different	  
sub	   clusters	   (1-­‐10).	   Clusters	   representing	   a	   high	   flux	   phenotype	   are	   shown	   in	   red	   (5),	   and	  
clusters	  including	  deletion	  mutants	  with	  a	  low	  flux	  phenotype	  are	  shown	  in	  blue	  (2,	  3	  and	  8).	  	   	  




Table	   SVII)	   Cluster	   of	   unchanged	   genes,	   ordered	   by	   gene	   name.	   Clusters	   derived	   from	  


































































































































Table	  SVIII)	  Cluster	  containing	  genes	  with	  a	  low	  flux	  phenotype,	  ordered	  by	  1%	  low	  flux	  value.	  

























































































Table	  SIX)	  Cluster	  containing	  genes	  with	  a	  high	  flux	  phenotype,	  ordered	  by	  5%	  high	  flux	  value.	  
Clusters	  derived	  from	  dendrogram	  in	  Figure	  SIII.	  Genes	  that	  showed	  enrichment	   in	  both	  high	  





	   	  




Table	  SX)	  Growth	  rates	  of	   the	  E.	  coli	  BW25110	  wild	   type	  strain,	   the	  10	  knockout	  strains	   that	  
showed	  the	  highest	  enrichment	  in	  the	  low	  flux	  pools	  and	  the	  three	  knockout	  strains	  from	  the	  
high	  flux	  analysis.	  
	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Galactose	   Glucose	  
Deletion/	  
strain	  name	  
max	  growth	  rate	  
(h-­‐1)	  
OD600
a)	   max	  growth	  rate	  
(h-­‐1)	  
OD	  600b)	  
Wild	  type	   0.223	  ±	  0.006	   0.14	  ±	  0.044	   0.416	  ±	  0.052	   0.49	  ±	  0.16	  
Low	  flux	  pool	   	   	  
ybaL	   0.245	  ±	  0.001	   0.10	  ±	  0.001	   0.336	  ±	  0.044	   0.42	  ±	  0.25	  
yafT	   0.231	  ±	  0.009	   0.13	  ±	  0.01	   0.37	  ±	  0.039	   0.7	  ±	  0.24	  
yjjY	   0.269	  ±	  0.017	   0.09	  ±	  0.001	   0.483	  ±	  0.094	   0.67	  ±	  0.17	  
aceK	   0.215	  ±	  0.009	   0.13	  ±	  0.01	   0.344	  ±	  0.028	   0.84	  ±	  0.09	  
fliM	   0.203	  ±	  0.021	   0.10	  ±	  0.003	   0.379	  ±	  0.014	   0.75	  ±	  0.09	  
yedZ	   0.214	  ±	  0.009	   0.11	  ±	  0.004	   0.416	  ±	  0.021	   0.82	  ±	  0.13	  
gatC	   0.216	  ±	  0.000	   0.17	  ±	  0.06	   0.38	  ±	  0.023	   0.68	  ±	  0.21	  
nanK	   0.213	  ±	  0.000	   0.19	  ±	  0.21	   0.366	  ±	  0.028	   0.72	  ±	  0.2	  
adhP	   0.221	  ±	  0.007	   0.16	  ±	  0.02	   0.409	  ±	  0.04	   0.65	  ±	  0.23	  
rimJ	   0.225	  ±	  0.002	   0.11	  ±	  0.01	   0.285	  ±	  0.064	   0.54	  ±	  0.3	  
High	  flux	  pool	   	   	  
ompC	   0.356	  ±	  0.006	   0.51	  ±	  0.07	   0.295	  ±	  0.034	   0.46	  ±	  0.24	  
rpiA	   0.308	  ±	  0.005	   0.85	  ±	  0.44	   0.362	  ±	  0.007	   0.16	  ±	  0.04	  
ynfHc	   0.212	  ±	  0.007	   0.13	  ±	  0.02	   0.439	  ±	  0.035	   0.64	  ±	  0.14	  
	  
a)	  at	  16	  h	  









Figure	  S	  IV)	  Analysis	  of	  growth	  and	  fluorescence	  over	  time	  in	  a	  plate	  reader.	  To	  identify	  which	  
time	   point	   is	   suitable	   for	   screening	   by	   FACS	   at	   a	   single	   time	   point,	  we	   analyzed	   the	   growth	  
behavior	   and	   the	   GFP	   per	   OD	   in	   the	   wild	   type	   harboring	   pFlux	   growing	   in	   three	   different	  
carbon	   sources	   (glucose:	   green,	   glycerol:	   blue	   and	   pyruvate:	   red)	   ,	   and	   for	   the	   Δcra	  mutant	  
harboring	   pFlux	   in	   glucose	   (orange).	   (A)	   Growth	   profile	   of	   the	   different	   strains.	   (B)	   Specific	  












	   	  











	   	  




	   	  




4.1 Summary	  and	  conclusion	  
The	   aim	   of	   this	   study	   was	   to	   develop	   and	   characterize	   an	   improved	   glycolytic	   flux	  
biosensor	  and	  apply	  it	  in	  a	  high-­‐throughput	  screen	  to	  identify	  genes	  affected	  glycolytic	  flux	  in	  
E.	  coli.	  	  
	  
The	  glycolytic	  flux	  sensor	  is	  based	  on	  the	  E.	  coli	  transcription	  factor	  Cra,	  an	  idea	  originally	  
introduced	  by	  Kochanowski	  et	  al.	  in	  2013.	  	  In	  chapter	  2,	  the	  design	  of	  an	  improved	  biosensor	  is	  
described.	  The	   relative	  expression	  strengths	  of	   three	  native	  E.	   coli	  promoters	   (pykF,	  ppc	   and	  
ppsA)	   controlling	   the	   expression	   of	   GFP	   were	   compared	   under	   different	   conditions.	   The	  
expression	   levels	  of	  GFP	  when	  grown	  on	  glucose	  compared	  to	  galactose	  follow	  the	  expected	  
tendencies	  of	  a	  glycolytic	  flux	  reporter.	  It	  is	  expected	  that	  the	  signal	  intensity	  of	  the	  activated	  
promoter	   of	   ppsA	   increases	   with	   decreasing	   flux	   whereas	   the	   signal	   intensity	   of	   the	   two	  
repressed	  promoters	  pykF	  and	  ppc	  decreases	  with	  decreasing	  flux.	  Interestingly,	  the	  growth	  on	  
the	   gluconeogenic	   carbon	   source	   pyruvate	   resulted	   in	   the	   highest	   fluorescent	   signal	   for	   all	  
three	  cases.	  There	  is	  experimental	  evidence	  for	  the	  mode	  of	  action	  of	  the	  different	  promoters	  
(Bledig	  et	  al,	  1996b;	  Nègre	  et	  al,	  1998;	  Shimada	  et	  al,	  2011b),	  proving	  that	  the	  highest	  values	  
of	  pykF	  and	  ppc	  promoters	  in	  pyruvate	  must	  have	  another	  reason.	  It	  can	  be	  assumed	  that	  this	  
observed	   effect	   correlates	   with	   the	   highly	   different	   growth	   rates	   between	   glycolytic	   and	  
gluconeogenic	   carbon	   sources	   (Klumpp	   et	   al,	   2009).	   During	   bacterial	   cell	   division,	   the	  
intracellular	  fluorescent	  protein	  concentration	  is	  diluted.	  If	  a	  bacterial	  cell	  is	  growing	  fast,	  the	  
gfp	   production	   is	   not	   fast	   enough	   to	   compensate	   for	   this	   effect.	   In	   contrast,	   if	   the	   cells	   are	  
growing	   slow	   there	   is	  more	   time	   to	   accumulate	  gfp	   in	   the	   cells.	   This	   observed	   effect	  made	  
comparison	   of	   the	   promoters	   more	   difficult,	   as	   there	   was	   a	   definite	   bias	   in	   the	   data.	  
Nevertheless,	  ppsA	   appeared	   to	   be	   the	  most	   interesting	   candidate	   to	   proceed	   further,	   as	   it	  
showed	  the	  by	  far	  highest	  dynamic	  range	  additionally	  to	  a	  comparably	   low	  expression	   in	  the	  
OFF	  state	  (Glucose)	  (Figure	  2.1B).	  
	  
The	   effects	   of	   growth	   rates	   and	   possible	   other	   environmental	   effects	   emphasized	   the	  
necessity	   of	   an	   internal	   reference	   to	   create	   a	   biosensor	   with	   a	   reliable	   single	   cell	   output.	  
Kochanowski	   et	   al.	   applied	   an	   external	   control	   in	   which	   they	   compared	   the	   fluorescent	  
expression	  from	  a	  promoter	  with	  a	  native	  and	  a	  scrambled	  Cra	  binding	  site.	  This	  approach	  was	  
combined	  with	   a	   two-­‐colour	   screening	  method,	  which	   has	   been	  previously	   shown	  by	   Kosuri	  




and	   co-­‐workers	   to	   be	   a	   reliable	   setup	   for	   FACS	   experiments	   (Kosuri	   et	   al,	   2013),	   for	   the	  
construction	  of	  our	  final	  flux	  sensing	  plasmid	  (pFlux).	  	  
	  
pFlux	  was	  tested	  in	  different	  E.	  coli	  strains	  on	  gluconeogenic	  carbon	  sources,	  additionally	  
to	  the	  glycolytic	  carbon	  sources	  that	  were	  previously	  described	  in	  the	  study	  of	  Kochanowski	  et	  
al.	   The	   presented	   findings	   (Figure	   2.3)	   give	   a	   clear	   and	   consistent	   correlation	   between	  
different	   carbon	   sources,	   inducing	   different	   glycolytic	   fluxes,	   and	   Cra	   activity,	  monitored	   via	  
the	   fluorescence	   signal	   of	   the	   flux	   biosensor.	   It	   was	   furthermore	   possible	   to	   show	   that	   the	  
screening	  capabilities	  of	  pFlux	  exceed	  the	  normal,	  physiological	   range	  by	  using	   it	   to	  measure	  
the	   increased	  glycolytic	   flux	  during	  mevalonate	  production	   from	  pMevT	  (Martin	  et	  al,	  2003).	  
This	  characteristic	  of	  pFlux	  can	  be	  of	  high	  interest	  for	  further	  applications	  of	  this	  biosensor	  in	  
metabolic	   engineering,	   as	   an	   increase	   in	   total	   flux	   could	   be	   used	   to	   increase	   the	   flux	   in	   the	  
production	  pathway	  as	  well	  (LaCroix	  et	  al,	  2015).	  
	  
The	  presented	  findings	  in	  chapter	  2	  also	  support	  the	  claims	  of	  Kochanowski	  et	  al.	  that	  Cra	  
functions	  as	  a	  direct	  glycolytic	   flux	  sensor	   in	  E.	  coli,	  even	  though	   it	  has	  different	   functions	   in	  
other	   organism	   (Chavarría	   et	   al,	   2014).	   Nevertheless	   it	   needs	   to	   be	   noted	   that	   Cra,	   and	  
consequently	  pFlux,	  have	  limitations	  in	  the	  capabilities	  as	  flux	  sensors.	  We	  could	  show	  that	  the	  
growth	  on	  fructose	  resulted	  in	  the	  lowest	  signal	  ratio	  of	  GFP	  to	  RFP	  (Figure	  2.3),	  even	  though	  
fructose	   should	   not	   induce	   the	   highest	   glycolytic	   flux.	   However,	   this	   finding	   does	   not	   come	  
unexpected,	   as	   the	   affinity	   of	   Cra	   is	   actually	   higher	   for	   F1P,	   an	   intracellular	   metabolite	   of	  
fructose	  metabolism,	  than	  FBP	  (Ramseier	  et	  al,	  1993).	  Accordingly,	  it	  emphasises	  that	  the	  Cra	  
activity	   is	  actually	   controlled	  by	   the	  dynamic	  equilibrium	  between	  Cra,	   FBP	  and	  F1P	  and	  not	  
only	  the	  interaction	  between	  FBP	  and	  Cra.	  In	  most	  cases,	  the	  intracellular	  concentration	  of	  F1P	  
is	  negligible	  and	  the	  correlation	  between	  FBP	  and	  glycolytic	  flux	  can	  be	  assumed	  (Kochanowski	  
et	  al,	  2013).	  Nevertheless,	  it	  is	  important	  to	  keep	  this	  finding	  in	  mind	  when	  applying	  pFlux.	  
	  
Chapter	   3	   regards	   the	   application	   of	   pFlux	   in	   a	   large-­‐scale	   physiological	   study	   of	   E.	   coli	  
knockout	  mutants	  and	  their	  effect	  on	  the	  glycolytic	  flux.	  The	  aim	  is	  to	  use	  pFlux	  to	  enable	  rapid	  
identification	  of	  gene	  knockouts	  or	  potentially	  other	  genetic	  variants	  that	  affect	  glycolytic	  flux	  
in	   E.	   coli.	   Currently,	   it	   is	   not	   possible	   to	   obtain	   information	   about	   metabolic	   fluxes	   in	   high	  
throughput.	   Techniques	   such	   as	   13C	   flux	   analysis	   have	   high	   resolution	   and	   give	   detailed	  
information	  about	  the	  whole	   flux	  network,	  but	  are	  time	  consuming	  and	  thus	  the	  throughput	  
only	  allows	  screening	  of	  individually	  selected	  mutants	  (Fischer	  et	  al,	  2004;	  Crown	  et	  al,	  2015).	  




Depending	   on	   the	   application,	   established	   techniques	   give	   high-­‐resolution	   information	   of	  
different	   fluxes	   (Leighty	   &	   Antoniewicz,	   2013)	   in	   individual	   strains,	   whereas	   the	   Cra-­‐based	  
biosensor	   provides	   an	   opportunity	   to	   screen,	   compare	   and	   sort	   up	   to	   a	   theoretical	   105	  
different	  variants	  per	  second,	   limited	  by	   the	  current	  physical	   screening	  capacities	  of	  modern	  
flow	  cytometers	  and	  FACS	  instruments.	  	  
	  
In	   this	   study	  we	  have	   successfully	   screened	  a	   library	  of	  2,126	  E.	  coli	   deletion	  mutants	  of	  
the	  KEIO	  collection	  for	  their	  effects	  on	  the	  glycolytic	  flux	  when	  grown	  on	  galactose.	  The	  ∆rpiA	  
strain	   was	   one	   of	   the	   rare	   examples	   with	   a	   high	   flux	   phenotype	   and	   is	   furthermore	   a	   very	  
unexpected	  candidate	  for	  the	  increase	  of	  glycolytic	  flux.	  After	  further	  research,	  it	  appears	  that	  
these	   effects	   might	   correlate	   to	   an	   altered	   expression	   of	   RpiB,	   which	   has	   thus	   far	   been	  
considered	   a	   rather	   irrelevant	   enzyme	   (Sørensen	   &	   Hove-­‐Jensen,	   1996).	   In	   another	   more	  
recent	   study	   though,	   it	   already	   appeared	   that	   RpiB	   might	   have	   a	   larger	   impact	   on	   the	  
metabolism	   of	   E.	   coli	   as	   so	   far	   anticipated	   (Kim	   &	   Reed,	   2012),	   which	   is	   supported	   by	   our	  
findings.	  
In	  regard	  to	  the	  genes	  with	  a	  low	  flux	  phenotype,	  certain	  genes	  could	  be	  directly	  linked	  to	  
the	   galactose	  metabolism	   (galS,	  galR),	   which	   is	   a	   good	   indication	   that	   the	   allocation	   of	   the	  
genes	  in	  low	  and	  high	  flux	  pools	  correlates	  with	  the	  actual	  low	  and	  high	  flux	  state	  of	  the	  cells.	  
Additionally	  to	  the	  expected	  galactose	  metabolism	  genes,	  it	  could	  be	  shown	  that	  the	  deletion	  
of	   flagella	   related	   genes	   as	  well	   as	  many	   phage	   and	   prophage	   genes	   and	   genes	  with	   so	   far	  
unknown	   function	   result	   in	   a	   decreased	   glycolytic	   flux.	   As	   those	   deletion	   strains	   were	   not	  
outcompeted	  by	  the	  strains	  with	  little	  to	  no	  flux	  changes,	  the	  knockout	  of	  these	  genes	  seemed	  
not	  to	  cause	  a	  severe	  fitness	  defect,	  even	  though	  they	  had	  a	  decreased	  flux.	  This	  characteristic	  
of	   a	   low	   flux	   phenotype	  while	  maintaining	   a	   competitive	   fitness	  makes	   those	   strains	   highly	  
interesting	   for	   possible	   production	   strains,	   since	   those	   strains	   may	   have	   a	   lower	   metabolic	  
maintenance	   requirement	   compared	   to	   the	   wild	   type	   potentially	   enabling	   the	   direction	   of	  
more	  flux	  towards	  production	  objectives.	  	  
	  
	  
To	  summarize,	  the	  most	  important	  improvement	  of	  the	  here	  presented	  pFlux	  biosensor	  is	  
that	  it	  can	  be	  applied	  in	  flow	  cytometry	  and	  FACS	  experiments.	  This	  enables	  fast,	  easy,	  cheap	  
and	   parallelizable	   high-­‐throughput	   comparisons	   of	   glycolytic	   fluxes.	   Furthermore,	   the	  
application	   of	   pFlux	   in	   an	   explorative	   library	   screen	   successfully	   identified	   possible	   genetic	  
targets	  in	  order	  to	  improve	  future	  production	  strains.	  





In	  this	  PhD	  study	  the	  fully	  functional	  biosensor	  pFlux	  was	  developed,	  tested	  and	  applied	  to	  
study	   the	  effects	  of	   specific	   gene	  knockouts	  on	   the	   glycolytic	   flux	   in	  E.	   coli.	  An	   initial	   test	   in	  
combination	  with	   a	   production	  pathway	   and	   its	   application	   in	   a	   FlowSeq	  experiment	   gave	   a	  
first	  glimpse	  in	  the	  vast	  amount	  of	  possible	  applications	  pFlux	  can	  be	  used	  for.	  
	  
Based	  on	  the	  presented	  research	   in	  chapter	  2,	   the	  next	  steps	   in	  order	  to	  establish	  pFlux,	  
would	   be	   to	   apply	   it	   in	   an	   actual	   metabolic	   engineering	   approach,	   possibly	   for	   the	   further	  
development	  of	  the	  mevalonate	  pathway.	  More	  interestingly	  though,	  would	  be	  the	  integration	  
of	  the	  Cra	  biosensor	  together	  with	  a	  product	  sensor	  in	  a	  synthetic	  regulation	  circuit.	  
Initial	   steps	   have	   been	   taken	   in	   order	   to	   create	   a	   selection	   system	  based	   on	   Cra,	  which	  
could	  facilitate	  elaborated	  control	  circuits,	  which	  could	  for	  example	  be	  applied	   in	  production	  
processes.	  By	  detecting	  as	  well	  the	  state	  of	  the	  glycolytic	  flux	  as	  the	  expression	  level	  of	  a	  target	  
molecule,	  it	  could	  be	  possible	  to	  delete	  cells	  with	  no	  production	  but	  high	  growth	  rate	  from	  the	  
process,	  limiting	  the	  chances	  that	  the	  fermentation	  will	  be	  overgrown	  by	  bacteria	  that	  escaped	  
the	   production	   (Lieder	   et	   al,	   2014;	   Delvigne	  &	  Goffin,	   2014).	   It	   has	   been	   shown	   for	   several	  
different	   species	   and	   as	  well	   for	   the	   production	   of	   small	  molecules	   as	   for	   the	   expression	   of	  
whole	  proteins,	  that	  production	  strains	  tend	  to	  exit	  the	  production.	  	  
One	   of	   the	  main	   advantages	   of	   pFlux	   is	   that	   it	   is	   not	   product	   or	   pathway	   specific.	   The	  
applications	   of	   most	   current	   biotechnologically	   relevant	   biosensors	   focus	   on	   improving	   the	  
production	   of	   one	   specific	   target	   or	   a	   group	   of	   structurally	   related	   targets	   like	   for	   example	  
fatty	  acids	  (Xu	  et	  al,	  2014).	  pFlux,	  however,	  is	  highly	  versatile	  as	  it	  can	  be	  applied	  in	  any	  study	  
that	   targets	   or	   involves	   the	   glycolytic	   flux	   in	   E.	   coli.	   Recent	   research	   on	   host	   orthogonality	  
proved	   the	   possibility	   to	   not	   only	   successfully	   transfer	   repressors,	   but	   also	   activators	   from	  
E.	  coli	  to	  yeast	  (Skjoedt	  et	  al,	  2016).	  Especially	  due	  to	  the	  application	  versatility	  of	  Cra,	  it	  could	  
be	   a	   very	   interesting	   candidate	   for	   further	   developments	   in	   yeast,	   also	   because	   no	   similar	  
regulation	  mechanism	  is	  known	  yet	  in	  yeast.	  	  
	  
In	   regards	   to	   chapter	   3,	   the	   next	   step	  will	   be	   to	   apply	   the	   identified	  mutants	   for	   actual	  
expression	  pathways	  in	  order	  to	  validate	  the	  increase	  in	  yield	  or	  productivity.	  A	  very	  promising	  
candidate	  would	  be	  the	  deletion	  of	  flagella,	  as	  this	  production	  of	  flagella	  is	  very	  costly	  and	  not	  
necessary	  in	  a	  stirred	  fermenter.	  It	  will	  be	  interesting	  to	  see,	  whether	  the	  lower	  house	  keeping	  
demand	  will	  actually	  result	   in	  a	  higher	  production	  phenotype.	  Additionally,	  the	  ∆rpiA	  mutant	  




requires	   further	   studies	   in	   order	   to	   explore	   the	   causes	   for	   the	   very	   and	   unexpected	   high	  
growth	   rates.	  A	   sequence	  analysis	  of	   the	  ∆rpiA	   genome	  could	   reveal	  mutations	  and	  possibly	  
support	   the	   hypothesis	   that	   RpiB	   plays	   a	   way	   more	   important	   role	   than	   thus	   far	   expected	  
(Sørensen	  &	  Hove-­‐Jensen,	  1996;	  Kim	  &	  Reed,	  2012).	  
Another	  logical	  follow-­‐up	  experiment	  would	  be	  the	  screening	  of	  an	  overexpression	  library	  
as	  for	  example	  the	  ASKA	  collection	  (Kitagawa	  et	  al,	  2006),	  in	  order	  to	  see	  how	  those	  effect	  the	  
glycolytic	  flux.	  Besides	  finding	  other	  possible	  candidates	  for	  biotechnology,	  it	  would	  be	  highly	  
interesting	  to	  see	  the	  correlations	  between	  the	  effects	  when	  a	  gene	  is	  knocked	  out	  compared	  
to	  being	  overexpressed.	  Matching	  both	  data	   sets	   could	  help	   to	  decide	  which	  of	   the	   thus	   far	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The	  results	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  in	  chapter	  2	  and	  3	  were	  presented	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  results	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  chapter	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  3.	  
**)	  	   Only	  minor	  contributions;	  results	  from	  this	  publication	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  considered	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  thesis.	  	  
